id	sid	tid	token	lemma	pos
ajlm-2613	1	1	abstract	abstract	ADJ
ajlm-2613	1	2	introduction	introduction	NOUN
ajlm-2613	1	3	methods	method	NOUN
ajlm-2613	1	4	results	result	VERB
ajlm-2613	1	5	discussion	discussion	NOUN
ajlm-2613	1	6	acknowledgements	acknowledgement	NOUN
ajlm-2613	1	7	references	reference	NOUN
ajlm-2613	1	8	about	about	ADP
ajlm-2613	1	9	the	the	DET
ajlm-2613	1	10	author(s	author(s	NOUN
ajlm-2613	1	11	)	)	PUNCT
ajlm-2613	1	12	abdulrazaq	abdulrazaq	PROPN
ajlm-2613	1	13	a.	a.	PROPN
ajlm-2613	1	14	jimoh	jimoh	PROPN
ajlm-2613	1	15	department	department	PROPN
ajlm-2613	1	16	of	of	ADP
ajlm-2613	1	17	anatomic	anatomic	ADJ
ajlm-2613	1	18	pathology	pathology	NOUN
ajlm-2613	1	19	and	and	CCONJ
ajlm-2613	1	20	forensic	forensic	ADJ
ajlm-2613	1	21	medicine	medicine	NOUN
ajlm-2613	1	22	,	,	PUNCT
ajlm-2613	1	23	faculty	faculty	NOUN
ajlm-2613	1	24	of	of	ADP
ajlm-2613	1	25	basic	basic	ADJ
ajlm-2613	1	26	clinical	clinical	ADJ
ajlm-2613	1	27	sciences	science	NOUN
ajlm-2613	1	28	,	,	PUNCT
ajlm-2613	1	29	federal	federal	ADJ
ajlm-2613	1	30	university	university	PROPN
ajlm-2613	1	31	of	of	ADP
ajlm-2613	1	32	health	health	PROPN
ajlm-2613	1	33	sciences	sciences	PROPN
ajlm-2613	1	34	,	,	PUNCT
ajlm-2613	1	35	azare	azare	NOUN
ajlm-2613	1	36	,	,	PUNCT
ajlm-2613	1	37	nigeria	nigeria	PROPN
ajlm-2613	1	38	zainab	zainab	PROPN
ajlm-2613	1	39	a.	a.	PROPN
ajlm-2613	1	40	adamu	adamu	PROPN
ajlm-2613	1	41	department	department	PROPN
ajlm-2613	1	42	of	of	ADP
ajlm-2613	1	43	pathology	pathology	PROPN
ajlm-2613	1	44	,	,	PUNCT
ajlm-2613	1	45	faculty	faculty	NOUN
ajlm-2613	1	46	of	of	ADP
ajlm-2613	1	47	basic	basic	ADJ
ajlm-2613	1	48	clinical	clinical	ADJ
ajlm-2613	1	49	sciences	science	NOUN
ajlm-2613	1	50	,	,	PUNCT
ajlm-2613	1	51	ahmadu	ahmadu	PROPN
ajlm-2613	1	52	bello	bello	PROPN
ajlm-2613	1	53	university	university	PROPN
ajlm-2613	1	54	,	,	PUNCT
ajlm-2613	1	55	kaduna	kaduna	PROPN
ajlm-2613	1	56	,	,	PUNCT
ajlm-2613	1	57	nigeria	nigeria	PROPN
ajlm-2613	1	58	mumini	mumini	PROPN
ajlm-2613	1	59	w.	w.	PROPN
ajlm-2613	1	60	rasheed	rasheed	PROPN
ajlm-2613	1	61	department	department	PROPN
ajlm-2613	1	62	of	of	ADP
ajlm-2613	1	63	anatomic	anatomic	ADJ
ajlm-2613	1	64	pathology	pathology	NOUN
ajlm-2613	1	65	,	,	PUNCT
ajlm-2613	1	66	faculty	faculty	NOUN
ajlm-2613	1	67	of	of	ADP
ajlm-2613	1	68	basic	basic	ADJ
ajlm-2613	1	69	clinical	clinical	ADJ
ajlm-2613	1	70	sciences	science	NOUN
ajlm-2613	1	71	,	,	PUNCT
ajlm-2613	1	72	federal	federal	ADJ
ajlm-2613	1	73	university	university	NOUN
ajlm-2613	1	74	dutse	dutse	NOUN
ajlm-2613	1	75	,	,	PUNCT
ajlm-2613	1	76	jigawa	jigawa	PROPN
ajlm-2613	1	77	,	,	PUNCT
ajlm-2613	1	78	nigeria	nigeria	PROPN
ajlm-2613	1	79	samuel	samuel	PROPN
ajlm-2613	1	80	k.	k.	PROPN
ajlm-2613	1	81	richard	richard	PROPN
ajlm-2613	1	82	department	department	PROPN
ajlm-2613	1	83	of	of	ADP
ajlm-2613	1	84	pathology	pathology	PROPN
ajlm-2613	1	85	,	,	PUNCT
ajlm-2613	1	86	faculty	faculty	NOUN
ajlm-2613	1	87	of	of	ADP
ajlm-2613	1	88	basic	basic	ADJ
ajlm-2613	1	89	clinical	clinical	ADJ
ajlm-2613	1	90	sciences	science	NOUN
ajlm-2613	1	91	,	,	PUNCT
ajlm-2613	1	92	university	university	NOUN
ajlm-2613	1	93	of	of	ADP
ajlm-2613	1	94	abuja	abuja	PROPN
ajlm-2613	1	95	,	,	PUNCT
ajlm-2613	1	96	gwagwalada	gwagwalada	PROPN
ajlm-2613	1	97	,	,	PUNCT
ajlm-2613	1	98	abuja	abuja	PROPN
ajlm-2613	1	99	,	,	PUNCT
ajlm-2613	1	100	nigeria	nigeria	PROPN
ajlm-2613	1	101	citation	citation	PROPN
ajlm-2613	1	102	jimoh	jimoh	PROPN
ajlm-2613	1	103	aa	aa	PROPN
ajlm-2613	1	104	,	,	PUNCT
ajlm-2613	1	105	adamu	adamu	PROPN
ajlm-2613	1	106	za	za	PROPN
ajlm-2613	1	107	,	,	PUNCT
ajlm-2613	1	108	rasheed	rasheed	NOUN
ajlm-2613	1	109	mw	mw	PROPN
ajlm-2613	1	110	,	,	PUNCT
ajlm-2613	1	111	richard	richard	PROPN
ajlm-2613	1	112	sk	sk	PROPN
ajlm-2613	1	113	.	.	PROPN
ajlm-2613	1	114	expression	expression	NOUN
ajlm-2613	1	115	of	of	ADP
ajlm-2613	1	116	cyclooxygenase-2	cyclooxygenase-2	NUM
ajlm-2613	1	117	(	(	PUNCT
ajlm-2613	1	118	cox-2	cox-2	NOUN
ajlm-2613	1	119	)	)	PUNCT
ajlm-2613	1	120	in	in	ADP
ajlm-2613	1	121	colorectal	colorectal	ADJ
ajlm-2613	1	122	adenoma	adenoma	NOUN
ajlm-2613	1	123	in	in	ADP
ajlm-2613	1	124	an	an	DET
ajlm-2613	1	125	indigenous	indigenous	ADJ
ajlm-2613	1	126	african	african	ADJ
ajlm-2613	1	127	population	population	NOUN
ajlm-2613	1	128	in	in	ADP
ajlm-2613	1	129	northern	northern	PROPN
ajlm-2613	1	130	nigeria	nigeria	PROPN
ajlm-2613	1	131	.	.	PUNCT
ajlm-2613	2	1	afr	afr	PROPN
ajlm-2613	2	2	j	j	PROPN
ajlm-2613	2	3	lab	lab	PROPN
ajlm-2613	2	4	med	med	PROPN
ajlm-2613	2	5	.	.	PUNCT
ajlm-2613	3	1	2025;14(1	2025;14(1	NUM
ajlm-2613	3	2	)	)	PUNCT
ajlm-2613	3	3	,	,	PUNCT
ajlm-2613	3	4	a2613	a2613	PROPN
ajlm-2613	3	5	.	.	PROPN
ajlm-2613	3	6	https://doi.org/10.4102/ajlm.v14i1.2613	https://doi.org/10.4102/ajlm.v14i1.2613	NUM
ajlm-2613	3	7	original	original	ADJ
ajlm-2613	3	8	research	research	NOUN
ajlm-2613	3	9	expression	expression	NOUN
ajlm-2613	3	10	of	of	ADP
ajlm-2613	3	11	cyclooxygenase-2	cyclooxygenase-2	NUM
ajlm-2613	3	12	(	(	PUNCT
ajlm-2613	3	13	cox-2	cox-2	NOUN
ajlm-2613	3	14	)	)	PUNCT
ajlm-2613	3	15	in	in	ADP
ajlm-2613	3	16	colorectal	colorectal	ADJ
ajlm-2613	3	17	adenoma	adenoma	NOUN
ajlm-2613	3	18	in	in	ADP
ajlm-2613	3	19	an	an	DET
ajlm-2613	3	20	indigenous	indigenous	ADJ
ajlm-2613	3	21	african	african	ADJ
ajlm-2613	3	22	population	population	NOUN
ajlm-2613	3	23	in	in	ADP
ajlm-2613	3	24	northern	northern	PROPN
ajlm-2613	3	25	nigeria	nigeria	PROPN
ajlm-2613	3	26	abdulrazaq	abdulrazaq	PROPN
ajlm-2613	3	27	a.	a.	PROPN
ajlm-2613	3	28	jimoh	jimoh	PROPN
ajlm-2613	3	29	,	,	PUNCT
ajlm-2613	3	30	zainab	zainab	PROPN
ajlm-2613	3	31	a.	a.	PROPN
ajlm-2613	3	32	adamu	adamu	PROPN
ajlm-2613	3	33	,	,	PUNCT
ajlm-2613	3	34	mumini	mumini	PROPN
ajlm-2613	3	35	w.	w.	PROPN
ajlm-2613	3	36	rasheed	rasheed	PROPN
ajlm-2613	3	37	,	,	PUNCT
ajlm-2613	3	38	samuel	samuel	PROPN
ajlm-2613	3	39	k.	k.	PROPN
ajlm-2613	3	40	richard	richard	PROPN
ajlm-2613	3	41	received	receive	VERB
ajlm-2613	3	42	:	:	PUNCT
ajlm-2613	3	43	24	24	NUM
ajlm-2613	3	44	aug	aug	PROPN
ajlm-2613	3	45	.	.	PROPN
ajlm-2613	3	46	2024	2024	NUM
ajlm-2613	3	47	;	;	PUNCT
ajlm-2613	3	48	accepted	accept	VERB
ajlm-2613	3	49	:	:	PUNCT
ajlm-2613	3	50	07	07	NUM
ajlm-2613	3	51	apr	apr	NOUN
ajlm-2613	3	52	.	.	PUNCT
ajlm-2613	3	53	2025	2025	NUM
ajlm-2613	3	54	;	;	PUNCT
ajlm-2613	3	55	published	publish	VERB
ajlm-2613	3	56	:	:	PUNCT
ajlm-2613	3	57	30	30	NUM
ajlm-2613	3	58	july	july	NOUN
ajlm-2613	3	59	2025	2025	NUM
ajlm-2613	3	60	copyright	copyright	NOUN
ajlm-2613	3	61	:	:	PUNCT
ajlm-2613	3	62	©	©	PROPN
ajlm-2613	3	63	2025	2025	NUM
ajlm-2613	3	64	.	.	PUNCT
ajlm-2613	4	1	the	the	DET
ajlm-2613	4	2	author(s	author(s	PROPN
ajlm-2613	4	3	)	)	PUNCT
ajlm-2613	4	4	.	.	PUNCT
ajlm-2613	5	1	licensee	licensee	NOUN
ajlm-2613	5	2	:	:	PUNCT
ajlm-2613	5	3	aosis	aosis	NOUN
ajlm-2613	5	4	.	.	PUNCT
ajlm-2613	6	1	this	this	PRON
ajlm-2613	6	2	is	be	AUX
ajlm-2613	6	3	an	an	DET
ajlm-2613	6	4	open	open	ADJ
ajlm-2613	6	5	access	access	NOUN
ajlm-2613	6	6	article	article	NOUN
ajlm-2613	6	7	distributed	distribute	VERB
ajlm-2613	6	8	under	under	ADP
ajlm-2613	6	9	the	the	DET
ajlm-2613	6	10	terms	term	NOUN
ajlm-2613	6	11	of	of	ADP
ajlm-2613	6	12	the	the	DET
ajlm-2613	6	13	creative	creative	ADJ
ajlm-2613	6	14	commons	common	NOUN
ajlm-2613	6	15	attribution	attribution	NOUN
ajlm-2613	6	16	license	license	NOUN
ajlm-2613	6	17	,	,	PUNCT
ajlm-2613	6	18	which	which	PRON
ajlm-2613	6	19	permits	permit	VERB
ajlm-2613	6	20	unrestricted	unrestricted	ADJ
ajlm-2613	6	21	use	use	NOUN
ajlm-2613	6	22	,	,	PUNCT
ajlm-2613	6	23	distribution	distribution	NOUN
ajlm-2613	6	24	,	,	PUNCT
ajlm-2613	6	25	and	and	CCONJ
ajlm-2613	6	26	reproduction	reproduction	NOUN
ajlm-2613	6	27	in	in	ADP
ajlm-2613	6	28	any	any	DET
ajlm-2613	6	29	medium	medium	NOUN
ajlm-2613	6	30	,	,	PUNCT
ajlm-2613	6	31	provided	provide	VERB
ajlm-2613	6	32	the	the	DET
ajlm-2613	6	33	original	original	ADJ
ajlm-2613	6	34	work	work	NOUN
ajlm-2613	6	35	is	be	AUX
ajlm-2613	6	36	properly	properly	ADV
ajlm-2613	6	37	cited	cite	VERB
ajlm-2613	6	38	.	.	PUNCT
ajlm-2613	7	1	abstract	abstract	ADJ
ajlm-2613	7	2	background	background	NOUN
ajlm-2613	7	3	:	:	PUNCT
ajlm-2613	7	4	the	the	DET
ajlm-2613	7	5	clinical	clinical	ADJ
ajlm-2613	7	6	significance	significance	NOUN
ajlm-2613	7	7	of	of	ADP
ajlm-2613	7	8	adenoma	adenoma	ADJ
ajlm-2613	7	9	is	be	AUX
ajlm-2613	7	10	as	as	ADP
ajlm-2613	7	11	a	a	DET
ajlm-2613	7	12	result	result	NOUN
ajlm-2613	7	13	of	of	ADP
ajlm-2613	7	14	being	be	AUX
ajlm-2613	7	15	a	a	DET
ajlm-2613	7	16	precancerous	precancerous	ADJ
ajlm-2613	7	17	lesion	lesion	NOUN
ajlm-2613	7	18	with	with	ADP
ajlm-2613	7	19	long	long	ADJ
ajlm-2613	7	20	latency	latency	NOUN
ajlm-2613	7	21	,	,	PUNCT
ajlm-2613	7	22	harbouring	harbouring	NOUN
ajlm-2613	7	23	of	of	ADP
ajlm-2613	7	24	invasive	invasive	ADJ
ajlm-2613	7	25	carcinoma	carcinoma	NOUN
ajlm-2613	7	26	,	,	PUNCT
ajlm-2613	7	27	bearing	bear	VERB
ajlm-2613	7	28	similar	similar	ADJ
ajlm-2613	7	29	clinical	clinical	ADJ
ajlm-2613	7	30	features	feature	NOUN
ajlm-2613	7	31	with	with	ADP
ajlm-2613	7	32	colorectal	colorectal	ADJ
ajlm-2613	7	33	cancer	cancer	NOUN
ajlm-2613	7	34	,	,	PUNCT
ajlm-2613	7	35	and	and	CCONJ
ajlm-2613	7	36	as	as	ADP
ajlm-2613	7	37	part	part	NOUN
ajlm-2613	7	38	of	of	ADP
ajlm-2613	7	39	hereditary	hereditary	ADJ
ajlm-2613	7	40	colorectal	colorectal	ADJ
ajlm-2613	7	41	cancer	cancer	NOUN
ajlm-2613	7	42	syndromes	syndrome	NOUN
ajlm-2613	7	43	.	.	PUNCT
ajlm-2613	8	1	over	over	ADP
ajlm-2613	8	2	-	-	PUNCT
ajlm-2613	8	3	expression	expression	NOUN
ajlm-2613	8	4	of	of	ADP
ajlm-2613	8	5	the	the	DET
ajlm-2613	8	6	cyclooxygenase-2	cyclooxygenase-2	NUM
ajlm-2613	8	7	(	(	PUNCT
ajlm-2613	8	8	cox-2	cox-2	NOUN
ajlm-2613	8	9	)	)	PUNCT
ajlm-2613	8	10	enzyme	enzyme	NOUN
ajlm-2613	8	11	has	have	AUX
ajlm-2613	8	12	been	be	AUX
ajlm-2613	8	13	noticed	notice	VERB
ajlm-2613	8	14	in	in	ADP
ajlm-2613	8	15	adenomas	adenoma	NOUN
ajlm-2613	8	16	with	with	ADP
ajlm-2613	8	17	unfavourable	unfavourable	ADJ
ajlm-2613	8	18	features	feature	NOUN
ajlm-2613	8	19	.	.	PUNCT
ajlm-2613	9	1	however	however	ADV
ajlm-2613	9	2	,	,	PUNCT
ajlm-2613	9	3	this	this	DET
ajlm-2613	9	4	information	information	NOUN
ajlm-2613	9	5	is	be	AUX
ajlm-2613	9	6	limited	limit	VERB
ajlm-2613	9	7	in	in	ADP
ajlm-2613	9	8	africa	africa	PROPN
ajlm-2613	9	9	.	.	PUNCT
ajlm-2613	10	1	objective	objective	NOUN
ajlm-2613	10	2	:	:	PUNCT
ajlm-2613	10	3	this	this	DET
ajlm-2613	10	4	study	study	NOUN
ajlm-2613	10	5	aimed	aim	VERB
ajlm-2613	10	6	to	to	PART
ajlm-2613	10	7	assess	assess	VERB
ajlm-2613	10	8	the	the	DET
ajlm-2613	10	9	proportion	proportion	NOUN
ajlm-2613	10	10	of	of	ADP
ajlm-2613	10	11	adenomas	adenoma	NOUN
ajlm-2613	10	12	in	in	ADP
ajlm-2613	10	13	northern	northern	PROPN
ajlm-2613	10	14	nigeria	nigeria	PROPN
ajlm-2613	10	15	that	that	SCONJ
ajlm-2613	10	16	over	over	ADP
ajlm-2613	10	17	-	-	PUNCT
ajlm-2613	10	18	express	express	VERB
ajlm-2613	10	19	cox-2	cox-2	NOUN
ajlm-2613	10	20	.	.	PUNCT
ajlm-2613	11	1	methods	method	NOUN
ajlm-2613	11	2	:	:	PUNCT
ajlm-2613	11	3	this	this	DET
ajlm-2613	11	4	5	5	NUM
ajlm-2613	11	5	-	-	PUNCT
ajlm-2613	11	6	year	year	NOUN
ajlm-2613	11	7	retrospective	retrospective	NOUN
ajlm-2613	11	8	,	,	PUNCT
ajlm-2613	11	9	descriptive	descriptive	ADJ
ajlm-2613	11	10	,	,	PUNCT
ajlm-2613	11	11	hospital	hospital	NOUN
ajlm-2613	11	12	-	-	PUNCT
ajlm-2613	11	13	based	base	VERB
ajlm-2613	11	14	study	study	NOUN
ajlm-2613	11	15	examined	examine	VERB
ajlm-2613	11	16	the	the	DET
ajlm-2613	11	17	cox-2	cox-2	ADJ
ajlm-2613	11	18	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2613	11	19	of	of	ADP
ajlm-2613	11	20	all	all	DET
ajlm-2613	11	21	histologically	histologically	ADV
ajlm-2613	11	22	diagnosed	diagnose	VERB
ajlm-2613	11	23	colorectal	colorectal	ADJ
ajlm-2613	11	24	adenomas	adenoma	NOUN
ajlm-2613	11	25	in	in	ADP
ajlm-2613	11	26	aminu	aminu	PROPN
ajlm-2613	11	27	kano	kano	PROPN
ajlm-2613	11	28	teaching	teaching	PROPN
ajlm-2613	11	29	hospital	hospital	PROPN
ajlm-2613	11	30	,	,	PUNCT
ajlm-2613	11	31	kano	kano	PROPN
ajlm-2613	11	32	,	,	PUNCT
ajlm-2613	11	33	nigeria	nigeria	PROPN
ajlm-2613	11	34	,	,	PUNCT
ajlm-2613	11	35	between	between	ADP
ajlm-2613	11	36	01	01	NUM
ajlm-2613	11	37	january	january	PROPN
ajlm-2613	11	38	2015	2015	NUM
ajlm-2613	11	39	and	and	CCONJ
ajlm-2613	11	40	31	31	NUM
ajlm-2613	11	41	december	december	PROPN
ajlm-2613	11	42	2019	2019	NUM
ajlm-2613	11	43	.	.	PUNCT
ajlm-2613	12	1	age	age	NOUN
ajlm-2613	12	2	,	,	PUNCT
ajlm-2613	12	3	sex	sex	NOUN
ajlm-2613	12	4	,	,	PUNCT
ajlm-2613	12	5	site	site	NOUN
ajlm-2613	12	6	,	,	PUNCT
ajlm-2613	12	7	diagnosis	diagnosis	NOUN
ajlm-2613	12	8	,	,	PUNCT
ajlm-2613	12	9	and	and	CCONJ
ajlm-2613	12	10	grade	grade	NOUN
ajlm-2613	12	11	were	be	AUX
ajlm-2613	12	12	obtained	obtain	VERB
ajlm-2613	12	13	from	from	ADP
ajlm-2613	12	14	the	the	DET
ajlm-2613	12	15	kano	kano	PROPN
ajlm-2613	12	16	cancer	cancer	NOUN
ajlm-2613	12	17	registry	registry	NOUN
ajlm-2613	12	18	and	and	CCONJ
ajlm-2613	12	19	slide	slide	NOUN
ajlm-2613	12	20	reviews	review	NOUN
ajlm-2613	12	21	of	of	ADP
ajlm-2613	12	22	cases	case	NOUN
ajlm-2613	12	23	.	.	PUNCT
ajlm-2613	13	1	results	result	NOUN
ajlm-2613	13	2	:	:	PUNCT
ajlm-2613	13	3	there	there	PRON
ajlm-2613	13	4	were	be	VERB
ajlm-2613	13	5	cases	case	NOUN
ajlm-2613	13	6	of	of	ADP
ajlm-2613	13	7	29	29	NUM
ajlm-2613	13	8	adenoma	adenoma	ADJ
ajlm-2613	13	9	(	(	PUNCT
ajlm-2613	13	10	male	male	NOUN
ajlm-2613	13	11	,	,	PUNCT
ajlm-2613	13	12	n	n	NOUN
ajlm-2613	13	13	=	=	SYM
ajlm-2613	13	14	20	20	NUM
ajlm-2613	13	15	;	;	PUNCT
ajlm-2613	13	16	female	female	NOUN
ajlm-2613	13	17	,	,	PUNCT
ajlm-2613	13	18	n	n	NOUN
ajlm-2613	13	19	=	=	NOUN
ajlm-2613	13	20	9	9	NUM
ajlm-2613	13	21	)	)	PUNCT
ajlm-2613	13	22	.	.	PUNCT
ajlm-2613	14	1	adenoma	adenoma	ADV
ajlm-2613	14	2	occurred	occur	VERB
ajlm-2613	14	3	more	more	ADV
ajlm-2613	14	4	commonly	commonly	ADV
ajlm-2613	14	5	among	among	ADP
ajlm-2613	14	6	male	male	ADJ
ajlm-2613	14	7	patients	patient	NOUN
ajlm-2613	14	8	(	(	PUNCT
ajlm-2613	14	9	m	m	NOUN
ajlm-2613	14	10	:	:	PUNCT
ajlm-2613	14	11	f	f	X
ajlm-2613	14	12	,	,	PUNCT
ajlm-2613	14	13	2.2:1	2.2:1	NUM
ajlm-2613	14	14	)	)	PUNCT
ajlm-2613	14	15	,	,	PUNCT
ajlm-2613	14	16	in	in	ADP
ajlm-2613	14	17	the	the	DET
ajlm-2613	14	18	age	age	NOUN
ajlm-2613	14	19	group	group	NOUN
ajlm-2613	14	20	40–79	40–79	ADV
ajlm-2613	14	21	years	year	NOUN
ajlm-2613	14	22	,	,	PUNCT
ajlm-2613	14	23	and	and	CCONJ
ajlm-2613	14	24	included	include	VERB
ajlm-2613	14	25	tubular	tubular	ADJ
ajlm-2613	14	26	adenomas	adenoma	NOUN
ajlm-2613	14	27	(	(	PUNCT
ajlm-2613	14	28	62.1	62.1	NUM
ajlm-2613	14	29	%	%	NOUN
ajlm-2613	14	30	)	)	PUNCT
ajlm-2613	14	31	,	,	PUNCT
ajlm-2613	14	32	tubulovillous	tubulovillous	ADJ
ajlm-2613	14	33	adenomas	adenoma	NOUN
ajlm-2613	14	34	(	(	PUNCT
ajlm-2613	14	35	27.6	27.6	NUM
ajlm-2613	14	36	%	%	NOUN
ajlm-2613	14	37	)	)	PUNCT
ajlm-2613	14	38	,	,	PUNCT
ajlm-2613	14	39	and	and	CCONJ
ajlm-2613	14	40	villous	villous	ADJ
ajlm-2613	14	41	adenomas	adenoma	NOUN
ajlm-2613	14	42	(	(	PUNCT
ajlm-2613	14	43	10.3	10.3	NUM
ajlm-2613	14	44	%	%	NOUN
ajlm-2613	14	45	)	)	PUNCT
ajlm-2613	14	46	.	.	PUNCT
ajlm-2613	15	1	over	over	ADP
ajlm-2613	15	2	-	-	PUNCT
ajlm-2613	15	3	expression	expression	NOUN
ajlm-2613	15	4	of	of	ADP
ajlm-2613	15	5	cox-2	cox-2	NUM
ajlm-2613	15	6	was	be	AUX
ajlm-2613	15	7	observed	observe	VERB
ajlm-2613	15	8	in	in	ADP
ajlm-2613	15	9	3.4	3.4	NUM
ajlm-2613	15	10	%	%	NOUN
ajlm-2613	15	11	.	.	PUNCT
ajlm-2613	16	1	there	there	PRON
ajlm-2613	16	2	was	be	VERB
ajlm-2613	16	3	no	no	DET
ajlm-2613	16	4	association	association	NOUN
ajlm-2613	16	5	between	between	ADP
ajlm-2613	16	6	cox-2	cox-2	NOUN
ajlm-2613	16	7	expression	expression	NOUN
ajlm-2613	16	8	and	and	CCONJ
ajlm-2613	16	9	age	age	NOUN
ajlm-2613	16	10	,	,	PUNCT
ajlm-2613	16	11	sex	sex	NOUN
ajlm-2613	16	12	,	,	PUNCT
ajlm-2613	16	13	site	site	NOUN
ajlm-2613	16	14	,	,	PUNCT
ajlm-2613	16	15	histological	histological	ADJ
ajlm-2613	16	16	subtype	subtype	NOUN
ajlm-2613	16	17	,	,	PUNCT
ajlm-2613	16	18	or	or	CCONJ
ajlm-2613	16	19	grade	grade	NOUN
ajlm-2613	16	20	.	.	PUNCT
ajlm-2613	17	1	conclusion	conclusion	NOUN
ajlm-2613	17	2	:	:	PUNCT
ajlm-2613	17	3	over	over	ADV
ajlm-2613	17	4	-	-	PUNCT
ajlm-2613	17	5	expressed	express	VERB
ajlm-2613	17	6	cox-2	cox-2	NUM
ajlm-2613	17	7	was	be	AUX
ajlm-2613	17	8	observed	observe	VERB
ajlm-2613	17	9	in	in	ADP
ajlm-2613	17	10	only	only	ADV
ajlm-2613	17	11	3.4	3.4	NUM
ajlm-2613	17	12	%	%	NOUN
ajlm-2613	17	13	of	of	ADP
ajlm-2613	17	14	adenomas	adenoma	NOUN
ajlm-2613	17	15	,	,	PUNCT
ajlm-2613	17	16	which	which	PRON
ajlm-2613	17	17	may	may	AUX
ajlm-2613	17	18	indicate	indicate	VERB
ajlm-2613	17	19	its	its	PRON
ajlm-2613	17	20	early	early	ADJ
ajlm-2613	17	21	involvement	involvement	NOUN
ajlm-2613	17	22	in	in	ADP
ajlm-2613	17	23	the	the	DET
ajlm-2613	17	24	spectrum	spectrum	NOUN
ajlm-2613	17	25	of	of	ADP
ajlm-2613	17	26	adenoma	adenoma	ADJ
ajlm-2613	17	27	-	-	PUNCT
ajlm-2613	17	28	carcinoma	carcinoma	NOUN
ajlm-2613	17	29	sequence	sequence	NOUN
ajlm-2613	17	30	.	.	PUNCT
ajlm-2613	18	1	what	what	PRON
ajlm-2613	18	2	this	this	DET
ajlm-2613	18	3	study	study	NOUN
ajlm-2613	18	4	adds	add	VERB
ajlm-2613	18	5	:	:	PUNCT
ajlm-2613	18	6	it	it	PRON
ajlm-2613	18	7	provides	provide	VERB
ajlm-2613	18	8	key	key	ADJ
ajlm-2613	18	9	information	information	NOUN
ajlm-2613	18	10	about	about	ADP
ajlm-2613	18	11	cox-2	cox-2	NOUN
ajlm-2613	18	12	expression	expression	NOUN
ajlm-2613	18	13	in	in	ADP
ajlm-2613	18	14	adenoma	adenoma	ADJ
ajlm-2613	18	15	in	in	ADP
ajlm-2613	18	16	an	an	DET
ajlm-2613	18	17	african	african	ADJ
ajlm-2613	18	18	population	population	NOUN
ajlm-2613	18	19	,	,	PUNCT
ajlm-2613	18	20	which	which	PRON
ajlm-2613	18	21	may	may	AUX
ajlm-2613	18	22	serve	serve	VERB
ajlm-2613	18	23	as	as	ADP
ajlm-2613	18	24	a	a	DET
ajlm-2613	18	25	rationale	rationale	NOUN
ajlm-2613	18	26	for	for	ADP
ajlm-2613	18	27	other	other	ADJ
ajlm-2613	18	28	studies	study	NOUN
ajlm-2613	18	29	regarding	regard	VERB
ajlm-2613	18	30	cox-2	cox-2	SYM
ajlm-2613	18	31	targets	target	NOUN
ajlm-2613	18	32	for	for	ADP
ajlm-2613	18	33	chemoprevention	chemoprevention	NOUN
ajlm-2613	18	34	and	and	CCONJ
ajlm-2613	18	35	therapy	therapy	NOUN
ajlm-2613	18	36	in	in	ADP
ajlm-2613	18	37	adenoma	adenoma	ADJ
ajlm-2613	18	38	and	and	CCONJ
ajlm-2613	18	39	colorectal	colorectal	ADJ
ajlm-2613	18	40	cancer	cancer	NOUN
ajlm-2613	18	41	.	.	PUNCT
ajlm-2613	19	1	keywords	keyword	NOUN
ajlm-2613	19	2	:	:	PUNCT
ajlm-2613	19	3	cyclooxygenase-2	cyclooxygenase-2	NUM
ajlm-2613	19	4	;	;	PUNCT
ajlm-2613	19	5	expression	expression	NOUN
ajlm-2613	19	6	;	;	PUNCT
ajlm-2613	19	7	colorectal	colorectal	ADJ
ajlm-2613	19	8	adenoma	adenoma	NOUN
ajlm-2613	19	9	;	;	PUNCT
ajlm-2613	19	10	nigeria	nigeria	PROPN
ajlm-2613	19	11	;	;	PUNCT
ajlm-2613	19	12	africa	africa	PROPN
ajlm-2613	19	13	.	.	PUNCT
ajlm-2613	20	1	introduction	introduction	NOUN
ajlm-2613	20	2	colorectal	colorectal	ADJ
ajlm-2613	20	3	adenomas	adenoma	NOUN
ajlm-2613	20	4	or	or	CCONJ
ajlm-2613	20	5	adenomatous	adenomatous	ADJ
ajlm-2613	20	6	polyps	polyp	NOUN
ajlm-2613	20	7	,	,	PUNCT
ajlm-2613	20	8	which	which	PRON
ajlm-2613	20	9	are	be	AUX
ajlm-2613	20	10	the	the	DET
ajlm-2613	20	11	major	major	ADJ
ajlm-2613	20	12	sub	sub	NOUN
ajlm-2613	20	13	-	-	NOUN
ajlm-2613	20	14	types	type	NOUN
ajlm-2613	20	15	of	of	ADP
ajlm-2613	20	16	colorectal	colorectal	ADJ
ajlm-2613	20	17	polyps	polyp	NOUN
ajlm-2613	20	18	,	,	PUNCT
ajlm-2613	20	19	are	be	AUX
ajlm-2613	20	20	benign	benign	ADJ
ajlm-2613	20	21	glandular	glandular	ADJ
ajlm-2613	20	22	neoplasms	neoplasm	NOUN
ajlm-2613	20	23	of	of	ADP
ajlm-2613	20	24	colorectal	colorectal	ADJ
ajlm-2613	20	25	epithelium	epithelium	NOUN
ajlm-2613	20	26	that	that	PRON
ajlm-2613	20	27	occur	occur	VERB
ajlm-2613	20	28	either	either	CCONJ
ajlm-2613	20	29	sporadically	sporadically	ADV
ajlm-2613	20	30	or	or	CCONJ
ajlm-2613	20	31	as	as	ADP
ajlm-2613	20	32	part	part	NOUN
ajlm-2613	20	33	of	of	ADP
ajlm-2613	20	34	a	a	DET
ajlm-2613	20	35	polyposis	polyposis	NOUN
ajlm-2613	20	36	syndrome	syndrome	NOUN
ajlm-2613	20	37	,	,	PUNCT
ajlm-2613	20	38	with	with	ADP
ajlm-2613	20	39	some	some	PRON
ajlm-2613	20	40	having	have	VERB
ajlm-2613	20	41	malignant	malignant	ADJ
ajlm-2613	20	42	potential	potential	NOUN
ajlm-2613	20	43	.	.	PUNCT
ajlm-2613	21	1	in	in	ADP
ajlm-2613	21	2	nigeria	nigeria	PROPN
ajlm-2613	21	3	,	,	PUNCT
ajlm-2613	21	4	the	the	DET
ajlm-2613	21	5	proportion	proportion	NOUN
ajlm-2613	21	6	of	of	ADP
ajlm-2613	21	7	colorectal	colorectal	ADJ
ajlm-2613	21	8	polyps	polyp	NOUN
ajlm-2613	21	9	that	that	PRON
ajlm-2613	21	10	are	be	AUX
ajlm-2613	21	11	adenomatous	adenomatous	ADJ
ajlm-2613	21	12	ranges	range	NOUN
ajlm-2613	21	13	from	from	ADP
ajlm-2613	21	14	28.8	28.8	NUM
ajlm-2613	21	15	%	%	NOUN
ajlm-2613	21	16	to	to	ADP
ajlm-2613	21	17	47.5%.1,2,3,4,5	47.5%.1,2,3,4,5	NUM
ajlm-2613	21	18	the	the	DET
ajlm-2613	21	19	distinct	distinct	ADJ
ajlm-2613	21	20	parameters	parameter	NOUN
ajlm-2613	21	21	that	that	PRON
ajlm-2613	21	22	make	make	VERB
ajlm-2613	21	23	adenoma	adenoma	ADJ
ajlm-2613	21	24	relevant	relevant	ADJ
ajlm-2613	21	25	clinically	clinically	ADV
ajlm-2613	21	26	include	include	VERB
ajlm-2613	21	27	being	be	AUX
ajlm-2613	21	28	a	a	DET
ajlm-2613	21	29	precursor	precursor	NOUN
ajlm-2613	21	30	lesion	lesion	NOUN
ajlm-2613	21	31	,	,	PUNCT
ajlm-2613	21	32	harbouring	harbour	VERB
ajlm-2613	21	33	invasive	invasive	ADJ
ajlm-2613	21	34	carcinoma	carcinoma	NOUN
ajlm-2613	21	35	,	,	PUNCT
ajlm-2613	21	36	long	long	ADJ
ajlm-2613	21	37	latency	latency	NOUN
ajlm-2613	21	38	period	period	NOUN
ajlm-2613	21	39	of	of	ADP
ajlm-2613	21	40	malignant	malignant	ADJ
ajlm-2613	21	41	transformation	transformation	NOUN
ajlm-2613	21	42	,	,	PUNCT
ajlm-2613	21	43	having	have	VERB
ajlm-2613	21	44	similar	similar	ADJ
ajlm-2613	21	45	clinical	clinical	ADJ
ajlm-2613	21	46	features	feature	NOUN
ajlm-2613	21	47	with	with	ADP
ajlm-2613	21	48	colorectal	colorectal	ADJ
ajlm-2613	21	49	cancer	cancer	NOUN
ajlm-2613	21	50	(	(	PUNCT
ajlm-2613	21	51	crc	crc	NOUN
ajlm-2613	21	52	)	)	PUNCT
ajlm-2613	21	53	,	,	PUNCT
ajlm-2613	21	54	and	and	CCONJ
ajlm-2613	21	55	as	as	ADP
ajlm-2613	21	56	part	part	NOUN
ajlm-2613	21	57	of	of	ADP
ajlm-2613	21	58	hereditary	hereditary	ADJ
ajlm-2613	21	59	crc	crc	NOUN
ajlm-2613	21	60	syndrome.6,7,8,9	syndrome.6,7,8,9	NOUN
ajlm-2613	21	61	emerging	emerge	VERB
ajlm-2613	21	62	evidence	evidence	NOUN
ajlm-2613	21	63	implicates	implicate	VERB
ajlm-2613	21	64	the	the	DET
ajlm-2613	21	65	role	role	NOUN
ajlm-2613	21	66	of	of	ADP
ajlm-2613	21	67	the	the	DET
ajlm-2613	21	68	cyclooxygenase-2	cyclooxygenase-2	NUM
ajlm-2613	21	69	(	(	PUNCT
ajlm-2613	21	70	cox-2	cox-2	NOUN
ajlm-2613	21	71	)	)	PUNCT
ajlm-2613	21	72	enzyme	enzyme	NOUN
ajlm-2613	21	73	in	in	ADP
ajlm-2613	21	74	adenoma	adenoma	ADJ
ajlm-2613	21	75	.	.	PUNCT
ajlm-2613	22	1	carriers	carrier	NOUN
ajlm-2613	22	2	of	of	ADP
ajlm-2613	22	3	the	the	DET
ajlm-2613	22	4	cox-2	cox-2	ADJ
ajlm-2613	22	5	a-1195	a-1195	NOUN
ajlm-2613	22	6	g	g	PROPN
ajlm-2613	22	7	ag	ag	PROPN
ajlm-2613	22	8	genotype	genotype	NOUN
ajlm-2613	22	9	are	be	AUX
ajlm-2613	22	10	at	at	ADP
ajlm-2613	22	11	a	a	DET
ajlm-2613	22	12	twofold	twofold	NOUN
ajlm-2613	22	13	increased	increase	VERB
ajlm-2613	22	14	risk	risk	NOUN
ajlm-2613	22	15	of	of	ADP
ajlm-2613	22	16	developing	develop	VERB
ajlm-2613	22	17	colorectal	colorectal	ADJ
ajlm-2613	22	18	adenomas	adenoma	NOUN
ajlm-2613	22	19	,	,	PUNCT
ajlm-2613	22	20	and	and	CCONJ
ajlm-2613	22	21	2.9	2.9	NUM
ajlm-2613	22	22	times	time	NOUN
ajlm-2613	22	23	increased	increase	VERB
ajlm-2613	22	24	risk	risk	NOUN
ajlm-2613	22	25	of	of	ADP
ajlm-2613	22	26	developing	develop	VERB
ajlm-2613	22	27	cancer	cancer	NOUN
ajlm-2613	22	28	,	,	PUNCT
ajlm-2613	22	29	suggesting	suggest	VERB
ajlm-2613	22	30	a	a	DET
ajlm-2613	22	31	role	role	NOUN
ajlm-2613	22	32	of	of	ADP
ajlm-2613	22	33	cox-2	cox-2	NOUN
ajlm-2613	22	34	as	as	ADP
ajlm-2613	22	35	a	a	DET
ajlm-2613	22	36	potential	potential	ADJ
ajlm-2613	22	37	biomarker	biomarker	NOUN
ajlm-2613	22	38	for	for	ADP
ajlm-2613	22	39	cancer	cancer	NOUN
ajlm-2613	22	40	risk.10	risk.10	NOUN
ajlm-2613	22	41	contrastingly	contrastingly	ADV
ajlm-2613	22	42	,	,	PUNCT
ajlm-2613	22	43	the	the	DET
ajlm-2613	22	44	carriers	carrier	NOUN
ajlm-2613	22	45	of	of	ADP
ajlm-2613	22	46	cox-2	cox-2	NOUN
ajlm-2613	22	47	a-1195	a-1195	NOUN
ajlm-2613	22	48	g	g	NOUN
ajlm-2613	22	49	aa	aa	NOUN
ajlm-2613	22	50	genotype	genotype	NOUN
ajlm-2613	22	51	have	have	VERB
ajlm-2613	22	52	1.8	1.8	NUM
ajlm-2613	22	53	times	time	NOUN
ajlm-2613	22	54	reduced	reduced	ADJ
ajlm-2613	22	55	risk	risk	NOUN
ajlm-2613	22	56	of	of	ADP
ajlm-2613	22	57	developing	develop	VERB
ajlm-2613	22	58	adenomas	adenoma	NOUN
ajlm-2613	22	59	,	,	PUNCT
ajlm-2613	22	60	and	and	CCONJ
ajlm-2613	22	61	3.1	3.1	NUM
ajlm-2613	22	62	times	time	NOUN
ajlm-2613	22	63	reduced	reduce	VERB
ajlm-2613	22	64	risk	risk	NOUN
ajlm-2613	22	65	of	of	ADP
ajlm-2613	22	66	developing	develop	VERB
ajlm-2613	22	67	crc.10	crc.10	ADJ
ajlm-2613	22	68	chronic	chronic	ADJ
ajlm-2613	22	69	use	use	NOUN
ajlm-2613	22	70	of	of	ADP
ajlm-2613	22	71	cyclooxygenase	cyclooxygenase	ADJ
ajlm-2613	22	72	antagonists	antagonist	NOUN
ajlm-2613	22	73	such	such	ADJ
ajlm-2613	22	74	as	as	ADP
ajlm-2613	22	75	nonsteroidal	nonsteroidal	NOUN
ajlm-2613	22	76	anti	anti	ADJ
ajlm-2613	22	77	-	-	ADJ
ajlm-2613	22	78	inflammatory	inflammatory	ADJ
ajlm-2613	22	79	drugs	drug	NOUN
ajlm-2613	22	80	,	,	PUNCT
ajlm-2613	22	81	particularly	particularly	ADV
ajlm-2613	22	82	aspirin	aspirin	NOUN
ajlm-2613	22	83	,	,	PUNCT
ajlm-2613	22	84	is	be	AUX
ajlm-2613	22	85	associated	associate	VERB
ajlm-2613	22	86	with	with	ADP
ajlm-2613	22	87	reduced	reduce	VERB
ajlm-2613	22	88	adenoma	adenoma	ADJ
ajlm-2613	22	89	incidence	incidence	NOUN
ajlm-2613	22	90	,	,	PUNCT
ajlm-2613	22	91	aggressiveness	aggressiveness	NOUN
ajlm-2613	22	92	,	,	PUNCT
ajlm-2613	22	93	size	size	NOUN
ajlm-2613	22	94	,	,	PUNCT
ajlm-2613	22	95	and	and	CCONJ
ajlm-2613	22	96	recurrence.11,12,13,14	recurrence.11,12,13,14	ADV
ajlm-2613	22	97	inhibitors	inhibitor	NOUN
ajlm-2613	22	98	of	of	ADP
ajlm-2613	22	99	cyclooxygenases	cyclooxygenase	NOUN
ajlm-2613	22	100	such	such	ADJ
ajlm-2613	22	101	as	as	ADP
ajlm-2613	22	102	nonsteroidal	nonsteroidal	NOUN
ajlm-2613	22	103	anti	anti	ADJ
ajlm-2613	22	104	-	-	ADJ
ajlm-2613	22	105	inflammatory	inflammatory	ADJ
ajlm-2613	22	106	drugs	drug	NOUN
ajlm-2613	22	107	are	be	AUX
ajlm-2613	22	108	useful	useful	ADJ
ajlm-2613	22	109	in	in	ADP
ajlm-2613	22	110	the	the	DET
ajlm-2613	22	111	chemoprevention	chemoprevention	NOUN
ajlm-2613	22	112	and	and	CCONJ
ajlm-2613	22	113	management	management	NOUN
ajlm-2613	22	114	of	of	ADP
ajlm-2613	22	115	adenoma	adenoma	ADJ
ajlm-2613	22	116	,	,	PUNCT
ajlm-2613	22	117	and	and	CCONJ
ajlm-2613	22	118	they	they	PRON
ajlm-2613	22	119	exert	exert	VERB
ajlm-2613	22	120	their	their	PRON
ajlm-2613	22	121	effects	effect	NOUN
ajlm-2613	22	122	by	by	ADP
ajlm-2613	22	123	inhibiting	inhibit	VERB
ajlm-2613	22	124	cyclooxygenases	cyclooxygenase	NOUN
ajlm-2613	22	125	(	(	PUNCT
ajlm-2613	22	126	cyclooxygenase-1	cyclooxygenase-1	NOUN
ajlm-2613	22	127	and	and	CCONJ
ajlm-2613	22	128	cox-2	cox-2	NUM
ajlm-2613	22	129	)	)	PUNCT
ajlm-2613	22	130	,	,	PUNCT
ajlm-2613	22	131	which	which	PRON
ajlm-2613	22	132	are	be	AUX
ajlm-2613	22	133	enzymes	enzyme	NOUN
ajlm-2613	22	134	required	require	VERB
ajlm-2613	22	135	for	for	ADP
ajlm-2613	22	136	the	the	DET
ajlm-2613	22	137	metabolism	metabolism	NOUN
ajlm-2613	22	138	of	of	ADP
ajlm-2613	22	139	arachidonic	arachidonic	ADJ
ajlm-2613	22	140	acid	acid	NOUN
ajlm-2613	22	141	to	to	PART
ajlm-2613	22	142	prostaglandins.15,16,17	prostaglandins.15,16,17	VERB
ajlm-2613	22	143	the	the	DET
ajlm-2613	22	144	expression	expression	NOUN
ajlm-2613	22	145	of	of	ADP
ajlm-2613	22	146	cox-2	cox-2	NOUN
ajlm-2613	22	147	is	be	AUX
ajlm-2613	22	148	highly	highly	ADV
ajlm-2613	22	149	induced	induce	VERB
ajlm-2613	22	150	by	by	ADP
ajlm-2613	22	151	tumour	tumour	NOUN
ajlm-2613	22	152	promoters	promoter	NOUN
ajlm-2613	22	153	,	,	PUNCT
ajlm-2613	22	154	mitogens	mitogen	NOUN
ajlm-2613	22	155	,	,	PUNCT
ajlm-2613	22	156	and	and	CCONJ
ajlm-2613	22	157	cytokines.15	cytokines.15	VERB
ajlm-2613	22	158	over	over	ADP
ajlm-2613	22	159	-	-	PUNCT
ajlm-2613	22	160	expression	expression	NOUN
ajlm-2613	22	161	of	of	ADP
ajlm-2613	22	162	cox-2	cox-2	NUM
ajlm-2613	22	163	is	be	AUX
ajlm-2613	22	164	associated	associate	VERB
ajlm-2613	22	165	with	with	ADP
ajlm-2613	22	166	inflammation	inflammation	NOUN
ajlm-2613	22	167	,	,	PUNCT
ajlm-2613	22	168	initiation	initiation	NOUN
ajlm-2613	22	169	of	of	ADP
ajlm-2613	22	170	cancer	cancer	NOUN
ajlm-2613	22	171	,	,	PUNCT
ajlm-2613	22	172	cancer	cancer	NOUN
ajlm-2613	22	173	progression	progression	NOUN
ajlm-2613	22	174	,	,	PUNCT
ajlm-2613	22	175	proliferation	proliferation	NOUN
ajlm-2613	22	176	of	of	ADP
ajlm-2613	22	177	surviving	survive	VERB
ajlm-2613	22	178	cancer	cancer	NOUN
ajlm-2613	22	179	stem	stem	NOUN
ajlm-2613	22	180	cells	cell	NOUN
ajlm-2613	22	181	,	,	PUNCT
ajlm-2613	22	182	activation	activation	NOUN
ajlm-2613	22	183	of	of	ADP
ajlm-2613	22	184	vascular	vascular	ADJ
ajlm-2613	22	185	endothelial	endothelial	ADJ
ajlm-2613	22	186	growth	growth	NOUN
ajlm-2613	22	187	factor	factor	NOUN
ajlm-2613	22	188	,	,	PUNCT
ajlm-2613	22	189	angiogenesis	angiogenesis	NOUN
ajlm-2613	22	190	,	,	PUNCT
ajlm-2613	22	191	invasion	invasion	NOUN
ajlm-2613	22	192	,	,	PUNCT
ajlm-2613	22	193	metastasis	metastasis	NOUN
ajlm-2613	22	194	,	,	PUNCT
ajlm-2613	22	195	and	and	CCONJ
ajlm-2613	22	196	tumour	tumour	ADJ
ajlm-2613	22	197	relapse	relapse	NOUN
ajlm-2613	22	198	after	after	ADP
ajlm-2613	22	199	therapy.16,17	therapy.16,17	VERB
ajlm-2613	22	200	the	the	DET
ajlm-2613	22	201	rate	rate	NOUN
ajlm-2613	22	202	of	of	ADP
ajlm-2613	22	203	cox-2	cox-2	SYM
ajlm-2613	22	204	over	over	ADP
ajlm-2613	22	205	-	-	PUNCT
ajlm-2613	22	206	expression	expression	NOUN
ajlm-2613	22	207	increases	increase	NOUN
ajlm-2613	22	208	during	during	ADP
ajlm-2613	22	209	the	the	DET
ajlm-2613	22	210	course	course	NOUN
ajlm-2613	22	211	of	of	ADP
ajlm-2613	22	212	crc	crc	PROPN
ajlm-2613	22	213	development	development	NOUN
ajlm-2613	22	214	from	from	ADP
ajlm-2613	22	215	adenoma	adenoma	ADJ
ajlm-2613	22	216	to	to	ADP
ajlm-2613	22	217	crc	crc	NOUN
ajlm-2613	22	218	in	in	ADP
ajlm-2613	22	219	situ	situ	NOUN
ajlm-2613	22	220	to	to	ADP
ajlm-2613	22	221	invasive	invasive	ADJ
ajlm-2613	22	222	crc	crc	NOUN
ajlm-2613	22	223	,	,	PUNCT
ajlm-2613	22	224	thus	thus	ADV
ajlm-2613	22	225	recapitulating	recapitulate	VERB
ajlm-2613	22	226	events	event	NOUN
ajlm-2613	22	227	in	in	ADP
ajlm-2613	22	228	the	the	DET
ajlm-2613	22	229	adenoma	adenoma	ADJ
ajlm-2613	22	230	-	-	PUNCT
ajlm-2613	22	231	carcinoma	carcinoma	NOUN
ajlm-2613	22	232	progression.18	progression.18	NOUN
ajlm-2613	22	233	it	it	PRON
ajlm-2613	22	234	may	may	AUX
ajlm-2613	22	235	,	,	PUNCT
ajlm-2613	22	236	therefore	therefore	ADV
ajlm-2613	22	237	,	,	PUNCT
ajlm-2613	22	238	imply	imply	VERB
ajlm-2613	22	239	that	that	SCONJ
ajlm-2613	22	240	cox-2	cox-2	ADV
ajlm-2613	22	241	over	over	ADP
ajlm-2613	22	242	-	-	PUNCT
ajlm-2613	22	243	expression	expression	NOUN
ajlm-2613	22	244	may	may	AUX
ajlm-2613	22	245	be	be	AUX
ajlm-2613	22	246	a	a	DET
ajlm-2613	22	247	marker	marker	NOUN
ajlm-2613	22	248	of	of	ADP
ajlm-2613	22	249	the	the	DET
ajlm-2613	22	250	progression	progression	NOUN
ajlm-2613	22	251	of	of	ADP
ajlm-2613	22	252	crcs	crcs	PROPN
ajlm-2613	22	253	from	from	ADP
ajlm-2613	22	254	adenomas.18	adenomas.18	PROPN
ajlm-2613	22	255	however	however	ADV
ajlm-2613	22	256	,	,	PUNCT
ajlm-2613	22	257	studies	study	NOUN
ajlm-2613	22	258	on	on	ADP
ajlm-2613	22	259	cox-2	cox-2	NOUN
ajlm-2613	22	260	and	and	CCONJ
ajlm-2613	22	261	its	its	PRON
ajlm-2613	22	262	antagonists	antagonist	NOUN
ajlm-2613	22	263	in	in	ADP
ajlm-2613	22	264	colorectal	colorectal	ADJ
ajlm-2613	22	265	adenomas	adenoma	NOUN
ajlm-2613	22	266	are	be	AUX
ajlm-2613	22	267	limited	limit	VERB
ajlm-2613	22	268	in	in	ADP
ajlm-2613	22	269	africa	africa	PROPN
ajlm-2613	22	270	,	,	PUNCT
ajlm-2613	22	271	as	as	SCONJ
ajlm-2613	22	272	most	most	ADJ
ajlm-2613	22	273	studies	study	NOUN
ajlm-2613	22	274	are	be	AUX
ajlm-2613	22	275	from	from	ADP
ajlm-2613	22	276	asia	asia	PROPN
ajlm-2613	22	277	and	and	CCONJ
ajlm-2613	22	278	western	western	ADJ
ajlm-2613	22	279	countries	country	NOUN
ajlm-2613	22	280	.	.	PUNCT
ajlm-2613	23	1	this	this	DET
ajlm-2613	23	2	study	study	NOUN
ajlm-2613	23	3	examined	examine	VERB
ajlm-2613	23	4	cox-2	cox-2	DET
ajlm-2613	23	5	expression	expression	NOUN
ajlm-2613	23	6	in	in	ADP
ajlm-2613	23	7	adenoma	adenoma	ADJ
ajlm-2613	23	8	in	in	ADP
ajlm-2613	23	9	an	an	DET
ajlm-2613	23	10	african	african	ADJ
ajlm-2613	23	11	population	population	NOUN
ajlm-2613	23	12	,	,	PUNCT
ajlm-2613	23	13	and	and	CCONJ
ajlm-2613	23	14	it	it	PRON
ajlm-2613	23	15	may	may	AUX
ajlm-2613	23	16	serve	serve	VERB
ajlm-2613	23	17	as	as	ADP
ajlm-2613	23	18	a	a	DET
ajlm-2613	23	19	rationale	rationale	NOUN
ajlm-2613	23	20	for	for	ADP
ajlm-2613	23	21	other	other	ADJ
ajlm-2613	23	22	studies	study	NOUN
ajlm-2613	23	23	on	on	ADP
ajlm-2613	23	24	cox-2	cox-2	NOUN
ajlm-2613	23	25	and	and	CCONJ
ajlm-2613	23	26	its	its	PRON
ajlm-2613	23	27	target	target	NOUN
ajlm-2613	23	28	in	in	ADP
ajlm-2613	23	29	colorectal	colorectal	ADJ
ajlm-2613	23	30	adenoma	adenoma	ADJ
ajlm-2613	23	31	and	and	CCONJ
ajlm-2613	23	32	carcinoma	carcinoma	NOUN
ajlm-2613	23	33	chemoprevention	chemoprevention	NOUN
ajlm-2613	23	34	and	and	CCONJ
ajlm-2613	23	35	therapy	therapy	NOUN
ajlm-2613	23	36	.	.	PUNCT
ajlm-2613	24	1	this	this	DET
ajlm-2613	24	2	study	study	NOUN
ajlm-2613	24	3	aimed	aim	VERB
ajlm-2613	24	4	to	to	PART
ajlm-2613	24	5	assess	assess	VERB
ajlm-2613	24	6	the	the	DET
ajlm-2613	24	7	proportion	proportion	NOUN
ajlm-2613	24	8	of	of	ADP
ajlm-2613	24	9	adenomas	adenoma	NOUN
ajlm-2613	24	10	in	in	ADP
ajlm-2613	24	11	northern	northern	PROPN
ajlm-2613	24	12	nigeria	nigeria	PROPN
ajlm-2613	24	13	that	that	SCONJ
ajlm-2613	24	14	over	over	ADP
ajlm-2613	24	15	-	-	PUNCT
ajlm-2613	24	16	express	express	VERB
ajlm-2613	24	17	cox-2	cox-2	NOUN
ajlm-2613	24	18	and	and	CCONJ
ajlm-2613	24	19	establish	establish	VERB
ajlm-2613	24	20	any	any	DET
ajlm-2613	24	21	relationship	relationship	NOUN
ajlm-2613	24	22	between	between	ADP
ajlm-2613	24	23	cox-2	cox-2	NOUN
ajlm-2613	24	24	over	over	ADP
ajlm-2613	24	25	-	-	PUNCT
ajlm-2613	24	26	expression	expression	NOUN
ajlm-2613	24	27	with	with	ADP
ajlm-2613	24	28	clinicopathological	clinicopathological	ADJ
ajlm-2613	24	29	features	feature	NOUN
ajlm-2613	24	30	such	such	ADJ
ajlm-2613	24	31	as	as	ADP
ajlm-2613	24	32	age	age	NOUN
ajlm-2613	24	33	,	,	PUNCT
ajlm-2613	24	34	sex	sex	NOUN
ajlm-2613	24	35	,	,	PUNCT
ajlm-2613	24	36	histological	histological	ADJ
ajlm-2613	24	37	subtype	subtype	NOUN
ajlm-2613	24	38	,	,	PUNCT
ajlm-2613	24	39	and	and	CCONJ
ajlm-2613	24	40	tumour	tumour	NOUN
ajlm-2613	24	41	grade	grade	NOUN
ajlm-2613	24	42	.	.	PUNCT
ajlm-2613	25	1	methods	method	NOUN
ajlm-2613	25	2	ethical	ethical	ADJ
ajlm-2613	25	3	considerations	consideration	NOUN
ajlm-2613	25	4	ethical	ethical	ADJ
ajlm-2613	25	5	approval	approval	NOUN
ajlm-2613	25	6	for	for	ADP
ajlm-2613	25	7	this	this	DET
ajlm-2613	25	8	study	study	NOUN
ajlm-2613	25	9	was	be	AUX
ajlm-2613	25	10	obtained	obtain	VERB
ajlm-2613	25	11	from	from	ADP
ajlm-2613	25	12	the	the	DET
ajlm-2613	25	13	health	health	NOUN
ajlm-2613	25	14	and	and	CCONJ
ajlm-2613	25	15	research	research	NOUN
ajlm-2613	25	16	ethics	ethic	NOUN
ajlm-2613	25	17	committee	committee	PROPN
ajlm-2613	25	18	of	of	ADP
ajlm-2613	25	19	aminu	aminu	PROPN
ajlm-2613	25	20	kano	kano	PROPN
ajlm-2613	25	21	teaching	teaching	PROPN
ajlm-2613	25	22	hospital	hospital	NOUN
ajlm-2613	25	23	,	,	PUNCT
ajlm-2613	25	24	kano	kano	PROPN
ajlm-2613	25	25	(	(	PUNCT
ajlm-2613	25	26	ethical	ethical	ADJ
ajlm-2613	25	27	review	review	NOUN
ajlm-2613	25	28	reference	reference	NOUN
ajlm-2613	25	29	number	number	NOUN
ajlm-2613	25	30	:	:	PUNCT
ajlm-2613	25	31	akth	akth	NOUN
ajlm-2613	25	32	/	/	SYM
ajlm-2613	25	33	mac	mac	NOUN
ajlm-2613	25	34	/	/	SYM
ajlm-2613	25	35	sub/12a	sub/12a	NOUN
ajlm-2613	25	36	/	/	SYM
ajlm-2613	25	37	p-3	p-3	NOUN
ajlm-2613	25	38	/	/	SYM
ajlm-2613	25	39	v1/2904	v1/2904	NOUN
ajlm-2613	25	40	)	)	PUNCT
ajlm-2613	25	41	.	.	PUNCT
ajlm-2613	26	1	additional	additional	ADJ
ajlm-2613	26	2	consent	consent	NOUN
ajlm-2613	26	3	of	of	ADP
ajlm-2613	26	4	individuals	individual	NOUN
ajlm-2613	26	5	whose	whose	DET
ajlm-2613	26	6	samples	sample	NOUN
ajlm-2613	26	7	were	be	AUX
ajlm-2613	26	8	used	use	VERB
ajlm-2613	26	9	in	in	ADP
ajlm-2613	26	10	this	this	DET
ajlm-2613	26	11	study	study	NOUN
ajlm-2613	26	12	was	be	AUX
ajlm-2613	26	13	waived	waive	VERB
ajlm-2613	26	14	,	,	PUNCT
ajlm-2613	26	15	as	as	SCONJ
ajlm-2613	26	16	is	be	AUX
ajlm-2613	26	17	the	the	DET
ajlm-2613	26	18	institutional	institutional	ADJ
ajlm-2613	26	19	ethical	ethical	ADJ
ajlm-2613	26	20	committee	committee	NOUN
ajlm-2613	26	21	’s	’s	PART
ajlm-2613	26	22	policy	policy	NOUN
ajlm-2613	26	23	for	for	ADP
ajlm-2613	26	24	retrospective	retrospective	ADJ
ajlm-2613	26	25	studies	study	NOUN
ajlm-2613	26	26	involving	involve	VERB
ajlm-2613	26	27	non	non	ADJ
ajlm-2613	26	28	-	-	ADJ
ajlm-2613	26	29	human	human	ADJ
ajlm-2613	26	30	subjects	subject	NOUN
ajlm-2613	26	31	.	.	PUNCT
ajlm-2613	27	1	patients	patient	NOUN
ajlm-2613	27	2	’	'	PUNCT
ajlm-2613	27	3	identities	identity	NOUN
ajlm-2613	27	4	were	be	AUX
ajlm-2613	27	5	concealed	conceal	VERB
ajlm-2613	27	6	at	at	ADP
ajlm-2613	27	7	all	all	DET
ajlm-2613	27	8	times	time	NOUN
ajlm-2613	27	9	,	,	PUNCT
ajlm-2613	27	10	and	and	CCONJ
ajlm-2613	27	11	records	record	NOUN
ajlm-2613	27	12	were	be	AUX
ajlm-2613	27	13	kept	keep	VERB
ajlm-2613	27	14	under	under	ADP
ajlm-2613	27	15	lock	lock	NOUN
ajlm-2613	27	16	.	.	PUNCT
ajlm-2613	28	1	study	study	NOUN
ajlm-2613	28	2	design	design	NOUN
ajlm-2613	28	3	and	and	CCONJ
ajlm-2613	28	4	setting	set	VERB
ajlm-2613	28	5	this	this	DET
ajlm-2613	28	6	retrospective	retrospective	ADJ
ajlm-2613	28	7	,	,	PUNCT
ajlm-2613	28	8	descriptive	descriptive	ADJ
ajlm-2613	28	9	,	,	PUNCT
ajlm-2613	28	10	hospital	hospital	NOUN
ajlm-2613	28	11	-	-	PUNCT
ajlm-2613	28	12	based	base	VERB
ajlm-2613	28	13	study	study	NOUN
ajlm-2613	28	14	was	be	AUX
ajlm-2613	28	15	carried	carry	VERB
ajlm-2613	28	16	out	out	ADP
ajlm-2613	28	17	in	in	ADP
ajlm-2613	28	18	the	the	DET
ajlm-2613	28	19	histopathology	histopathology	NOUN
ajlm-2613	28	20	laboratory	laboratory	NOUN
ajlm-2613	28	21	of	of	ADP
ajlm-2613	28	22	the	the	DET
ajlm-2613	28	23	department	department	PROPN
ajlm-2613	28	24	of	of	ADP
ajlm-2613	28	25	histopathology	histopathology	NOUN
ajlm-2613	28	26	,	,	PUNCT
ajlm-2613	28	27	aminu	aminu	PROPN
ajlm-2613	28	28	kano	kano	PROPN
ajlm-2613	28	29	teaching	teaching	PROPN
ajlm-2613	28	30	hospital	hospital	NOUN
ajlm-2613	28	31	,	,	PUNCT
ajlm-2613	28	32	kano	kano	PROPN
ajlm-2613	28	33	(	(	PUNCT
ajlm-2613	28	34	north	north	NOUN
ajlm-2613	28	35	-	-	PUNCT
ajlm-2613	28	36	western	western	NOUN
ajlm-2613	28	37	nigeria	nigeria	PROPN
ajlm-2613	28	38	)	)	PUNCT
ajlm-2613	28	39	.	.	PUNCT
ajlm-2613	29	1	aminu	aminu	PROPN
ajlm-2613	29	2	kano	kano	PROPN
ajlm-2613	29	3	teaching	teaching	PROPN
ajlm-2613	29	4	hospital	hospital	NOUN
ajlm-2613	29	5	is	be	AUX
ajlm-2613	29	6	a	a	DET
ajlm-2613	29	7	tertiary	tertiary	ADJ
ajlm-2613	29	8	hospital	hospital	NOUN
ajlm-2613	29	9	with	with	ADP
ajlm-2613	29	10	over	over	ADP
ajlm-2613	29	11	700	700	NUM
ajlm-2613	29	12	-	-	PUNCT
ajlm-2613	29	13	bed	bed	NOUN
ajlm-2613	29	14	capacity	capacity	NOUN
ajlm-2613	29	15	.	.	PUNCT
ajlm-2613	30	1	the	the	DET
ajlm-2613	30	2	histopathology	histopathology	NOUN
ajlm-2613	30	3	department	department	PROPN
ajlm-2613	30	4	of	of	ADP
ajlm-2613	30	5	aminu	aminu	PROPN
ajlm-2613	30	6	kano	kano	PROPN
ajlm-2613	30	7	teaching	teaching	PROPN
ajlm-2613	30	8	hospital	hospital	NOUN
ajlm-2613	30	9	receives	receive	VERB
ajlm-2613	30	10	an	an	DET
ajlm-2613	30	11	average	average	NOUN
ajlm-2613	30	12	of	of	ADP
ajlm-2613	30	13	5500	5500	NUM
ajlm-2613	30	14	histological	histological	ADJ
ajlm-2613	30	15	samples	sample	NOUN
ajlm-2613	30	16	per	per	ADP
ajlm-2613	30	17	annum	annum	NOUN
ajlm-2613	30	18	,	,	PUNCT
ajlm-2613	30	19	and	and	CCONJ
ajlm-2613	30	20	renders	render	VERB
ajlm-2613	30	21	services	service	NOUN
ajlm-2613	30	22	including	include	VERB
ajlm-2613	30	23	cytology	cytology	NOUN
ajlm-2613	30	24	,	,	PUNCT
ajlm-2613	30	25	histology	histology	NOUN
ajlm-2613	30	26	,	,	PUNCT
ajlm-2613	30	27	autopsy	autopsy	ADJ
ajlm-2613	30	28	,	,	PUNCT
ajlm-2613	30	29	and	and	CCONJ
ajlm-2613	30	30	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2613	30	31	.	.	PUNCT
ajlm-2613	31	1	inclusion	inclusion	NOUN
ajlm-2613	31	2	and	and	CCONJ
ajlm-2613	31	3	exclusion	exclusion	NOUN
ajlm-2613	31	4	criteria	criterion	NOUN
ajlm-2613	31	5	adenoma	adenoma	ADJ
ajlm-2613	31	6	cases	case	NOUN
ajlm-2613	31	7	included	include	VERB
ajlm-2613	31	8	in	in	ADP
ajlm-2613	31	9	this	this	DET
ajlm-2613	31	10	study	study	NOUN
ajlm-2613	31	11	were	be	AUX
ajlm-2613	31	12	all	all	PRON
ajlm-2613	31	13	cases	case	NOUN
ajlm-2613	31	14	that	that	PRON
ajlm-2613	31	15	were	be	AUX
ajlm-2613	31	16	histologically	histologically	ADV
ajlm-2613	31	17	diagnosed	diagnose	VERB
ajlm-2613	31	18	with	with	ADP
ajlm-2613	31	19	colorectal	colorectal	ADJ
ajlm-2613	31	20	adenoma	adenoma	NOUN
ajlm-2613	31	21	in	in	ADP
ajlm-2613	31	22	the	the	DET
ajlm-2613	31	23	study	study	NOUN
ajlm-2613	31	24	centre	centre	NOUN
ajlm-2613	31	25	from	from	ADP
ajlm-2613	31	26	01	01	NUM
ajlm-2613	31	27	january	january	PROPN
ajlm-2613	31	28	2015	2015	NUM
ajlm-2613	31	29	to	to	ADP
ajlm-2613	31	30	31	31	NUM
ajlm-2613	31	31	december	december	PROPN
ajlm-2613	31	32	2019	2019	NUM
ajlm-2613	31	33	.	.	PUNCT
ajlm-2613	32	1	cases	case	NOUN
ajlm-2613	32	2	with	with	ADP
ajlm-2613	32	3	insufficient	insufficient	ADJ
ajlm-2613	32	4	clinical	clinical	ADJ
ajlm-2613	32	5	information	information	NOUN
ajlm-2613	32	6	,	,	PUNCT
ajlm-2613	32	7	particularly	particularly	ADV
ajlm-2613	32	8	biodata	biodata	ADJ
ajlm-2613	32	9	,	,	PUNCT
ajlm-2613	32	10	missing	missing	ADJ
ajlm-2613	32	11	or	or	CCONJ
ajlm-2613	32	12	damaged	damaged	ADJ
ajlm-2613	32	13	blocks	block	NOUN
ajlm-2613	32	14	,	,	PUNCT
ajlm-2613	32	15	and	and	CCONJ
ajlm-2613	32	16	tissue	tissue	NOUN
ajlm-2613	32	17	blocks	block	NOUN
ajlm-2613	32	18	with	with	ADP
ajlm-2613	32	19	insufficient	insufficient	ADJ
ajlm-2613	32	20	tissue	tissue	NOUN
ajlm-2613	32	21	were	be	AUX
ajlm-2613	32	22	excluded	exclude	VERB
ajlm-2613	32	23	(	(	PUNCT
ajlm-2613	32	24	in	in	ADP
ajlm-2613	32	25	this	this	DET
ajlm-2613	32	26	regard	regard	NOUN
ajlm-2613	32	27	,	,	PUNCT
ajlm-2613	32	28	excluded	exclude	VERB
ajlm-2613	32	29	case	case	NOUN
ajlm-2613	32	30	is	be	AUX
ajlm-2613	32	31	zero	zero	NUM
ajlm-2613	32	32	)	)	PUNCT
ajlm-2613	32	33	.	.	PUNCT
ajlm-2613	33	1	data	datum	NOUN
ajlm-2613	33	2	collection	collection	NOUN
ajlm-2613	33	3	data	datum	NOUN
ajlm-2613	33	4	,	,	PUNCT
ajlm-2613	33	5	such	such	ADJ
ajlm-2613	33	6	as	as	ADP
ajlm-2613	33	7	age	age	NOUN
ajlm-2613	33	8	,	,	PUNCT
ajlm-2613	33	9	site	site	NOUN
ajlm-2613	33	10	of	of	ADP
ajlm-2613	33	11	lesion	lesion	NOUN
ajlm-2613	33	12	,	,	PUNCT
ajlm-2613	33	13	histologic	histologic	ADJ
ajlm-2613	33	14	diagnosis	diagnosis	NOUN
ajlm-2613	33	15	,	,	PUNCT
ajlm-2613	33	16	and	and	CCONJ
ajlm-2613	33	17	grade	grade	NOUN
ajlm-2613	33	18	of	of	ADP
ajlm-2613	33	19	the	the	DET
ajlm-2613	33	20	disease	disease	NOUN
ajlm-2613	33	21	was	be	AUX
ajlm-2613	33	22	obtained	obtain	VERB
ajlm-2613	33	23	from	from	ADP
ajlm-2613	33	24	kano	kano	PROPN
ajlm-2613	33	25	cancer	cancer	PROPN
ajlm-2613	33	26	registry	registry	PROPN
ajlm-2613	33	27	,	,	PUNCT
ajlm-2613	33	28	pathology	pathology	NOUN
ajlm-2613	33	29	request	request	NOUN
ajlm-2613	33	30	forms	form	NOUN
ajlm-2613	33	31	,	,	PUNCT
ajlm-2613	33	32	patients	patient	NOUN
ajlm-2613	33	33	’	'	PUNCT
ajlm-2613	33	34	case	case	NOUN
ajlm-2613	33	35	notes	note	VERB
ajlm-2613	33	36	,	,	PUNCT
ajlm-2613	33	37	duplicate	duplicate	ADJ
ajlm-2613	33	38	copies	copy	NOUN
ajlm-2613	33	39	of	of	ADP
ajlm-2613	33	40	histopathological	histopathological	ADJ
ajlm-2613	33	41	reports	report	NOUN
ajlm-2613	33	42	,	,	PUNCT
ajlm-2613	33	43	and	and	CCONJ
ajlm-2613	33	44	slide	slide	NOUN
ajlm-2613	33	45	reviews	review	NOUN
ajlm-2613	33	46	of	of	ADP
ajlm-2613	33	47	cases	case	NOUN
ajlm-2613	33	48	.	.	PUNCT
ajlm-2613	34	1	the	the	DET
ajlm-2613	34	2	patient	patient	NOUN
ajlm-2613	34	3	’s	’s	PART
ajlm-2613	34	4	identity	identity	NOUN
ajlm-2613	34	5	was	be	AUX
ajlm-2613	34	6	concealed	conceal	VERB
ajlm-2613	34	7	at	at	ADP
ajlm-2613	34	8	all	all	DET
ajlm-2613	34	9	times	time	NOUN
ajlm-2613	34	10	.	.	PUNCT
ajlm-2613	35	1	the	the	DET
ajlm-2613	35	2	cases	case	NOUN
ajlm-2613	35	3	were	be	AUX
ajlm-2613	35	4	classified	classify	VERB
ajlm-2613	35	5	and	and	CCONJ
ajlm-2613	35	6	graded	grade	VERB
ajlm-2613	35	7	according	accord	VERB
ajlm-2613	35	8	to	to	ADP
ajlm-2613	35	9	the	the	DET
ajlm-2613	35	10	world	world	PROPN
ajlm-2613	35	11	health	health	NOUN
ajlm-2613	35	12	organization	organization	PROPN
ajlm-2613	35	13	classification	classification	NOUN
ajlm-2613	35	14	of	of	ADP
ajlm-2613	35	15	tumours	tumour	NOUN
ajlm-2613	35	16	of	of	ADP
ajlm-2613	35	17	the	the	DET
ajlm-2613	35	18	colon	colon	NOUN
ajlm-2613	35	19	and	and	CCONJ
ajlm-2613	35	20	rectum.19	rectum.19	NOUN
ajlm-2613	35	21	the	the	DET
ajlm-2613	35	22	two	two	NUM
ajlm-2613	35	23	-	-	PUNCT
ajlm-2613	35	24	tiered	tiere	VERB
ajlm-2613	35	25	system	system	NOUN
ajlm-2613	35	26	of	of	ADP
ajlm-2613	35	27	grading	grading	NOUN
ajlm-2613	35	28	was	be	AUX
ajlm-2613	35	29	used	use	VERB
ajlm-2613	35	30	based	base	VERB
ajlm-2613	35	31	on	on	ADP
ajlm-2613	35	32	prognosis	prognosis	NOUN
ajlm-2613	35	33	:	:	PUNCT
ajlm-2613	35	34	low	low	ADJ
ajlm-2613	35	35	grade	grade	NOUN
ajlm-2613	35	36	and	and	CCONJ
ajlm-2613	35	37	high	high	ADJ
ajlm-2613	35	38	grade.19	grade.19	NOUN
ajlm-2613	35	39	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2613	35	40	for	for	SCONJ
ajlm-2613	35	41	cyclooxygenase-2	cyclooxygenase-2	NUM
ajlm-2613	35	42	expression	expression	NOUN
ajlm-2613	35	43	immunohistochemical	immunohistochemical	ADJ
ajlm-2613	35	44	staining	staining	NOUN
ajlm-2613	35	45	was	be	AUX
ajlm-2613	35	46	performed	perform	VERB
ajlm-2613	35	47	using	use	VERB
ajlm-2613	35	48	anti	anti	ADJ
ajlm-2613	35	49	-	-	ADJ
ajlm-2613	35	50	cox-2	cox-2	ADJ
ajlm-2613	35	51	rabbit	rabbit	NOUN
ajlm-2613	35	52	polyclonal	polyclonal	ADJ
ajlm-2613	35	53	antibody	antibody	NOUN
ajlm-2613	35	54	(	(	PUNCT
ajlm-2613	35	55	elabscience	elabscience	NOUN
ajlm-2613	35	56	,	,	PUNCT
ajlm-2613	35	57	houston	houston	PROPN
ajlm-2613	35	58	,	,	PUNCT
ajlm-2613	35	59	texas	texas	PROPN
ajlm-2613	35	60	,	,	PUNCT
ajlm-2613	35	61	united	united	PROPN
ajlm-2613	35	62	states	states	PROPN
ajlm-2613	35	63	;	;	PUNCT
ajlm-2613	36	1	catalogue	catalogue	NOUN
ajlm-2613	36	2	no	no	NOUN
ajlm-2613	36	3	.	.	PUNCT
ajlm-2613	37	1	e	e	X
ajlm-2613	37	2	-	-	NOUN
ajlm-2613	37	3	ab-70031	ab-70031	NOUN
ajlm-2613	37	4	)	)	PUNCT
ajlm-2613	37	5	,	,	PUNCT
ajlm-2613	37	6	used	use	VERB
ajlm-2613	37	7	at	at	ADP
ajlm-2613	37	8	a	a	DET
ajlm-2613	37	9	1:500	1:500	NUM
ajlm-2613	37	10	dilution	dilution	NOUN
ajlm-2613	37	11	according	accord	VERB
ajlm-2613	37	12	to	to	ADP
ajlm-2613	37	13	standard	standard	ADJ
ajlm-2613	37	14	immunohistochemical	immunohistochemical	ADJ
ajlm-2613	37	15	staining	stain	VERB
ajlm-2613	37	16	protocols	protocol	NOUN
ajlm-2613	37	17	.	.	PUNCT
ajlm-2613	38	1	the	the	DET
ajlm-2613	38	2	antibody	antibody	NOUN
ajlm-2613	38	3	was	be	AUX
ajlm-2613	38	4	stored	store	VERB
ajlm-2613	38	5	at	at	ADP
ajlm-2613	38	6	−20	−20	PROPN
ajlm-2613	38	7	°	°	ADP
ajlm-2613	38	8	c	c	NOUN
ajlm-2613	38	9	(	(	PUNCT
ajlm-2613	38	10	using	use	VERB
ajlm-2613	38	11	−25	−25	PROPN
ajlm-2613	38	12	°	°	ADP
ajlm-2613	38	13	c	c	NOUN
ajlm-2613	38	14	freezer	freezer	NOUN
ajlm-2613	38	15	110	110	NUM
ajlm-2613	38	16	l	l	NOUN
ajlm-2613	38	17	,	,	PUNCT
ajlm-2613	38	18	biobase	biobase	PROPN
ajlm-2613	38	19	scientific	scientific	PROPN
ajlm-2613	38	20	,	,	PUNCT
ajlm-2613	38	21	jinan	jinan	PROPN
ajlm-2613	38	22	,	,	PUNCT
ajlm-2613	38	23	shandong	shandong	PROPN
ajlm-2613	38	24	,	,	PUNCT
ajlm-2613	38	25	china	china	PROPN
ajlm-2613	38	26	)	)	PUNCT
ajlm-2613	38	27	and	and	CCONJ
ajlm-2613	38	28	it	it	PRON
ajlm-2613	38	29	was	be	AUX
ajlm-2613	38	30	centrifuged	centrifuge	VERB
ajlm-2613	38	31	(	(	PUNCT
ajlm-2613	38	32	using	use	VERB
ajlm-2613	38	33	lc-4k-2	lc-4k-2	NOUN
ajlm-2613	38	34	centrifuge	centrifuge	NOUN
ajlm-2613	38	35	,	,	PUNCT
ajlm-2613	38	36	biobase	biobase	PROPN
ajlm-2613	38	37	scientific	scientific	PROPN
ajlm-2613	38	38	,	,	PUNCT
ajlm-2613	38	39	jinan	jinan	PROPN
ajlm-2613	38	40	,	,	PUNCT
ajlm-2613	38	41	shandong	shandong	PROPN
ajlm-2613	38	42	,	,	PUNCT
ajlm-2613	38	43	china	china	PROPN
ajlm-2613	38	44	)	)	PUNCT
ajlm-2613	38	45	before	before	ADP
ajlm-2613	38	46	opening	open	VERB
ajlm-2613	38	47	to	to	PART
ajlm-2613	38	48	ensure	ensure	VERB
ajlm-2613	38	49	complete	complete	ADJ
ajlm-2613	38	50	recovery	recovery	NOUN
ajlm-2613	38	51	of	of	ADP
ajlm-2613	38	52	contents	content	NOUN
ajlm-2613	38	53	.	.	PUNCT
ajlm-2613	39	1	a	a	DET
ajlm-2613	39	2	kidney	kidney	NOUN
ajlm-2613	39	3	sample	sample	NOUN
ajlm-2613	39	4	(	(	PUNCT
ajlm-2613	39	5	an	an	DET
ajlm-2613	39	6	autopsy	autopsy	ADJ
ajlm-2613	39	7	sample	sample	NOUN
ajlm-2613	39	8	)	)	PUNCT
ajlm-2613	39	9	with	with	ADP
ajlm-2613	39	10	intact	intact	ADJ
ajlm-2613	39	11	renal	renal	ADJ
ajlm-2613	39	12	tubules	tubule	NOUN
ajlm-2613	39	13	was	be	AUX
ajlm-2613	39	14	used	use	VERB
ajlm-2613	39	15	as	as	ADP
ajlm-2613	39	16	a	a	DET
ajlm-2613	39	17	positive	positive	ADJ
ajlm-2613	39	18	control	control	NOUN
ajlm-2613	39	19	,	,	PUNCT
ajlm-2613	39	20	while	while	SCONJ
ajlm-2613	39	21	a	a	DET
ajlm-2613	39	22	negative	negative	ADJ
ajlm-2613	39	23	control	control	NOUN
ajlm-2613	39	24	was	be	AUX
ajlm-2613	39	25	obtained	obtain	VERB
ajlm-2613	39	26	by	by	ADP
ajlm-2613	39	27	replacing	replace	VERB
ajlm-2613	39	28	the	the	DET
ajlm-2613	39	29	primary	primary	ADJ
ajlm-2613	39	30	antibody	antibody	NOUN
ajlm-2613	39	31	with	with	ADP
ajlm-2613	39	32	distilled	distil	VERB
ajlm-2613	39	33	water	water	NOUN
ajlm-2613	39	34	.	.	PUNCT
ajlm-2613	40	1	tissue	tissue	NOUN
ajlm-2613	40	2	preparations	preparation	NOUN
ajlm-2613	40	3	(	(	PUNCT
ajlm-2613	40	4	formalin	formalin	NOUN
ajlm-2613	40	5	-	-	PUNCT
ajlm-2613	40	6	fixed	fix	VERB
ajlm-2613	40	7	paraffin	paraffin	NOUN
ajlm-2613	40	8	-	-	PUNCT
ajlm-2613	40	9	embedded	embed	VERB
ajlm-2613	40	10	tissue	tissue	NOUN
ajlm-2613	40	11	blocks	block	NOUN
ajlm-2613	40	12	)	)	PUNCT
ajlm-2613	40	13	formalin	formalin	NOUN
ajlm-2613	40	14	-	-	PUNCT
ajlm-2613	40	15	fixed	fix	VERB
ajlm-2613	40	16	paraffin	paraffin	NOUN
ajlm-2613	40	17	-	-	PUNCT
ajlm-2613	40	18	embedded	embed	VERB
ajlm-2613	40	19	tissues	tissue	NOUN
ajlm-2613	40	20	retrieved	retrieve	VERB
ajlm-2613	40	21	were	be	AUX
ajlm-2613	40	22	cut	cut	VERB
ajlm-2613	40	23	or	or	CCONJ
ajlm-2613	40	24	sectioned	section	VERB
ajlm-2613	40	25	at	at	ADP
ajlm-2613	40	26	3	3	NUM
ajlm-2613	40	27	µm	µm	ADP
ajlm-2613	40	28	using	use	VERB
ajlm-2613	40	29	a	a	DET
ajlm-2613	40	30	bk-2218	bk-2218	NOUN
ajlm-2613	40	31	microtome	microtome	NOUN
ajlm-2613	40	32	(	(	PUNCT
ajlm-2613	40	33	biobase	biobase	PROPN
ajlm-2613	40	34	scientific	scientific	PROPN
ajlm-2613	40	35	,	,	PUNCT
ajlm-2613	40	36	jinan	jinan	PROPN
ajlm-2613	40	37	,	,	PUNCT
ajlm-2613	40	38	shandong	shandong	PROPN
ajlm-2613	40	39	,	,	PUNCT
ajlm-2613	40	40	china	china	PROPN
ajlm-2613	40	41	)	)	PUNCT
ajlm-2613	40	42	.	.	PUNCT
ajlm-2613	41	1	the	the	DET
ajlm-2613	41	2	tissue	tissue	NOUN
ajlm-2613	41	3	slides	slide	NOUN
ajlm-2613	41	4	were	be	AUX
ajlm-2613	41	5	left	leave	VERB
ajlm-2613	41	6	to	to	PART
ajlm-2613	41	7	dry	dry	VERB
ajlm-2613	41	8	in	in	ADP
ajlm-2613	41	9	an	an	DET
ajlm-2613	41	10	oven	oven	NOUN
ajlm-2613	41	11	for	for	ADP
ajlm-2613	41	12	2	2	NUM
ajlm-2613	41	13	h	h	NOUN
ajlm-2613	41	14	at	at	ADP
ajlm-2613	41	15	60	60	NUM
ajlm-2613	41	16	°	°	ADP
ajlm-2613	41	17	c	c	NOUN
ajlm-2613	41	18	after	after	ADP
ajlm-2613	41	19	microtomy	microtomy	NOUN
ajlm-2613	41	20	.	.	PUNCT
ajlm-2613	42	1	then	then	ADV
ajlm-2613	42	2	,	,	PUNCT
ajlm-2613	42	3	the	the	DET
ajlm-2613	42	4	slides	slide	NOUN
ajlm-2613	42	5	were	be	AUX
ajlm-2613	42	6	dewaxed	dewaxe	VERB
ajlm-2613	42	7	in	in	ADP
ajlm-2613	42	8	xylene	xylene	NOUN
ajlm-2613	42	9	(	(	PUNCT
ajlm-2613	42	10	obtained	obtain	VERB
ajlm-2613	42	11	from	from	ADP
ajlm-2613	42	12	central	central	ADJ
ajlm-2613	42	13	drug	drug	PROPN
ajlm-2613	42	14	house	house	PROPN
ajlm-2613	42	15	ltd	ltd	PROPN
ajlm-2613	42	16	,	,	PUNCT
ajlm-2613	42	17	daryaganji	daryaganji	PROPN
ajlm-2613	42	18	,	,	PUNCT
ajlm-2613	42	19	new	new	ADJ
ajlm-2613	42	20	delhi	delhi	PROPN
ajlm-2613	42	21	,	,	PUNCT
ajlm-2613	42	22	india	india	PROPN
ajlm-2613	42	23	)	)	PUNCT
ajlm-2613	42	24	for	for	ADP
ajlm-2613	42	25	1	1	NUM
ajlm-2613	42	26	min	min	NOUN
ajlm-2613	42	27	,	,	PUNCT
ajlm-2613	42	28	and	and	CCONJ
ajlm-2613	42	29	then	then	ADV
ajlm-2613	42	30	passed	pass	VERB
ajlm-2613	42	31	through	through	ADP
ajlm-2613	42	32	decreasing	decrease	VERB
ajlm-2613	42	33	concentrations	concentration	NOUN
ajlm-2613	42	34	of	of	ADP
ajlm-2613	42	35	alcohol	alcohol	NOUN
ajlm-2613	42	36	at	at	ADP
ajlm-2613	42	37	100	100	NUM
ajlm-2613	42	38	%	%	NOUN
ajlm-2613	42	39	,	,	PUNCT
ajlm-2613	42	40	95	95	NUM
ajlm-2613	42	41	%	%	NOUN
ajlm-2613	42	42	and	and	CCONJ
ajlm-2613	42	43	70	70	NUM
ajlm-2613	42	44	%	%	NOUN
ajlm-2613	42	45	for	for	ADP
ajlm-2613	42	46	1	1	NUM
ajlm-2613	42	47	min	min	NOUN
ajlm-2613	42	48	each	each	PRON
ajlm-2613	42	49	for	for	ADP
ajlm-2613	42	50	rehydration	rehydration	NOUN
ajlm-2613	42	51	of	of	ADP
ajlm-2613	42	52	sections	section	NOUN
ajlm-2613	42	53	.	.	PUNCT
ajlm-2613	43	1	antigen	antigen	ADJ
ajlm-2613	43	2	retrieval	retrieval	NOUN
ajlm-2613	43	3	or	or	CCONJ
ajlm-2613	43	4	unmasking	unmask	VERB
ajlm-2613	43	5	of	of	ADP
ajlm-2613	43	6	antigen	antigen	ADJ
ajlm-2613	43	7	sites	site	NOUN
ajlm-2613	43	8	antigen	antigen	ADP
ajlm-2613	43	9	retrieval	retrieval	NOUN
ajlm-2613	43	10	was	be	AUX
ajlm-2613	43	11	done	do	VERB
ajlm-2613	43	12	by	by	ADP
ajlm-2613	43	13	placing	place	VERB
ajlm-2613	43	14	the	the	DET
ajlm-2613	43	15	slides	slide	NOUN
ajlm-2613	43	16	in	in	ADP
ajlm-2613	43	17	100	100	NUM
ajlm-2613	43	18	ml	ml	NOUN
ajlm-2613	43	19	of	of	ADP
ajlm-2613	43	20	citrate	citrate	NOUN
ajlm-2613	43	21	buffer	buffer	NOUN
ajlm-2613	43	22	(	(	PUNCT
ajlm-2613	43	23	ph	ph	NOUN
ajlm-2613	43	24	6	6	NUM
ajlm-2613	43	25	)	)	PUNCT
ajlm-2613	43	26	(	(	PUNCT
ajlm-2613	43	27	obtained	obtain	VERB
ajlm-2613	43	28	from	from	ADP
ajlm-2613	43	29	central	central	ADJ
ajlm-2613	43	30	drug	drug	PROPN
ajlm-2613	43	31	house	house	PROPN
ajlm-2613	43	32	ltd	ltd	PROPN
ajlm-2613	43	33	,	,	PUNCT
ajlm-2613	43	34	daryaganji	daryaganji	PROPN
ajlm-2613	43	35	,	,	PUNCT
ajlm-2613	43	36	new	new	ADJ
ajlm-2613	43	37	delhi	delhi	PROPN
ajlm-2613	43	38	,	,	PUNCT
ajlm-2613	43	39	india	india	PROPN
ajlm-2613	43	40	)	)	PUNCT
ajlm-2613	43	41	,	,	PUNCT
ajlm-2613	43	42	and	and	CCONJ
ajlm-2613	43	43	then	then	ADV
ajlm-2613	43	44	heating	heating	NOUN
ajlm-2613	43	45	using	use	VERB
ajlm-2613	43	46	the	the	DET
ajlm-2613	43	47	microwave	microwave	NOUN
ajlm-2613	43	48	(	(	PUNCT
ajlm-2613	43	49	tp	tp	NOUN
ajlm-2613	43	50	-	-	PUNCT
ajlm-2613	43	51	j1	j1	NOUN
ajlm-2613	43	52	-	-	PUNCT
ajlm-2613	43	53	8	8	NUM
ajlm-2613	43	54	microwave	microwave	NOUN
ajlm-2613	43	55	,	,	PUNCT
ajlm-2613	43	56	chongqing	chongqe	VERB
ajlm-2613	43	57	top	top	ADJ
ajlm-2613	43	58	oil	oil	NOUN
ajlm-2613	43	59	purifier	purifier	PROPN
ajlm-2613	43	60	co.	co.	PROPN
ajlm-2613	43	61	ltd	ltd	PROPN
ajlm-2613	43	62	,	,	PUNCT
ajlm-2613	43	63	jiulongpo	jiulongpo	NOUN
ajlm-2613	43	64	,	,	PUNCT
ajlm-2613	43	65	chongqing	chongqing	PROPN
ajlm-2613	43	66	,	,	PUNCT
ajlm-2613	43	67	china	china	PROPN
ajlm-2613	43	68	)	)	PUNCT
ajlm-2613	43	69	heating	heating	NOUN
ajlm-2613	43	70	retrieval	retrieval	NOUN
ajlm-2613	43	71	method	method	NOUN
ajlm-2613	43	72	at	at	ADP
ajlm-2613	43	73	100	100	NUM
ajlm-2613	43	74	°	°	ADP
ajlm-2613	43	75	c	c	NOUN
ajlm-2613	43	76	for	for	ADP
ajlm-2613	43	77	15	15	NUM
ajlm-2613	43	78	min	min	NOUN
ajlm-2613	43	79	–	–	PUNCT
ajlm-2613	43	80	20	20	NUM
ajlm-2613	43	81	min	min	NOUN
ajlm-2613	43	82	.	.	PROPN
ajlm-2613	44	1	slides	slide	NOUN
ajlm-2613	44	2	were	be	AUX
ajlm-2613	44	3	then	then	ADV
ajlm-2613	44	4	washed	wash	VERB
ajlm-2613	44	5	in	in	ADP
ajlm-2613	44	6	distilled	distil	VERB
ajlm-2613	44	7	water	water	NOUN
ajlm-2613	44	8	for	for	ADP
ajlm-2613	44	9	another	another	DET
ajlm-2613	44	10	2	2	NUM
ajlm-2613	44	11	min	min	NOUN
ajlm-2613	44	12	and	and	CCONJ
ajlm-2613	44	13	then	then	ADV
ajlm-2613	44	14	washed	wash	VERB
ajlm-2613	44	15	twice	twice	ADV
ajlm-2613	44	16	with	with	ADP
ajlm-2613	44	17	phosphate	phosphate	ADJ
ajlm-2613	44	18	buffer	buffer	NOUN
ajlm-2613	44	19	(	(	PUNCT
ajlm-2613	44	20	obtained	obtain	VERB
ajlm-2613	44	21	from	from	ADP
ajlm-2613	44	22	central	central	ADJ
ajlm-2613	44	23	drug	drug	PROPN
ajlm-2613	44	24	house	house	PROPN
ajlm-2613	44	25	ltd	ltd	PROPN
ajlm-2613	44	26	,	,	PUNCT
ajlm-2613	44	27	daryaganji	daryaganji	PROPN
ajlm-2613	44	28	,	,	PUNCT
ajlm-2613	44	29	new	new	ADJ
ajlm-2613	44	30	delhi	delhi	PROPN
ajlm-2613	44	31	,	,	PUNCT
ajlm-2613	44	32	india	india	PROPN
ajlm-2613	44	33	)	)	PUNCT
ajlm-2613	44	34	for	for	ADP
ajlm-2613	44	35	3	3	NUM
ajlm-2613	44	36	min	min	NOUN
ajlm-2613	44	37	each	each	PRON
ajlm-2613	44	38	.	.	PUNCT
ajlm-2613	45	1	they	they	PRON
ajlm-2613	45	2	were	be	AUX
ajlm-2613	45	3	then	then	ADV
ajlm-2613	45	4	rinsed	rinse	VERB
ajlm-2613	45	5	in	in	ADP
ajlm-2613	45	6	distilled	distil	VERB
ajlm-2613	45	7	water	water	NOUN
ajlm-2613	45	8	for	for	ADP
ajlm-2613	45	9	2	2	NUM
ajlm-2613	45	10	min	min	NOUN
ajlm-2613	45	11	;	;	PUNCT
ajlm-2613	45	12	3	3	NUM
ajlm-2613	45	13	%	%	NOUN
ajlm-2613	45	14	of	of	ADP
ajlm-2613	45	15	hydrogen	hydrogen	NOUN
ajlm-2613	45	16	peroxide	peroxide	NOUN
ajlm-2613	45	17	was	be	AUX
ajlm-2613	45	18	added	add	VERB
ajlm-2613	45	19	and	and	CCONJ
ajlm-2613	45	20	left	leave	VERB
ajlm-2613	45	21	for	for	ADP
ajlm-2613	45	22	10	10	NUM
ajlm-2613	45	23	min	min	NOUN
ajlm-2613	45	24	.	.	PUNCT
ajlm-2613	46	1	slides	slide	NOUN
ajlm-2613	46	2	were	be	AUX
ajlm-2613	46	3	then	then	ADV
ajlm-2613	46	4	washed	wash	VERB
ajlm-2613	46	5	in	in	ADP
ajlm-2613	46	6	running	run	VERB
ajlm-2613	46	7	distilled	distil	VERB
ajlm-2613	46	8	water	water	NOUN
ajlm-2613	46	9	for	for	ADP
ajlm-2613	46	10	2	2	NUM
ajlm-2613	46	11	min	min	NOUN
ajlm-2613	46	12	and	and	CCONJ
ajlm-2613	46	13	incubated	incubate	VERB
ajlm-2613	46	14	with	with	ADP
ajlm-2613	46	15	a	a	DET
ajlm-2613	46	16	blocking	block	VERB
ajlm-2613	46	17	reagent	reagent	NOUN
ajlm-2613	46	18	(	(	PUNCT
ajlm-2613	46	19	serum	serum	NOUN
ajlm-2613	46	20	;	;	PUNCT
ajlm-2613	46	21	elabscience	elabscience	NOUN
ajlm-2613	46	22	,	,	PUNCT
ajlm-2613	46	23	houston	houston	PROPN
ajlm-2613	46	24	,	,	PUNCT
ajlm-2613	46	25	texas	texas	PROPN
ajlm-2613	46	26	,	,	PUNCT
ajlm-2613	46	27	united	united	PROPN
ajlm-2613	46	28	states	states	PROPN
ajlm-2613	46	29	)	)	PUNCT
ajlm-2613	46	30	for	for	ADP
ajlm-2613	46	31	10	10	NUM
ajlm-2613	46	32	min	min	NOUN
ajlm-2613	46	33	.	.	NOUN
ajlm-2613	46	34	blockage	blockage	NOUN
ajlm-2613	46	35	of	of	ADP
ajlm-2613	46	36	endogenous	endogenous	ADJ
ajlm-2613	46	37	peroxidase	peroxidase	NOUN
ajlm-2613	46	38	to	to	PART
ajlm-2613	46	39	block	block	VERB
ajlm-2613	46	40	non	non	ADJ
ajlm-2613	46	41	-	-	ADJ
ajlm-2613	46	42	specific	specific	ADJ
ajlm-2613	46	43	antigen	antigen	ADJ
ajlm-2613	46	44	sites	site	NOUN
ajlm-2613	46	45	,	,	PUNCT
ajlm-2613	46	46	tissue	tissue	NOUN
ajlm-2613	46	47	sections	section	NOUN
ajlm-2613	46	48	were	be	AUX
ajlm-2613	46	49	incubated	incubate	VERB
ajlm-2613	46	50	for	for	ADP
ajlm-2613	46	51	1	1	NUM
ajlm-2613	46	52	h	h	NOUN
ajlm-2613	46	53	in	in	ADP
ajlm-2613	46	54	1.5	1.5	NUM
ajlm-2613	46	55	%	%	NOUN
ajlm-2613	46	56	bovine	bovine	NOUN
ajlm-2613	46	57	serum	serum	NOUN
ajlm-2613	46	58	albumin	albumin	NOUN
ajlm-2613	46	59	(	(	PUNCT
ajlm-2613	46	60	obtained	obtain	VERB
ajlm-2613	46	61	from	from	ADP
ajlm-2613	46	62	central	central	ADJ
ajlm-2613	46	63	drug	drug	PROPN
ajlm-2613	46	64	house	house	PROPN
ajlm-2613	46	65	ltd	ltd	PROPN
ajlm-2613	46	66	,	,	PUNCT
ajlm-2613	46	67	daryaganji	daryaganji	PROPN
ajlm-2613	46	68	,	,	PUNCT
ajlm-2613	46	69	new	new	ADJ
ajlm-2613	46	70	delhi	delhi	PROPN
ajlm-2613	46	71	,	,	PUNCT
ajlm-2613	46	72	india	india	PROPN
ajlm-2613	46	73	)	)	PUNCT
ajlm-2613	46	74	at	at	ADP
ajlm-2613	46	75	room	room	NOUN
ajlm-2613	46	76	temperature.20	temperature.20	NOUN
ajlm-2613	46	77	immunostaining	immunostaining	NOUN
ajlm-2613	46	78	procedure	procedure	NOUN
ajlm-2613	46	79	each	each	DET
ajlm-2613	46	80	slide	slide	NOUN
ajlm-2613	46	81	was	be	AUX
ajlm-2613	46	82	wiped	wipe	VERB
ajlm-2613	46	83	with	with	ADP
ajlm-2613	46	84	cotton	cotton	NOUN
ajlm-2613	46	85	wool	wool	NOUN
ajlm-2613	46	86	to	to	PART
ajlm-2613	46	87	remove	remove	VERB
ajlm-2613	46	88	excess	excess	ADJ
ajlm-2613	46	89	blocking	blocking	NOUN
ajlm-2613	46	90	solution	solution	NOUN
ajlm-2613	46	91	.	.	PUNCT
ajlm-2613	47	1	incubation	incubation	NOUN
ajlm-2613	47	2	with	with	ADP
ajlm-2613	47	3	the	the	DET
ajlm-2613	47	4	primary	primary	ADJ
ajlm-2613	47	5	antibodies	antibody	NOUN
ajlm-2613	47	6	was	be	AUX
ajlm-2613	47	7	carried	carry	VERB
ajlm-2613	47	8	out	out	ADP
ajlm-2613	47	9	at	at	ADP
ajlm-2613	47	10	room	room	NOUN
ajlm-2613	47	11	temperature	temperature	NOUN
ajlm-2613	47	12	for	for	ADP
ajlm-2613	47	13	30	30	NUM
ajlm-2613	47	14	min	min	NOUN
ajlm-2613	47	15	with	with	ADP
ajlm-2613	47	16	200	200	NUM
ajlm-2613	47	17	µl	µl	NOUN
ajlm-2613	47	18	of	of	ADP
ajlm-2613	47	19	anti	anti	ADJ
ajlm-2613	47	20	-	-	ADJ
ajlm-2613	47	21	cox-2	cox-2	ADJ
ajlm-2613	47	22	(	(	PUNCT
ajlm-2613	47	23	elabscience	elabscience	NOUN
ajlm-2613	47	24	,	,	PUNCT
ajlm-2613	47	25	houston	houston	PROPN
ajlm-2613	47	26	,	,	PUNCT
ajlm-2613	47	27	texas	texas	PROPN
ajlm-2613	47	28	,	,	PUNCT
ajlm-2613	47	29	united	united	PROPN
ajlm-2613	47	30	states	states	PROPN
ajlm-2613	47	31	;	;	PUNCT
ajlm-2613	47	32	catalogue	catalogue	NOUN
ajlm-2613	47	33	no	no	NOUN
ajlm-2613	47	34	.	.	PUNCT
ajlm-2613	48	1	e	e	X
ajlm-2613	48	2	-	-	NOUN
ajlm-2613	48	3	ab-70031	ab-70031	NOUN
ajlm-2613	48	4	)	)	PUNCT
ajlm-2613	48	5	.	.	PUNCT
ajlm-2613	49	1	following	follow	VERB
ajlm-2613	49	2	the	the	DET
ajlm-2613	49	3	primary	primary	ADJ
ajlm-2613	49	4	antibody	antibody	NOUN
ajlm-2613	49	5	incubation	incubation	NOUN
ajlm-2613	49	6	step	step	NOUN
ajlm-2613	49	7	,	,	PUNCT
ajlm-2613	49	8	a	a	DET
ajlm-2613	49	9	secondary	secondary	ADJ
ajlm-2613	49	10	antibody	antibody	NOUN
ajlm-2613	49	11	from	from	ADP
ajlm-2613	49	12	a	a	DET
ajlm-2613	49	13	streptavidin	streptavidin	NOUN
ajlm-2613	49	14	-	-	PUNCT
ajlm-2613	49	15	biotin	biotin	NOUN
ajlm-2613	49	16	complex	complex	ADJ
ajlm-2613	49	17	peroxidase	peroxidase	NOUN
ajlm-2613	49	18	kit	kit	NOUN
ajlm-2613	49	19	(	(	PUNCT
ajlm-2613	49	20	lsab+	lsab+	PROPN
ajlm-2613	49	21	kit	kit	PROPN
ajlm-2613	49	22	,	,	PUNCT
ajlm-2613	49	23	dako	dako	PROPN
ajlm-2613	49	24	,	,	PUNCT
ajlm-2613	49	25	copenhagen	copenhagen	PROPN
ajlm-2613	49	26	,	,	PUNCT
ajlm-2613	49	27	denmark	denmark	PROPN
ajlm-2613	49	28	)	)	PUNCT
ajlm-2613	49	29	was	be	AUX
ajlm-2613	49	30	then	then	ADV
ajlm-2613	49	31	incubated	incubate	VERB
ajlm-2613	49	32	by	by	ADP
ajlm-2613	49	33	the	the	DET
ajlm-2613	49	34	manufacturer	manufacturer	NOUN
ajlm-2613	49	35	’s	’s	PART
ajlm-2613	49	36	instructions	instruction	NOUN
ajlm-2613	49	37	.	.	PUNCT
ajlm-2613	50	1	peroxidase	peroxidase	NOUN
ajlm-2613	50	2	activity	activity	NOUN
ajlm-2613	50	3	was	be	AUX
ajlm-2613	50	4	also	also	ADV
ajlm-2613	50	5	developed	develop	VERB
ajlm-2613	50	6	with	with	ADP
ajlm-2613	50	7	the	the	DET
ajlm-2613	50	8	substrate	substrate	NOUN
ajlm-2613	50	9	3,3	3,3	NUM
ajlm-2613	50	10	-	-	ADJ
ajlm-2613	50	11	diaminobenzidine	diaminobenzidine	ADJ
ajlm-2613	50	12	tetrahydrochloride	tetrahydrochloride	NOUN
ajlm-2613	50	13	(	(	PUNCT
ajlm-2613	50	14	dako	dako	PROPN
ajlm-2613	50	15	)	)	PUNCT
ajlm-2613	50	16	by	by	ADP
ajlm-2613	50	17	incubating	incubate	VERB
ajlm-2613	50	18	the	the	DET
ajlm-2613	50	19	tissue	tissue	NOUN
ajlm-2613	50	20	sections	section	NOUN
ajlm-2613	50	21	in	in	ADP
ajlm-2613	50	22	3,3	3,3	NUM
ajlm-2613	50	23	-	-	ADJ
ajlm-2613	50	24	diaminobenzidine	diaminobenzidine	ADJ
ajlm-2613	50	25	tetrahydrochloride	tetrahydrochloride	NOUN
ajlm-2613	50	26	for	for	ADP
ajlm-2613	50	27	a	a	DET
ajlm-2613	50	28	period	period	NOUN
ajlm-2613	50	29	of	of	ADP
ajlm-2613	50	30	3	3	NUM
ajlm-2613	50	31	min.20	min.20	NOUN
ajlm-2613	50	32	the	the	DET
ajlm-2613	50	33	tissue	tissue	NOUN
ajlm-2613	50	34	slides	slide	NOUN
ajlm-2613	50	35	were	be	AUX
ajlm-2613	50	36	washed	wash	VERB
ajlm-2613	50	37	in	in	ADP
ajlm-2613	50	38	running	run	VERB
ajlm-2613	50	39	water	water	NOUN
ajlm-2613	50	40	for	for	ADP
ajlm-2613	50	41	a	a	DET
ajlm-2613	50	42	period	period	NOUN
ajlm-2613	50	43	of	of	ADP
ajlm-2613	50	44	3	3	NUM
ajlm-2613	50	45	min	min	NOUN
ajlm-2613	50	46	,	,	PUNCT
ajlm-2613	50	47	and	and	CCONJ
ajlm-2613	50	48	then	then	ADV
ajlm-2613	50	49	counterstained	counterstaine	VERB
ajlm-2613	50	50	with	with	ADP
ajlm-2613	50	51	haematoxylin	haematoxylin	NOUN
ajlm-2613	50	52	(	(	PUNCT
ajlm-2613	50	53	obtained	obtain	VERB
ajlm-2613	50	54	from	from	ADP
ajlm-2613	50	55	central	central	ADJ
ajlm-2613	50	56	drug	drug	PROPN
ajlm-2613	50	57	house	house	PROPN
ajlm-2613	50	58	ltd	ltd	PROPN
ajlm-2613	50	59	,	,	PUNCT
ajlm-2613	50	60	daryaganji	daryaganji	PROPN
ajlm-2613	50	61	,	,	PUNCT
ajlm-2613	50	62	new	new	ADJ
ajlm-2613	50	63	delhi	delhi	PROPN
ajlm-2613	50	64	,	,	PUNCT
ajlm-2613	50	65	india	india	PROPN
ajlm-2613	50	66	)	)	PUNCT
ajlm-2613	50	67	.	.	PUNCT
ajlm-2613	51	1	the	the	DET
ajlm-2613	51	2	tissue	tissue	NOUN
ajlm-2613	51	3	sections	section	NOUN
ajlm-2613	51	4	were	be	AUX
ajlm-2613	51	5	then	then	ADV
ajlm-2613	51	6	dehydrated	dehydrate	VERB
ajlm-2613	51	7	in	in	ADP
ajlm-2613	51	8	increasing	increase	VERB
ajlm-2613	51	9	concentrations	concentration	NOUN
ajlm-2613	51	10	of	of	ADP
ajlm-2613	51	11	alcohol	alcohol	NOUN
ajlm-2613	51	12	.	.	PUNCT
ajlm-2613	52	1	they	they	PRON
ajlm-2613	52	2	were	be	AUX
ajlm-2613	52	3	cleared	clear	VERB
ajlm-2613	52	4	in	in	ADP
ajlm-2613	52	5	xylene	xylene	NOUN
ajlm-2613	52	6	and	and	CCONJ
ajlm-2613	52	7	the	the	DET
ajlm-2613	52	8	application	application	NOUN
ajlm-2613	52	9	of	of	ADP
ajlm-2613	52	10	cover	cover	NOUN
ajlm-2613	52	11	slip	slip	NOUN
ajlm-2613	52	12	was	be	AUX
ajlm-2613	52	13	done	do	VERB
ajlm-2613	52	14	using	use	VERB
ajlm-2613	52	15	distyrene	distyrene	NOUN
ajlm-2613	52	16	plasticizer	plasticizer	NOUN
ajlm-2613	52	17	xylene	xylene	NOUN
ajlm-2613	52	18	(	(	PUNCT
ajlm-2613	52	19	obtained	obtain	VERB
ajlm-2613	52	20	from	from	ADP
ajlm-2613	52	21	central	central	ADJ
ajlm-2613	52	22	drug	drug	PROPN
ajlm-2613	52	23	house	house	PROPN
ajlm-2613	52	24	ltd	ltd	PROPN
ajlm-2613	52	25	,	,	PUNCT
ajlm-2613	52	26	daryaganji	daryaganji	PROPN
ajlm-2613	52	27	,	,	PUNCT
ajlm-2613	52	28	new	new	ADJ
ajlm-2613	52	29	delhi	delhi	PROPN
ajlm-2613	52	30	,	,	PUNCT
ajlm-2613	52	31	india	india	PROPN
ajlm-2613	52	32	)	)	PUNCT
ajlm-2613	52	33	and	and	CCONJ
ajlm-2613	52	34	they	they	PRON
ajlm-2613	52	35	were	be	AUX
ajlm-2613	52	36	allowed	allow	VERB
ajlm-2613	52	37	to	to	PART
ajlm-2613	52	38	dry	dry	VERB
ajlm-2613	52	39	.	.	PUNCT
ajlm-2613	53	1	the	the	DET
ajlm-2613	53	2	slides	slide	NOUN
ajlm-2613	53	3	were	be	AUX
ajlm-2613	53	4	viewed	view	VERB
ajlm-2613	53	5	under	under	ADP
ajlm-2613	53	6	the	the	DET
ajlm-2613	53	7	light	light	ADJ
ajlm-2613	53	8	microscope	microscope	NOUN
ajlm-2613	53	9	(	(	PUNCT
ajlm-2613	53	10	dm	dm	PROPN
ajlm-2613	53	11	500	500	NUM
ajlm-2613	53	12	binocular	binocular	ADJ
ajlm-2613	53	13	leica	leica	PROPN
ajlm-2613	53	14	microscope	microscope	PROPN
ajlm-2613	53	15	,	,	PUNCT
ajlm-2613	53	16	leica	leica	PROPN
ajlm-2613	53	17	microsystems	microsystem	NOUN
ajlm-2613	53	18	,	,	PUNCT
ajlm-2613	53	19	wetzlar	wetzlar	ADJ
ajlm-2613	53	20	,	,	PUNCT
ajlm-2613	53	21	hessen	hessen	PROPN
ajlm-2613	53	22	,	,	PUNCT
ajlm-2613	53	23	germany	germany	PROPN
ajlm-2613	53	24	)	)	PUNCT
ajlm-2613	53	25	,	,	PUNCT
ajlm-2613	53	26	brown	brown	ADJ
ajlm-2613	53	27	cytoplasmic	cytoplasmic	ADJ
ajlm-2613	53	28	and	and	CCONJ
ajlm-2613	53	29	membranous	membranous	ADJ
ajlm-2613	53	30	staining	stain	VERB
ajlm-2613	53	31	was	be	AUX
ajlm-2613	53	32	interpreted	interpret	VERB
ajlm-2613	53	33	as	as	ADP
ajlm-2613	53	34	positive	positive	ADJ
ajlm-2613	53	35	staining	staining	NOUN
ajlm-2613	53	36	,	,	PUNCT
ajlm-2613	53	37	and	and	CCONJ
ajlm-2613	53	38	was	be	AUX
ajlm-2613	53	39	scored	score	VERB
ajlm-2613	53	40	semi	semi	ADV
ajlm-2613	53	41	-	-	ADJ
ajlm-2613	53	42	quantitatively	quantitatively	ADV
ajlm-2613	53	43	using	use	VERB
ajlm-2613	53	44	the	the	DET
ajlm-2613	53	45	immunoreactive	immunoreactive	ADJ
ajlm-2613	53	46	score	score	NOUN
ajlm-2613	53	47	system	system	NOUN
ajlm-2613	53	48	,	,	PUNCT
ajlm-2613	53	49	a	a	DET
ajlm-2613	53	50	final	final	ADJ
ajlm-2613	53	51	score	score	NOUN
ajlm-2613	53	52	that	that	PRON
ajlm-2613	53	53	is	be	AUX
ajlm-2613	53	54	a	a	DET
ajlm-2613	53	55	product	product	NOUN
ajlm-2613	53	56	of	of	ADP
ajlm-2613	53	57	the	the	DET
ajlm-2613	53	58	intensity	intensity	NOUN
ajlm-2613	53	59	and	and	CCONJ
ajlm-2613	53	60	distribution	distribution	NOUN
ajlm-2613	53	61	of	of	ADP
ajlm-2613	53	62	cox-2	cox-2	NOUN
ajlm-2613	53	63	immunoreactivity.20,21,22	immunoreactivity.20,21,22	X
ajlm-2613	53	64	the	the	DET
ajlm-2613	53	65	intensity	intensity	NOUN
ajlm-2613	53	66	of	of	ADP
ajlm-2613	53	67	staining	stain	VERB
ajlm-2613	53	68	was	be	AUX
ajlm-2613	53	69	scored	score	VERB
ajlm-2613	53	70	as	as	ADP
ajlm-2613	53	71	0	0	NUM
ajlm-2613	53	72	for	for	ADP
ajlm-2613	53	73	no	no	DET
ajlm-2613	53	74	staining	stain	VERB
ajlm-2613	53	75	,	,	PUNCT
ajlm-2613	53	76	1	1	NUM
ajlm-2613	53	77	for	for	ADP
ajlm-2613	53	78	weak	weak	ADJ
ajlm-2613	53	79	staining	staining	NOUN
ajlm-2613	53	80	,	,	PUNCT
ajlm-2613	53	81	2	2	NUM
ajlm-2613	53	82	for	for	ADP
ajlm-2613	53	83	moderate	moderate	ADJ
ajlm-2613	53	84	,	,	PUNCT
ajlm-2613	53	85	and	and	CCONJ
ajlm-2613	53	86	3	3	NUM
ajlm-2613	53	87	for	for	ADP
ajlm-2613	53	88	strong	strong	ADJ
ajlm-2613	53	89	staining	staining	NOUN
ajlm-2613	53	90	.	.	PUNCT
ajlm-2613	54	1	the	the	DET
ajlm-2613	54	2	percentage	percentage	NOUN
ajlm-2613	54	3	of	of	ADP
ajlm-2613	54	4	positive	positive	ADJ
ajlm-2613	54	5	tumour	tumour	NOUN
ajlm-2613	54	6	cells	cell	NOUN
ajlm-2613	54	7	was	be	AUX
ajlm-2613	54	8	scored	score	VERB
ajlm-2613	54	9	:	:	PUNCT
ajlm-2613	54	10	0	0	NUM
ajlm-2613	54	11	indicating	indicate	VERB
ajlm-2613	54	12	no	no	DET
ajlm-2613	54	13	cell	cell	NOUN
ajlm-2613	54	14	with	with	ADP
ajlm-2613	54	15	a	a	DET
ajlm-2613	54	16	positive	positive	ADJ
ajlm-2613	54	17	reaction	reaction	NOUN
ajlm-2613	54	18	,	,	PUNCT
ajlm-2613	54	19	1	1	NUM
ajlm-2613	54	20	indicating	indicate	VERB
ajlm-2613	54	21	1	1	NUM
ajlm-2613	54	22	%	%	NOUN
ajlm-2613	54	23	–	–	PUNCT
ajlm-2613	54	24	10	10	NUM
ajlm-2613	54	25	%	%	NOUN
ajlm-2613	54	26	of	of	ADP
ajlm-2613	54	27	cells	cell	NOUN
ajlm-2613	54	28	with	with	ADP
ajlm-2613	54	29	a	a	DET
ajlm-2613	54	30	positive	positive	ADJ
ajlm-2613	54	31	reaction	reaction	NOUN
ajlm-2613	54	32	,	,	PUNCT
ajlm-2613	54	33	2	2	NUM
ajlm-2613	54	34	indicating	indicate	VERB
ajlm-2613	54	35	11	11	NUM
ajlm-2613	54	36	%	%	NOUN
ajlm-2613	54	37	–	–	PUNCT
ajlm-2613	54	38	50	50	NUM
ajlm-2613	54	39	%	%	NOUN
ajlm-2613	54	40	of	of	ADP
ajlm-2613	54	41	cells	cell	NOUN
ajlm-2613	54	42	with	with	ADP
ajlm-2613	54	43	a	a	DET
ajlm-2613	54	44	positive	positive	ADJ
ajlm-2613	54	45	reaction	reaction	NOUN
ajlm-2613	54	46	,	,	PUNCT
ajlm-2613	54	47	3	3	NUM
ajlm-2613	54	48	indicating	indicate	VERB
ajlm-2613	54	49	51	51	NUM
ajlm-2613	54	50	%	%	NOUN
ajlm-2613	54	51	–	–	PUNCT
ajlm-2613	54	52	80	80	NUM
ajlm-2613	54	53	%	%	NOUN
ajlm-2613	54	54	of	of	ADP
ajlm-2613	54	55	cells	cell	NOUN
ajlm-2613	54	56	with	with	ADP
ajlm-2613	54	57	a	a	DET
ajlm-2613	54	58	positive	positive	ADJ
ajlm-2613	54	59	reaction	reaction	NOUN
ajlm-2613	54	60	,	,	PUNCT
ajlm-2613	54	61	and	and	CCONJ
ajlm-2613	54	62	4	4	NUM
ajlm-2613	54	63	indicating	indicate	VERB
ajlm-2613	54	64	greater	great	ADJ
ajlm-2613	54	65	than	than	ADP
ajlm-2613	54	66	80	80	NUM
ajlm-2613	54	67	%	%	NOUN
ajlm-2613	54	68	of	of	ADP
ajlm-2613	54	69	cells	cell	NOUN
ajlm-2613	54	70	with	with	ADP
ajlm-2613	54	71	a	a	DET
ajlm-2613	54	72	positive	positive	ADJ
ajlm-2613	54	73	reaction	reaction	NOUN
ajlm-2613	54	74	.	.	PUNCT
ajlm-2613	55	1	the	the	DET
ajlm-2613	55	2	final	final	ADJ
ajlm-2613	55	3	immunoreactive	immunoreactive	ADJ
ajlm-2613	55	4	score	score	NOUN
ajlm-2613	55	5	obtained	obtain	VERB
ajlm-2613	55	6	by	by	ADP
ajlm-2613	55	7	multiplying	multiply	VERB
ajlm-2613	55	8	the	the	DET
ajlm-2613	55	9	distribution	distribution	NOUN
ajlm-2613	55	10	and	and	CCONJ
ajlm-2613	55	11	intensity	intensity	NOUN
ajlm-2613	55	12	for	for	ADP
ajlm-2613	55	13	each	each	DET
ajlm-2613	55	14	tumour	tumour	NOUN
ajlm-2613	55	15	was	be	AUX
ajlm-2613	55	16	graded	grade	VERB
ajlm-2613	55	17	as	as	SCONJ
ajlm-2613	55	18	follows	follow	VERB
ajlm-2613	55	19	:	:	PUNCT
ajlm-2613	55	20	9–12	9–12	NOUN
ajlm-2613	55	21	strongly	strongly	ADV
ajlm-2613	55	22	positive	positive	ADJ
ajlm-2613	55	23	,	,	PUNCT
ajlm-2613	55	24	5–8	5–8	NOUN
ajlm-2613	55	25	moderately	moderately	ADV
ajlm-2613	55	26	positive	positive	ADJ
ajlm-2613	55	27	,	,	PUNCT
ajlm-2613	55	28	1–4	1–4	NUM
ajlm-2613	55	29	weakly	weakly	ADV
ajlm-2613	55	30	positive	positive	ADJ
ajlm-2613	55	31	,	,	PUNCT
ajlm-2613	55	32	and	and	CCONJ
ajlm-2613	55	33	0	0	NUM
ajlm-2613	55	34	negative	negative	ADJ
ajlm-2613	55	35	.	.	PUNCT
ajlm-2613	56	1	cyclooxygenase-2	cyclooxygenase-2	NUM
ajlm-2613	56	2	was	be	AUX
ajlm-2613	56	3	considered	consider	VERB
ajlm-2613	56	4	over	over	ADV
ajlm-2613	56	5	-	-	PUNCT
ajlm-2613	56	6	expressed	express	VERB
ajlm-2613	56	7	if	if	SCONJ
ajlm-2613	56	8	the	the	DET
ajlm-2613	56	9	immunoreactive	immunoreactive	ADJ
ajlm-2613	56	10	score	score	NOUN
ajlm-2613	56	11	is	be	AUX
ajlm-2613	56	12	moderate	moderate	ADJ
ajlm-2613	56	13	to	to	ADP
ajlm-2613	56	14	strong	strong	ADJ
ajlm-2613	56	15	(	(	PUNCT
ajlm-2613	56	16	that	that	PRON
ajlm-2613	56	17	is	be	AUX
ajlm-2613	56	18	a	a	DET
ajlm-2613	56	19	score	score	NOUN
ajlm-2613	56	20	of	of	ADP
ajlm-2613	56	21	5	5	NUM
ajlm-2613	56	22	to	to	PART
ajlm-2613	56	23	12	12	NUM
ajlm-2613	56	24	)	)	PUNCT
ajlm-2613	56	25	(	(	PUNCT
ajlm-2613	56	26	table	table	NOUN
ajlm-2613	56	27	1	1	NUM
ajlm-2613	56	28	)	)	PUNCT
ajlm-2613	56	29	.	.	PUNCT
ajlm-2613	57	1	table	table	NOUN
ajlm-2613	57	2	1	1	NUM
ajlm-2613	57	3	:	:	PUNCT
ajlm-2613	57	4	 	 	SPACE
ajlm-2613	57	5	cyclooxygenase-2	cyclooxygenase-2	PROPN
ajlm-2613	57	6	immunoreactive	immunoreactive	ADJ
ajlm-2613	57	7	scoring	scoring	NOUN
ajlm-2613	57	8	system	system	NOUN
ajlm-2613	57	9	at	at	ADP
ajlm-2613	57	10	aminu	aminu	PROPN
ajlm-2613	57	11	kano	kano	PROPN
ajlm-2613	57	12	teaching	teaching	PROPN
ajlm-2613	57	13	hospital	hospital	PROPN
ajlm-2613	57	14	,	,	PUNCT
ajlm-2613	57	15	kano	kano	PROPN
ajlm-2613	57	16	,	,	PUNCT
ajlm-2613	57	17	nigeria	nigeria	PROPN
ajlm-2613	57	18	,	,	PUNCT
ajlm-2613	57	19	january	january	PROPN
ajlm-2613	57	20	2015	2015	NUM
ajlm-2613	57	21	–	–	PUNCT
ajlm-2613	57	22	december	december	PROPN
ajlm-2613	57	23	2019	2019	NUM
ajlm-2613	57	24	.	.	PUNCT
ajlm-2613	58	1	statistical	statistical	ADJ
ajlm-2613	58	2	analysis	analysis	NOUN
ajlm-2613	58	3	statistical	statistical	ADJ
ajlm-2613	58	4	analysis	analysis	NOUN
ajlm-2613	58	5	was	be	AUX
ajlm-2613	58	6	performed	perform	VERB
ajlm-2613	58	7	using	use	VERB
ajlm-2613	58	8	statistical	statistical	ADJ
ajlm-2613	58	9	package	package	NOUN
ajlm-2613	58	10	for	for	ADP
ajlm-2613	58	11	social	social	ADJ
ajlm-2613	58	12	sciences	science	NOUN
ajlm-2613	58	13	version	version	NOUN
ajlm-2613	58	14	25	25	NUM
ajlm-2613	58	15	(	(	PUNCT
ajlm-2613	58	16	ibm	ibm	PROPN
ajlm-2613	58	17	®	®	PROPN
ajlm-2613	58	18	corp	corp	PROPN
ajlm-2613	58	19	,	,	PUNCT
ajlm-2613	58	20	armonk	armonk	PROPN
ajlm-2613	58	21	,	,	PUNCT
ajlm-2613	58	22	new	new	PROPN
ajlm-2613	58	23	york	york	PROPN
ajlm-2613	58	24	,	,	PUNCT
ajlm-2613	58	25	united	united	PROPN
ajlm-2613	58	26	states	states	PROPN
ajlm-2613	58	27	)	)	PUNCT
ajlm-2613	58	28	.	.	PUNCT
ajlm-2613	59	1	chi	chi	ADJ
ajlm-2613	59	2	-	-	PUNCT
ajlm-2613	59	3	square	square	PROPN
ajlm-2613	59	4	was	be	AUX
ajlm-2613	59	5	used	use	VERB
ajlm-2613	59	6	with	with	ADP
ajlm-2613	59	7	statistical	statistical	ADJ
ajlm-2613	59	8	significance	significance	NOUN
ajlm-2613	59	9	set	set	VERB
ajlm-2613	59	10	at	at	ADP
ajlm-2613	59	11	p	p	NOUN
ajlm-2613	59	12	<	<	X
ajlm-2613	59	13	0.05	0.05	NUM
ajlm-2613	59	14	to	to	PART
ajlm-2613	59	15	test	test	VERB
ajlm-2613	59	16	the	the	DET
ajlm-2613	59	17	association	association	NOUN
ajlm-2613	59	18	between	between	ADP
ajlm-2613	59	19	the	the	DET
ajlm-2613	59	20	cox-2	cox-2	ADJ
ajlm-2613	59	21	expression	expression	NOUN
ajlm-2613	59	22	and	and	CCONJ
ajlm-2613	59	23	clinicopathological	clinicopathological	ADJ
ajlm-2613	59	24	parameters	parameter	NOUN
ajlm-2613	59	25	such	such	ADJ
ajlm-2613	59	26	as	as	ADP
ajlm-2613	59	27	age	age	NOUN
ajlm-2613	59	28	,	,	PUNCT
ajlm-2613	59	29	sex	sex	NOUN
ajlm-2613	59	30	,	,	PUNCT
ajlm-2613	59	31	histological	histological	ADJ
ajlm-2613	59	32	subtype	subtype	NOUN
ajlm-2613	59	33	,	,	PUNCT
ajlm-2613	59	34	and	and	CCONJ
ajlm-2613	59	35	grade	grade	NOUN
ajlm-2613	59	36	.	.	PUNCT
ajlm-2613	60	1	proportions	proportion	NOUN
ajlm-2613	60	2	and	and	CCONJ
ajlm-2613	60	3	central	central	ADJ
ajlm-2613	60	4	tendencies	tendency	NOUN
ajlm-2613	60	5	of	of	ADP
ajlm-2613	60	6	nominal	nominal	ADJ
ajlm-2613	60	7	and	and	CCONJ
ajlm-2613	60	8	continuous	continuous	ADJ
ajlm-2613	60	9	variables	variable	NOUN
ajlm-2613	60	10	were	be	AUX
ajlm-2613	60	11	obtained	obtain	VERB
ajlm-2613	60	12	by	by	ADP
ajlm-2613	60	13	descriptive	descriptive	ADJ
ajlm-2613	60	14	statistics	statistic	NOUN
ajlm-2613	60	15	of	of	ADP
ajlm-2613	60	16	frequency	frequency	NOUN
ajlm-2613	60	17	,	,	PUNCT
ajlm-2613	60	18	mean	mean	NOUN
ajlm-2613	60	19	and	and	CCONJ
ajlm-2613	60	20	median	median	ADJ
ajlm-2613	60	21	.	.	PUNCT
ajlm-2613	61	1	results	result	VERB
ajlm-2613	61	2	age	age	NOUN
ajlm-2613	61	3	distribution	distribution	NOUN
ajlm-2613	61	4	of	of	ADP
ajlm-2613	61	5	colorectal	colorectal	ADJ
ajlm-2613	61	6	adenomas	adenoma	NOUN
ajlm-2613	61	7	twenty	twenty	NUM
ajlm-2613	61	8	-	-	PUNCT
ajlm-2613	61	9	nine	nine	NUM
ajlm-2613	61	10	adenoma	adenoma	ADJ
ajlm-2613	61	11	cases	case	NOUN
ajlm-2613	61	12	were	be	AUX
ajlm-2613	61	13	analysed	analyse	VERB
ajlm-2613	61	14	,	,	PUNCT
ajlm-2613	61	15	and	and	CCONJ
ajlm-2613	61	16	26	26	NUM
ajlm-2613	61	17	cases	case	NOUN
ajlm-2613	61	18	were	be	AUX
ajlm-2613	61	19	endoscopic	endoscopic	ADJ
ajlm-2613	61	20	biopsies	biopsy	NOUN
ajlm-2613	61	21	.	.	PUNCT
ajlm-2613	62	1	the	the	DET
ajlm-2613	62	2	age	age	NOUN
ajlm-2613	62	3	distribution	distribution	NOUN
ajlm-2613	62	4	of	of	ADP
ajlm-2613	62	5	colorectal	colorectal	ADJ
ajlm-2613	62	6	adenoma	adenoma	ADJ
ajlm-2613	62	7	cases	case	NOUN
ajlm-2613	62	8	ranged	range	VERB
ajlm-2613	62	9	from	from	ADP
ajlm-2613	62	10	12	12	NUM
ajlm-2613	62	11	years	year	NOUN
ajlm-2613	62	12	to	to	ADP
ajlm-2613	62	13	80	80	NUM
ajlm-2613	62	14	years	year	NOUN
ajlm-2613	62	15	with	with	ADP
ajlm-2613	62	16	a	a	DET
ajlm-2613	62	17	mean	mean	ADJ
ajlm-2613	62	18	age	age	NOUN
ajlm-2613	62	19	of	of	ADP
ajlm-2613	62	20	53.4	53.4	NUM
ajlm-2613	62	21	(	(	PUNCT
ajlm-2613	62	22	standard	standard	ADJ
ajlm-2613	62	23	deviation	deviation	NOUN
ajlm-2613	62	24	=	=	SYM
ajlm-2613	62	25	16.0	16.0	NUM
ajlm-2613	62	26	)	)	PUNCT
ajlm-2613	62	27	years	year	NOUN
ajlm-2613	62	28	.	.	PUNCT
ajlm-2613	63	1	the	the	DET
ajlm-2613	63	2	largest	large	ADJ
ajlm-2613	63	3	proportion	proportion	NOUN
ajlm-2613	63	4	of	of	ADP
ajlm-2613	63	5	cases	case	NOUN
ajlm-2613	63	6	(	(	PUNCT
ajlm-2613	63	7	23	23	NUM
ajlm-2613	63	8	of	of	ADP
ajlm-2613	63	9	29	29	NUM
ajlm-2613	63	10	cases	case	NOUN
ajlm-2613	63	11	;	;	PUNCT
ajlm-2613	63	12	79.3	79.3	NUM
ajlm-2613	63	13	%	%	NOUN
ajlm-2613	63	14	)	)	PUNCT
ajlm-2613	63	15	clustered	cluster	VERB
ajlm-2613	63	16	within	within	ADP
ajlm-2613	63	17	the	the	DET
ajlm-2613	63	18	category	category	NOUN
ajlm-2613	63	19	of	of	ADP
ajlm-2613	63	20	patients	patient	NOUN
ajlm-2613	63	21	aged	age	VERB
ajlm-2613	63	22	40	40	NUM
ajlm-2613	63	23	years	year	NOUN
ajlm-2613	63	24	to	to	ADP
ajlm-2613	63	25	79	79	NUM
ajlm-2613	63	26	years	year	NOUN
ajlm-2613	63	27	and	and	CCONJ
ajlm-2613	63	28	peaked	peak	VERB
ajlm-2613	63	29	in	in	ADP
ajlm-2613	63	30	the	the	DET
ajlm-2613	63	31	6th	6th	ADJ
ajlm-2613	63	32	decade	decade	NOUN
ajlm-2613	63	33	.	.	PUNCT
ajlm-2613	64	1	eleven	eleven	NUM
ajlm-2613	64	2	cases	case	NOUN
ajlm-2613	64	3	of	of	ADP
ajlm-2613	64	4	adenomas	adenoma	NOUN
ajlm-2613	64	5	(	(	PUNCT
ajlm-2613	64	6	37.9	37.9	NUM
ajlm-2613	64	7	%	%	NOUN
ajlm-2613	64	8	)	)	PUNCT
ajlm-2613	64	9	occurred	occur	VERB
ajlm-2613	64	10	before	before	ADP
ajlm-2613	64	11	age	age	NOUN
ajlm-2613	64	12	50	50	NUM
ajlm-2613	64	13	years	year	NOUN
ajlm-2613	64	14	while	while	SCONJ
ajlm-2613	64	15	only	only	ADV
ajlm-2613	64	16	six	six	NUM
ajlm-2613	64	17	cases	case	NOUN
ajlm-2613	64	18	(	(	PUNCT
ajlm-2613	64	19	20.7	20.7	NUM
ajlm-2613	64	20	%	%	NOUN
ajlm-2613	64	21	)	)	PUNCT
ajlm-2613	64	22	occurred	occur	VERB
ajlm-2613	64	23	at	at	ADP
ajlm-2613	64	24	age	age	NOUN
ajlm-2613	64	25	70	70	NUM
ajlm-2613	64	26	years	year	NOUN
ajlm-2613	64	27	or	or	CCONJ
ajlm-2613	64	28	more	more	ADJ
ajlm-2613	64	29	(	(	PUNCT
ajlm-2613	64	30	table	table	NOUN
ajlm-2613	64	31	2	2	NUM
ajlm-2613	64	32	)	)	PUNCT
ajlm-2613	64	33	.	.	PUNCT
ajlm-2613	65	1	table	table	NOUN
ajlm-2613	65	2	2	2	NUM
ajlm-2613	65	3	:	:	PUNCT
ajlm-2613	65	4	 	 	SPACE
ajlm-2613	65	5	age	age	NOUN
ajlm-2613	65	6	distribution	distribution	NOUN
ajlm-2613	65	7	of	of	ADP
ajlm-2613	65	8	adenomas	adenoma	NOUN
ajlm-2613	65	9	with	with	ADP
ajlm-2613	65	10	sex	sex	NOUN
ajlm-2613	65	11	,	,	PUNCT
ajlm-2613	65	12	histological	histological	ADJ
ajlm-2613	65	13	sub	sub	NOUN
ajlm-2613	65	14	-	-	NOUN
ajlm-2613	65	15	types	type	NOUN
ajlm-2613	65	16	,	,	PUNCT
ajlm-2613	65	17	grade	grade	NOUN
ajlm-2613	65	18	,	,	PUNCT
ajlm-2613	65	19	and	and	CCONJ
ajlm-2613	65	20	site	site	NOUN
ajlm-2613	65	21	at	at	ADP
ajlm-2613	65	22	aminu	aminu	PROPN
ajlm-2613	65	23	kano	kano	PROPN
ajlm-2613	65	24	teaching	teaching	PROPN
ajlm-2613	65	25	hospital	hospital	PROPN
ajlm-2613	65	26	,	,	PUNCT
ajlm-2613	65	27	kano	kano	PROPN
ajlm-2613	65	28	,	,	PUNCT
ajlm-2613	65	29	nigeria	nigeria	PROPN
ajlm-2613	65	30	,	,	PUNCT
ajlm-2613	65	31	january	january	PROPN
ajlm-2613	65	32	2015	2015	NUM
ajlm-2613	65	33	–	–	PUNCT
ajlm-2613	65	34	december	december	PROPN
ajlm-2613	65	35	2019	2019	NUM
ajlm-2613	65	36	.	.	PUNCT
ajlm-2613	66	1	gender	gender	NOUN
ajlm-2613	66	2	distribution	distribution	NOUN
ajlm-2613	66	3	of	of	ADP
ajlm-2613	66	4	adenomas	adenoma	NOUN
ajlm-2613	66	5	there	there	PRON
ajlm-2613	66	6	were	be	VERB
ajlm-2613	66	7	20	20	NUM
ajlm-2613	66	8	male	male	ADJ
ajlm-2613	66	9	cases	case	NOUN
ajlm-2613	66	10	and	and	CCONJ
ajlm-2613	66	11	nine	nine	NUM
ajlm-2613	66	12	female	female	ADJ
ajlm-2613	66	13	cases	case	NOUN
ajlm-2613	66	14	,	,	PUNCT
ajlm-2613	66	15	giving	give	VERB
ajlm-2613	66	16	a	a	DET
ajlm-2613	66	17	male	male	NOUN
ajlm-2613	66	18	-	-	PUNCT
ajlm-2613	66	19	to	to	ADP
ajlm-2613	66	20	-	-	PUNCT
ajlm-2613	66	21	female	female	ADJ
ajlm-2613	66	22	ratio	ratio	NOUN
ajlm-2613	66	23	of	of	ADP
ajlm-2613	66	24	2.2:1	2.2:1	NUM
ajlm-2613	66	25	.	.	PUNCT
ajlm-2613	67	1	male	male	ADJ
ajlm-2613	67	2	cases	case	NOUN
ajlm-2613	67	3	occurred	occur	VERB
ajlm-2613	67	4	in	in	ADP
ajlm-2613	67	5	individuals	individual	NOUN
ajlm-2613	67	6	aged	age	VERB
ajlm-2613	67	7	12	12	NUM
ajlm-2613	67	8	years	year	NOUN
ajlm-2613	67	9	to	to	ADP
ajlm-2613	67	10	75	75	NUM
ajlm-2613	67	11	years	year	NOUN
ajlm-2613	67	12	,	,	PUNCT
ajlm-2613	67	13	with	with	ADP
ajlm-2613	67	14	a	a	DET
ajlm-2613	67	15	mean	mean	ADJ
ajlm-2613	67	16	age	age	NOUN
ajlm-2613	67	17	of	of	ADP
ajlm-2613	67	18	51.7	51.7	NUM
ajlm-2613	67	19	years	year	NOUN
ajlm-2613	67	20	.	.	PUNCT
ajlm-2613	68	1	the	the	DET
ajlm-2613	68	2	nine	nine	NUM
ajlm-2613	68	3	cases	case	NOUN
ajlm-2613	68	4	that	that	PRON
ajlm-2613	68	5	were	be	AUX
ajlm-2613	68	6	observed	observe	VERB
ajlm-2613	68	7	among	among	ADP
ajlm-2613	68	8	the	the	DET
ajlm-2613	68	9	female	female	ADJ
ajlm-2613	68	10	patients	patient	NOUN
ajlm-2613	68	11	occurred	occur	VERB
ajlm-2613	68	12	from	from	ADP
ajlm-2613	68	13	39	39	NUM
ajlm-2613	68	14	years	year	NOUN
ajlm-2613	68	15	to	to	ADP
ajlm-2613	68	16	80	80	NUM
ajlm-2613	68	17	years	year	NOUN
ajlm-2613	68	18	,	,	PUNCT
ajlm-2613	68	19	with	with	ADP
ajlm-2613	68	20	a	a	DET
ajlm-2613	68	21	mean	mean	ADJ
ajlm-2613	68	22	age	age	NOUN
ajlm-2613	68	23	of	of	ADP
ajlm-2613	68	24	57.2	57.2	NUM
ajlm-2613	68	25	years	year	NOUN
ajlm-2613	68	26	(	(	PUNCT
ajlm-2613	68	27	table	table	NOUN
ajlm-2613	68	28	2	2	NUM
ajlm-2613	68	29	)	)	PUNCT
ajlm-2613	68	30	.	.	PUNCT
ajlm-2613	69	1	histological	histological	ADJ
ajlm-2613	69	2	types	type	NOUN
ajlm-2613	69	3	of	of	ADP
ajlm-2613	69	4	adenomas	adenoma	NOUN
ajlm-2613	69	5	eighteen	eighteen	NUM
ajlm-2613	69	6	(	(	PUNCT
ajlm-2613	69	7	62.1	62.1	NUM
ajlm-2613	69	8	%	%	NOUN
ajlm-2613	69	9	)	)	PUNCT
ajlm-2613	69	10	cases	case	NOUN
ajlm-2613	69	11	of	of	ADP
ajlm-2613	69	12	colorectal	colorectal	ADJ
ajlm-2613	69	13	adenoma	adenoma	NOUN
ajlm-2613	69	14	were	be	AUX
ajlm-2613	69	15	tubular	tubular	ADJ
ajlm-2613	69	16	adenomas	adenoma	NOUN
ajlm-2613	69	17	;	;	PUNCT
ajlm-2613	69	18	of	of	ADP
ajlm-2613	69	19	these	these	PRON
ajlm-2613	69	20	,	,	PUNCT
ajlm-2613	69	21	eight	eight	NUM
ajlm-2613	69	22	cases	case	NOUN
ajlm-2613	69	23	were	be	AUX
ajlm-2613	69	24	high	high	ADJ
ajlm-2613	69	25	-	-	PUNCT
ajlm-2613	69	26	grade	grade	NOUN
ajlm-2613	69	27	lesions	lesion	NOUN
ajlm-2613	69	28	.	.	PUNCT
ajlm-2613	70	1	eight	eight	NUM
ajlm-2613	70	2	(	(	PUNCT
ajlm-2613	70	3	27.6	27.6	NUM
ajlm-2613	70	4	%	%	NOUN
ajlm-2613	70	5	)	)	PUNCT
ajlm-2613	70	6	cases	case	NOUN
ajlm-2613	70	7	were	be	AUX
ajlm-2613	70	8	tubulovillous	tubulovillous	ADJ
ajlm-2613	70	9	adenomas	adenoma	NOUN
ajlm-2613	70	10	(	(	PUNCT
ajlm-2613	70	11	five	five	NUM
ajlm-2613	70	12	of	of	ADP
ajlm-2613	70	13	which	which	PRON
ajlm-2613	70	14	were	be	AUX
ajlm-2613	70	15	high	high	ADJ
ajlm-2613	70	16	-	-	PUNCT
ajlm-2613	70	17	grade	grade	NOUN
ajlm-2613	70	18	)	)	PUNCT
ajlm-2613	70	19	,	,	PUNCT
ajlm-2613	70	20	and	and	CCONJ
ajlm-2613	70	21	only	only	ADV
ajlm-2613	70	22	three	three	NUM
ajlm-2613	70	23	(	(	PUNCT
ajlm-2613	70	24	10.3	10.3	NUM
ajlm-2613	70	25	%	%	NOUN
ajlm-2613	70	26	)	)	PUNCT
ajlm-2613	70	27	cases	case	NOUN
ajlm-2613	70	28	were	be	AUX
ajlm-2613	70	29	villous	villous	ADJ
ajlm-2613	70	30	adenomas	adenoma	NOUN
ajlm-2613	70	31	(	(	PUNCT
ajlm-2613	70	32	including	include	VERB
ajlm-2613	70	33	one	one	NUM
ajlm-2613	70	34	high	high	ADJ
ajlm-2613	70	35	-	-	PUNCT
ajlm-2613	70	36	grade	grade	NOUN
ajlm-2613	70	37	lesion	lesion	NOUN
ajlm-2613	70	38	,	,	PUNCT
ajlm-2613	70	39	figure	figure	NOUN
ajlm-2613	70	40	1	1	NUM
ajlm-2613	70	41	)	)	PUNCT
ajlm-2613	70	42	.	.	PUNCT
ajlm-2613	71	1	there	there	PRON
ajlm-2613	71	2	were	be	VERB
ajlm-2613	71	3	no	no	DET
ajlm-2613	71	4	significant	significant	ADJ
ajlm-2613	71	5	associations	association	NOUN
ajlm-2613	71	6	between	between	ADP
ajlm-2613	71	7	histological	histological	ADJ
ajlm-2613	71	8	type	type	NOUN
ajlm-2613	71	9	and	and	CCONJ
ajlm-2613	71	10	the	the	DET
ajlm-2613	71	11	age	age	NOUN
ajlm-2613	71	12	group	group	NOUN
ajlm-2613	71	13	(	(	PUNCT
ajlm-2613	71	14	χ2	χ2	PROPN
ajlm-2613	71	15	=	=	SYM
ajlm-2613	71	16	15.8538	15.8538	NUM
ajlm-2613	71	17	degrees	degree	NOUN
ajlm-2613	71	18	of	of	ADP
ajlm-2613	71	19	freedom	freedom	NOUN
ajlm-2613	71	20	[	[	X
ajlm-2613	71	21	df	df	X
ajlm-2613	71	22	]	]	X
ajlm-2613	71	23	=	=	NOUN
ajlm-2613	71	24	14	14	NUM
ajlm-2613	71	25	,	,	PUNCT
ajlm-2613	71	26	p	p	NOUN
ajlm-2613	71	27	=	=	NOUN
ajlm-2613	71	28	0.3224	0.3224	NUM
ajlm-2613	71	29	)	)	PUNCT
ajlm-2613	71	30	or	or	CCONJ
ajlm-2613	71	31	sex	sex	NOUN
ajlm-2613	71	32	(	(	PUNCT
ajlm-2613	71	33	χ2	χ2	PROPN
ajlm-2613	71	34	=	=	SYM
ajlm-2613	71	35	0.2529	0.2529	NUM
ajlm-2613	71	36	,	,	PUNCT
ajlm-2613	71	37	df	df	PROPN
ajlm-2613	71	38	=	=	SYM
ajlm-2613	71	39	2	2	NUM
ajlm-2613	71	40	,	,	PUNCT
ajlm-2613	71	41	p	p	NOUN
ajlm-2613	71	42	=	=	NOUN
ajlm-2613	71	43	0.8812	0.8812	NUM
ajlm-2613	71	44	)	)	PUNCT
ajlm-2613	71	45	.	.	PUNCT
ajlm-2613	72	1	figure	figure	VERB
ajlm-2613	72	2	1	1	NUM
ajlm-2613	72	3	:	:	PUNCT
ajlm-2613	72	4	haematoxylin	haematoxylin	NOUN
ajlm-2613	72	5	and	and	CCONJ
ajlm-2613	72	6	eosin	eosin	NOUN
ajlm-2613	72	7	and	and	CCONJ
ajlm-2613	72	8	cyclooxygenase-2	cyclooxygenase-2	NUM
ajlm-2613	72	9	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2613	72	10	photomicrographs	photomicrograph	NOUN
ajlm-2613	72	11	of	of	ADP
ajlm-2613	72	12	adenoma	adenoma	ADJ
ajlm-2613	72	13	cases	case	NOUN
ajlm-2613	72	14	at	at	ADP
ajlm-2613	72	15	aminu	aminu	PROPN
ajlm-2613	72	16	kano	kano	PROPN
ajlm-2613	72	17	teaching	teaching	PROPN
ajlm-2613	72	18	hospital	hospital	PROPN
ajlm-2613	72	19	,	,	PUNCT
ajlm-2613	72	20	kano	kano	PROPN
ajlm-2613	72	21	,	,	PUNCT
ajlm-2613	72	22	nigeria	nigeria	PROPN
ajlm-2613	72	23	.	.	PUNCT
ajlm-2613	73	1	(	(	PUNCT
ajlm-2613	73	2	a	a	X
ajlm-2613	73	3	)	)	PUNCT
ajlm-2613	73	4	low	low	ADJ
ajlm-2613	73	5	-	-	PUNCT
ajlm-2613	73	6	grade	grade	NOUN
ajlm-2613	73	7	tubular	tubular	ADJ
ajlm-2613	73	8	adenoma	adenoma	NOUN
ajlm-2613	73	9	,	,	PUNCT
ajlm-2613	73	10	haematoxylin	haematoxylin	NOUN
ajlm-2613	73	11	and	and	CCONJ
ajlm-2613	73	12	eosin	eosin	VERB
ajlm-2613	73	13	×40	×40	PROPN
ajlm-2613	73	14	,	,	PUNCT
ajlm-2613	73	15	(	(	PUNCT
ajlm-2613	73	16	b	b	NOUN
ajlm-2613	73	17	)	)	PUNCT
ajlm-2613	73	18	high	high	ADJ
ajlm-2613	73	19	-	-	PUNCT
ajlm-2613	73	20	grade	grade	NOUN
ajlm-2613	73	21	tubular	tubular	ADJ
ajlm-2613	73	22	adenoma	adenoma	NOUN
ajlm-2613	73	23	,	,	PUNCT
ajlm-2613	73	24	haematoxylin	haematoxylin	NOUN
ajlm-2613	73	25	and	and	CCONJ
ajlm-2613	73	26	eosin	eosin	VERB
ajlm-2613	73	27	×40	×40	PROPN
ajlm-2613	73	28	,	,	PUNCT
ajlm-2613	73	29	(	(	PUNCT
ajlm-2613	73	30	c	c	NOUN
ajlm-2613	73	31	)	)	PUNCT
ajlm-2613	73	32	low	low	ADJ
ajlm-2613	73	33	-	-	PUNCT
ajlm-2613	73	34	grade	grade	NOUN
ajlm-2613	73	35	tubulovillous	tubulovillous	ADJ
ajlm-2613	73	36	adenoma	adenoma	NOUN
ajlm-2613	73	37	,	,	PUNCT
ajlm-2613	73	38	haematoxylin	haematoxylin	NOUN
ajlm-2613	73	39	and	and	CCONJ
ajlm-2613	73	40	eosin	eosin	NOUN
ajlm-2613	73	41	×100	×100	PROPN
ajlm-2613	73	42	,	,	PUNCT
ajlm-2613	73	43	(	(	PUNCT
ajlm-2613	73	44	d	d	X
ajlm-2613	73	45	)	)	PUNCT
ajlm-2613	73	46	cyclooxygenase-2	cyclooxygenase-2	NUM
ajlm-2613	73	47	positive	positive	ADJ
ajlm-2613	73	48	control	control	NOUN
ajlm-2613	73	49	(	(	PUNCT
ajlm-2613	73	50	renal	renal	ADJ
ajlm-2613	73	51	tubules	tubule	NOUN
ajlm-2613	73	52	)	)	PUNCT
ajlm-2613	73	53	×400	×400	NOUN
ajlm-2613	73	54	,	,	PUNCT
ajlm-2613	73	55	(	(	PUNCT
ajlm-2613	73	56	e	e	NOUN
ajlm-2613	73	57	)	)	PUNCT
ajlm-2613	73	58	cyclooxygenase-2	cyclooxygenase-2	NUM
ajlm-2613	73	59	positive	positive	ADJ
ajlm-2613	73	60	(	(	PUNCT
ajlm-2613	73	61	low	low	ADJ
ajlm-2613	73	62	grade	grade	NOUN
ajlm-2613	73	63	tubular	tubular	ADJ
ajlm-2613	73	64	adenoma	adenoma	ADJ
ajlm-2613	73	65	)	)	PUNCT
ajlm-2613	73	66	×100	×100	NOUN
ajlm-2613	73	67	,	,	PUNCT
ajlm-2613	73	68	and	and	CCONJ
ajlm-2613	73	69	(	(	PUNCT
ajlm-2613	73	70	f	f	X
ajlm-2613	73	71	)	)	PUNCT
ajlm-2613	73	72	cyclooxygenase-2	cyclooxygenase-2	NUM
ajlm-2613	73	73	negative	negative	ADJ
ajlm-2613	73	74	,	,	PUNCT
ajlm-2613	73	75	(	(	PUNCT
ajlm-2613	73	76	low	low	ADJ
ajlm-2613	73	77	grade	grade	NOUN
ajlm-2613	73	78	tubular	tubular	ADJ
ajlm-2613	73	79	adenoma	adenoma	ADJ
ajlm-2613	73	80	)	)	PUNCT
ajlm-2613	73	81	×100	×100	NOUN
ajlm-2613	73	82	.	.	PUNCT
ajlm-2613	74	1	grading	grade	VERB
ajlm-2613	74	2	of	of	ADP
ajlm-2613	74	3	adenomas	adenoma	NOUN
ajlm-2613	74	4	fifteen	fifteen	NUM
ajlm-2613	74	5	cases	case	NOUN
ajlm-2613	74	6	(	(	PUNCT
ajlm-2613	74	7	51.7	51.7	NUM
ajlm-2613	74	8	%	%	NOUN
ajlm-2613	74	9	)	)	PUNCT
ajlm-2613	74	10	of	of	ADP
ajlm-2613	74	11	adenoma	adenoma	ADV
ajlm-2613	74	12	were	be	AUX
ajlm-2613	74	13	high	high	ADJ
ajlm-2613	74	14	-	-	PUNCT
ajlm-2613	74	15	grade	grade	NOUN
ajlm-2613	74	16	adenomas	adenoma	NOUN
ajlm-2613	74	17	(	(	PUNCT
ajlm-2613	74	18	table	table	NOUN
ajlm-2613	74	19	2	2	NUM
ajlm-2613	74	20	)	)	PUNCT
ajlm-2613	74	21	.	.	PUNCT
ajlm-2613	75	1	this	this	PRON
ajlm-2613	75	2	comprised	comprise	VERB
ajlm-2613	75	3	nine	nine	NUM
ajlm-2613	75	4	cases	case	NOUN
ajlm-2613	75	5	of	of	ADP
ajlm-2613	75	6	tubular	tubular	ADJ
ajlm-2613	75	7	,	,	PUNCT
ajlm-2613	75	8	five	five	NUM
ajlm-2613	75	9	cases	case	NOUN
ajlm-2613	75	10	of	of	ADP
ajlm-2613	75	11	tubulovillous	tubulovillous	ADJ
ajlm-2613	75	12	,	,	PUNCT
ajlm-2613	75	13	and	and	CCONJ
ajlm-2613	75	14	one	one	NUM
ajlm-2613	75	15	case	case	NOUN
ajlm-2613	75	16	of	of	ADP
ajlm-2613	75	17	villous	villous	ADJ
ajlm-2613	75	18	adenoma	adenoma	NOUN
ajlm-2613	75	19	.	.	PUNCT
ajlm-2613	76	1	fourteen	fourteen	NUM
ajlm-2613	76	2	cases	case	NOUN
ajlm-2613	76	3	(	(	PUNCT
ajlm-2613	76	4	48.3	48.3	NUM
ajlm-2613	76	5	%	%	NOUN
ajlm-2613	76	6	)	)	PUNCT
ajlm-2613	76	7	were	be	AUX
ajlm-2613	76	8	low	low	ADJ
ajlm-2613	76	9	-	-	PUNCT
ajlm-2613	76	10	grade	grade	NOUN
ajlm-2613	76	11	.	.	PUNCT
ajlm-2613	77	1	among	among	ADP
ajlm-2613	77	2	the	the	DET
ajlm-2613	77	3	female	female	ADJ
ajlm-2613	77	4	patients	patient	NOUN
ajlm-2613	77	5	,	,	PUNCT
ajlm-2613	77	6	there	there	PRON
ajlm-2613	77	7	were	be	VERB
ajlm-2613	77	8	only	only	ADV
ajlm-2613	77	9	five	five	NUM
ajlm-2613	77	10	cases	case	NOUN
ajlm-2613	77	11	(	(	PUNCT
ajlm-2613	77	12	33.3	33.3	NUM
ajlm-2613	77	13	%	%	NOUN
ajlm-2613	77	14	)	)	PUNCT
ajlm-2613	77	15	of	of	ADP
ajlm-2613	77	16	high	high	ADJ
ajlm-2613	77	17	-	-	PUNCT
ajlm-2613	77	18	grade	grade	NOUN
ajlm-2613	77	19	adenoma	adenoma	NOUN
ajlm-2613	77	20	,	,	PUNCT
ajlm-2613	77	21	and	and	CCONJ
ajlm-2613	77	22	four	four	NUM
ajlm-2613	77	23	cases	case	NOUN
ajlm-2613	77	24	(	(	PUNCT
ajlm-2613	77	25	28.6	28.6	NUM
ajlm-2613	77	26	%	%	NOUN
ajlm-2613	77	27	)	)	PUNCT
ajlm-2613	77	28	in	in	ADP
ajlm-2613	77	29	the	the	DET
ajlm-2613	77	30	low	low	ADJ
ajlm-2613	77	31	-	-	PUNCT
ajlm-2613	77	32	grade	grade	NOUN
ajlm-2613	77	33	tumours	tumour	NOUN
ajlm-2613	77	34	category	category	NOUN
ajlm-2613	77	35	.	.	PUNCT
ajlm-2613	78	1	there	there	PRON
ajlm-2613	78	2	were	be	VERB
ajlm-2613	78	3	no	no	DET
ajlm-2613	78	4	statistically	statistically	ADV
ajlm-2613	78	5	significant	significant	ADJ
ajlm-2613	78	6	associations	association	NOUN
ajlm-2613	78	7	between	between	ADP
ajlm-2613	78	8	the	the	DET
ajlm-2613	78	9	grade	grade	NOUN
ajlm-2613	78	10	of	of	ADP
ajlm-2613	78	11	tumour	tumour	NOUN
ajlm-2613	78	12	and	and	CCONJ
ajlm-2613	78	13	age	age	NOUN
ajlm-2613	78	14	(	(	PUNCT
ajlm-2613	78	15	χ2	χ2	PROPN
ajlm-2613	78	16	=	=	PUNCT
ajlm-2613	78	17	8.8808	8.8808	NUM
ajlm-2613	78	18	,	,	PUNCT
ajlm-2613	78	19	df	df	NOUN
ajlm-2613	78	20	=	=	SYM
ajlm-2613	78	21	7	7	NUM
ajlm-2613	78	22	,	,	PUNCT
ajlm-2613	78	23	p	p	NOUN
ajlm-2613	78	24	=	=	SYM
ajlm-2613	78	25	0.2613	0.2613	NUM
ajlm-2613	78	26	)	)	PUNCT
ajlm-2613	78	27	or	or	CCONJ
ajlm-2613	78	28	sex	sex	NOUN
ajlm-2613	78	29	(	(	PUNCT
ajlm-2613	78	30	χ2	χ2	PROPN
ajlm-2613	78	31	=	=	SYM
ajlm-2613	78	32	0.0762	0.0762	NUM
ajlm-2613	78	33	,	,	PUNCT
ajlm-2613	78	34	df	df	NOUN
ajlm-2613	78	35	=	=	SYM
ajlm-2613	78	36	1	1	NUM
ajlm-2613	78	37	,	,	PUNCT
ajlm-2613	78	38	p	p	X
ajlm-2613	78	39	=	=	NOUN
ajlm-2613	78	40	0.7818	0.7818	NUM
ajlm-2613	78	41	)	)	PUNCT
ajlm-2613	78	42	.	.	PUNCT
ajlm-2613	79	1	site	site	NOUN
ajlm-2613	79	2	of	of	ADP
ajlm-2613	79	3	adenomas	adenoma	NOUN
ajlm-2613	79	4	thirteen	thirteen	NUM
ajlm-2613	79	5	cases	case	NOUN
ajlm-2613	79	6	(	(	PUNCT
ajlm-2613	79	7	44.8	44.8	NUM
ajlm-2613	79	8	%	%	NOUN
ajlm-2613	79	9	)	)	PUNCT
ajlm-2613	79	10	of	of	ADP
ajlm-2613	79	11	adenoma	adenoma	ADV
ajlm-2613	79	12	were	be	AUX
ajlm-2613	79	13	colonic	colonic	ADJ
ajlm-2613	79	14	in	in	ADP
ajlm-2613	79	15	origin	origin	NOUN
ajlm-2613	79	16	,	,	PUNCT
ajlm-2613	79	17	while	while	SCONJ
ajlm-2613	79	18	the	the	DET
ajlm-2613	79	19	remaining	remain	VERB
ajlm-2613	79	20	cases	case	NOUN
ajlm-2613	79	21	were	be	AUX
ajlm-2613	79	22	rectal	rectal	ADJ
ajlm-2613	79	23	tumours	tumour	NOUN
ajlm-2613	79	24	(	(	PUNCT
ajlm-2613	79	25	table	table	NOUN
ajlm-2613	79	26	2	2	NUM
ajlm-2613	79	27	)	)	PUNCT
ajlm-2613	79	28	.	.	PUNCT
ajlm-2613	80	1	there	there	PRON
ajlm-2613	80	2	were	be	VERB
ajlm-2613	80	3	no	no	DET
ajlm-2613	80	4	statistically	statistically	ADV
ajlm-2613	80	5	significant	significant	ADJ
ajlm-2613	80	6	associations	association	NOUN
ajlm-2613	80	7	between	between	ADP
ajlm-2613	80	8	the	the	DET
ajlm-2613	80	9	site	site	NOUN
ajlm-2613	80	10	of	of	ADP
ajlm-2613	80	11	tumour	tumour	NOUN
ajlm-2613	80	12	and	and	CCONJ
ajlm-2613	80	13	age	age	NOUN
ajlm-2613	80	14	(	(	PUNCT
ajlm-2613	80	15	χ2	χ2	PROPN
ajlm-2613	80	16	=	=	SYM
ajlm-2613	80	17	5.2217	5.2217	NUM
ajlm-2613	80	18	,	,	PUNCT
ajlm-2613	80	19	df	df	NOUN
ajlm-2613	80	20	=	=	SYM
ajlm-2613	80	21	7	7	NUM
ajlm-2613	80	22	,	,	PUNCT
ajlm-2613	80	23	p	p	NOUN
ajlm-2613	80	24	=	=	NOUN
ajlm-2613	80	25	0.6329	0.6329	NUM
ajlm-2613	80	26	)	)	PUNCT
ajlm-2613	80	27	.	.	PUNCT
ajlm-2613	81	1	cyclooxygenase-2	cyclooxygenase-2	NUM
ajlm-2613	81	2	expression	expression	NOUN
ajlm-2613	81	3	in	in	ADP
ajlm-2613	81	4	adenomas	adenoma	NOUN
ajlm-2613	81	5	the	the	DET
ajlm-2613	81	6	only	only	ADJ
ajlm-2613	81	7	case	case	NOUN
ajlm-2613	81	8	that	that	PRON
ajlm-2613	81	9	showed	show	VERB
ajlm-2613	81	10	cox-2	cox-2	DET
ajlm-2613	81	11	positivity	positivity	NOUN
ajlm-2613	81	12	(	(	PUNCT
ajlm-2613	81	13	strong	strong	ADJ
ajlm-2613	81	14	positive	positive	ADJ
ajlm-2613	81	15	staining	staining	NOUN
ajlm-2613	81	16	)	)	PUNCT
ajlm-2613	81	17	was	be	AUX
ajlm-2613	81	18	a	a	DET
ajlm-2613	81	19	low	low	ADJ
ajlm-2613	81	20	-	-	PUNCT
ajlm-2613	81	21	grade	grade	NOUN
ajlm-2613	81	22	tubular	tubular	ADJ
ajlm-2613	81	23	adenoma	adenoma	NOUN
ajlm-2613	81	24	in	in	ADP
ajlm-2613	81	25	a	a	DET
ajlm-2613	81	26	60	60	NUM
ajlm-2613	81	27	-	-	PUNCT
ajlm-2613	81	28	year	year	NOUN
ajlm-2613	81	29	-	-	PUNCT
ajlm-2613	81	30	old	old	ADJ
ajlm-2613	81	31	man	man	NOUN
ajlm-2613	81	32	(	(	PUNCT
ajlm-2613	81	33	figure	figure	NOUN
ajlm-2613	81	34	1	1	NUM
ajlm-2613	81	35	)	)	PUNCT
ajlm-2613	81	36	.	.	PUNCT
ajlm-2613	82	1	there	there	PRON
ajlm-2613	82	2	was	be	VERB
ajlm-2613	82	3	no	no	DET
ajlm-2613	82	4	statistical	statistical	ADJ
ajlm-2613	82	5	association	association	NOUN
ajlm-2613	82	6	between	between	ADP
ajlm-2613	82	7	cox-2	cox-2	SYM
ajlm-2613	82	8	over	over	ADP
ajlm-2613	82	9	-	-	PUNCT
ajlm-2613	82	10	expression	expression	NOUN
ajlm-2613	82	11	and	and	CCONJ
ajlm-2613	82	12	age	age	NOUN
ajlm-2613	82	13	,	,	PUNCT
ajlm-2613	82	14	sex	sex	NOUN
ajlm-2613	82	15	,	,	PUNCT
ajlm-2613	82	16	or	or	CCONJ
ajlm-2613	82	17	histological	histological	ADJ
ajlm-2613	82	18	type	type	NOUN
ajlm-2613	82	19	of	of	ADP
ajlm-2613	82	20	the	the	DET
ajlm-2613	82	21	tumour	tumour	NOUN
ajlm-2613	82	22	.	.	PUNCT
ajlm-2613	83	1	discussion	discussion	NOUN
ajlm-2613	83	2	adenomas	adenoma	NOUN
ajlm-2613	83	3	occurred	occur	VERB
ajlm-2613	83	4	more	more	ADV
ajlm-2613	83	5	commonly	commonly	ADV
ajlm-2613	83	6	among	among	ADP
ajlm-2613	83	7	male	male	ADJ
ajlm-2613	83	8	patients	patient	NOUN
ajlm-2613	83	9	(	(	PUNCT
ajlm-2613	83	10	m	m	NOUN
ajlm-2613	83	11	:	:	PUNCT
ajlm-2613	83	12	f	f	X
ajlm-2613	83	13	,	,	PUNCT
ajlm-2613	83	14	2.2:1	2.2:1	NUM
ajlm-2613	83	15	)	)	PUNCT
ajlm-2613	83	16	,	,	PUNCT
ajlm-2613	83	17	in	in	ADP
ajlm-2613	83	18	the	the	DET
ajlm-2613	83	19	age	age	NOUN
ajlm-2613	83	20	group	group	NOUN
ajlm-2613	83	21	40–79	40–79	ADV
ajlm-2613	83	22	years	year	NOUN
ajlm-2613	83	23	,	,	PUNCT
ajlm-2613	83	24	and	and	CCONJ
ajlm-2613	83	25	they	they	PRON
ajlm-2613	83	26	were	be	AUX
ajlm-2613	83	27	composed	compose	VERB
ajlm-2613	83	28	of	of	ADP
ajlm-2613	83	29	tubular	tubular	ADJ
ajlm-2613	83	30	adenomas	adenoma	NOUN
ajlm-2613	83	31	(	(	PUNCT
ajlm-2613	83	32	62.1	62.1	NUM
ajlm-2613	83	33	%	%	NOUN
ajlm-2613	83	34	)	)	PUNCT
ajlm-2613	83	35	,	,	PUNCT
ajlm-2613	83	36	tubulovillous	tubulovillous	ADJ
ajlm-2613	83	37	adenomas	adenoma	NOUN
ajlm-2613	83	38	(	(	PUNCT
ajlm-2613	83	39	27.6	27.6	NUM
ajlm-2613	83	40	%	%	NOUN
ajlm-2613	83	41	)	)	PUNCT
ajlm-2613	83	42	,	,	PUNCT
ajlm-2613	83	43	and	and	CCONJ
ajlm-2613	83	44	villous	villous	ADJ
ajlm-2613	83	45	adenomas	adenoma	NOUN
ajlm-2613	83	46	(	(	PUNCT
ajlm-2613	83	47	10.3	10.3	NUM
ajlm-2613	83	48	%	%	NOUN
ajlm-2613	83	49	)	)	PUNCT
ajlm-2613	83	50	.	.	PUNCT
ajlm-2613	84	1	over	over	ADP
ajlm-2613	84	2	-	-	PUNCT
ajlm-2613	84	3	expression	expression	NOUN
ajlm-2613	84	4	of	of	ADP
ajlm-2613	84	5	cox-2	cox-2	NUM
ajlm-2613	84	6	was	be	AUX
ajlm-2613	84	7	observed	observe	VERB
ajlm-2613	84	8	in	in	ADP
ajlm-2613	84	9	3.4	3.4	NUM
ajlm-2613	84	10	%	%	NOUN
ajlm-2613	84	11	.	.	PUNCT
ajlm-2613	85	1	there	there	PRON
ajlm-2613	85	2	was	be	VERB
ajlm-2613	85	3	no	no	DET
ajlm-2613	85	4	association	association	NOUN
ajlm-2613	85	5	between	between	ADP
ajlm-2613	85	6	cox-2	cox-2	NOUN
ajlm-2613	85	7	expression	expression	NOUN
ajlm-2613	85	8	and	and	CCONJ
ajlm-2613	85	9	age	age	NOUN
ajlm-2613	85	10	,	,	PUNCT
ajlm-2613	85	11	sex	sex	NOUN
ajlm-2613	85	12	,	,	PUNCT
ajlm-2613	85	13	histological	histological	ADJ
ajlm-2613	85	14	subtype	subtype	NOUN
ajlm-2613	85	15	,	,	PUNCT
ajlm-2613	85	16	or	or	CCONJ
ajlm-2613	85	17	grade	grade	NOUN
ajlm-2613	85	18	.	.	PUNCT
ajlm-2613	86	1	colorectal	colorectal	ADJ
ajlm-2613	86	2	adenomas	adenoma	NOUN
ajlm-2613	86	3	are	be	AUX
ajlm-2613	86	4	known	know	VERB
ajlm-2613	86	5	precursor	precursor	NOUN
ajlm-2613	86	6	lesions	lesion	NOUN
ajlm-2613	86	7	for	for	ADP
ajlm-2613	86	8	crc	crc	NOUN
ajlm-2613	86	9	,	,	PUNCT
ajlm-2613	86	10	usually	usually	ADV
ajlm-2613	86	11	through	through	ADP
ajlm-2613	86	12	adenoma	adenoma	ADJ
ajlm-2613	86	13	-	-	PUNCT
ajlm-2613	86	14	carcinoma	carcinoma	NOUN
ajlm-2613	86	15	sequence	sequence	NOUN
ajlm-2613	86	16	,	,	PUNCT
ajlm-2613	86	17	and	and	CCONJ
ajlm-2613	86	18	they	they	PRON
ajlm-2613	86	19	also	also	ADV
ajlm-2613	86	20	share	share	VERB
ajlm-2613	86	21	similar	similar	ADJ
ajlm-2613	86	22	risk	risk	NOUN
ajlm-2613	86	23	factors	factor	NOUN
ajlm-2613	86	24	with	with	ADP
ajlm-2613	86	25	crc.6,7,8,9	crc.6,7,8,9	PROPN
ajlm-2613	86	26	they	they	PRON
ajlm-2613	86	27	,	,	PUNCT
ajlm-2613	86	28	therefore	therefore	ADV
ajlm-2613	86	29	,	,	PUNCT
ajlm-2613	86	30	provide	provide	VERB
ajlm-2613	86	31	a	a	DET
ajlm-2613	86	32	window	window	NOUN
ajlm-2613	86	33	for	for	ADP
ajlm-2613	86	34	prevention	prevention	NOUN
ajlm-2613	86	35	of	of	ADP
ajlm-2613	86	36	crc	crc	NOUN
ajlm-2613	86	37	through	through	ADP
ajlm-2613	86	38	screening	screening	NOUN
ajlm-2613	86	39	and	and	CCONJ
ajlm-2613	86	40	early	early	ADJ
ajlm-2613	86	41	detection	detection	NOUN
ajlm-2613	86	42	of	of	ADP
ajlm-2613	86	43	these	these	DET
ajlm-2613	86	44	premalignant	premalignant	NOUN
ajlm-2613	86	45	lesions.6	lesions.6	PUNCT
ajlm-2613	86	46	early	early	ADJ
ajlm-2613	86	47	detection	detection	NOUN
ajlm-2613	86	48	of	of	ADP
ajlm-2613	86	49	colorectal	colorectal	ADJ
ajlm-2613	86	50	adenomas	adenoma	NOUN
ajlm-2613	86	51	through	through	ADP
ajlm-2613	86	52	a	a	DET
ajlm-2613	86	53	surveillance	surveillance	NOUN
ajlm-2613	86	54	screening	screen	VERB
ajlm-2613	86	55	programme	programme	NOUN
ajlm-2613	86	56	is	be	AUX
ajlm-2613	86	57	therefore	therefore	ADV
ajlm-2613	86	58	essential	essential	ADJ
ajlm-2613	86	59	in	in	ADP
ajlm-2613	86	60	interrupting	interrupt	VERB
ajlm-2613	86	61	the	the	DET
ajlm-2613	86	62	possibility	possibility	NOUN
ajlm-2613	86	63	of	of	ADP
ajlm-2613	86	64	progression	progression	NOUN
ajlm-2613	86	65	to	to	ADP
ajlm-2613	86	66	colorectal	colorectal	ADJ
ajlm-2613	86	67	cancer	cancer	NOUN
ajlm-2613	86	68	.	.	PUNCT
ajlm-2613	87	1	the	the	DET
ajlm-2613	87	2	adenoma	adenoma	ADJ
ajlm-2613	87	3	occurrence	occurrence	NOUN
ajlm-2613	87	4	is	be	AUX
ajlm-2613	87	5	more	more	ADV
ajlm-2613	87	6	commonly	commonly	ADV
ajlm-2613	87	7	observed	observe	VERB
ajlm-2613	87	8	in	in	ADP
ajlm-2613	87	9	a	a	DET
ajlm-2613	87	10	relatively	relatively	ADV
ajlm-2613	87	11	young	young	ADJ
ajlm-2613	87	12	population	population	NOUN
ajlm-2613	87	13	in	in	ADP
ajlm-2613	87	14	our	our	PRON
ajlm-2613	87	15	society	society	NOUN
ajlm-2613	87	16	,	,	PUNCT
ajlm-2613	87	17	similar	similar	ADJ
ajlm-2613	87	18	to	to	ADP
ajlm-2613	87	19	the	the	DET
ajlm-2613	87	20	age	age	NOUN
ajlm-2613	87	21	pattern	pattern	NOUN
ajlm-2613	87	22	of	of	ADP
ajlm-2613	87	23	crc	crc	NOUN
ajlm-2613	87	24	as	as	SCONJ
ajlm-2613	87	25	demonstrated	demonstrate	VERB
ajlm-2613	87	26	by	by	ADP
ajlm-2613	87	27	a	a	DET
ajlm-2613	87	28	mean	mean	ADJ
ajlm-2613	87	29	age	age	NOUN
ajlm-2613	87	30	of	of	ADP
ajlm-2613	87	31	53.4	53.4	NUM
ajlm-2613	87	32	(	(	PUNCT
ajlm-2613	87	33	standard	standard	ADJ
ajlm-2613	87	34	deviation	deviation	NOUN
ajlm-2613	87	35	=	=	NOUN
ajlm-2613	87	36	16.00	16.00	NUM
ajlm-2613	87	37	)	)	PUNCT
ajlm-2613	87	38	and	and	CCONJ
ajlm-2613	87	39	peak	peak	NOUN
ajlm-2613	87	40	age	age	NOUN
ajlm-2613	87	41	in	in	ADP
ajlm-2613	87	42	the	the	DET
ajlm-2613	87	43	5th	5th	ADJ
ajlm-2613	87	44	decade	decade	NOUN
ajlm-2613	87	45	in	in	ADP
ajlm-2613	87	46	this	this	DET
ajlm-2613	87	47	study	study	NOUN
ajlm-2613	87	48	.	.	PUNCT
ajlm-2613	88	1	ibrahim	ibrahim	PROPN
ajlm-2613	88	2	and	and	CCONJ
ajlm-2613	88	3	dahiru	dahiru	PROPN
ajlm-2613	88	4	have	have	AUX
ajlm-2613	88	5	demonstrated	demonstrate	VERB
ajlm-2613	88	6	a	a	DET
ajlm-2613	88	7	mean	mean	ADJ
ajlm-2613	88	8	age	age	NOUN
ajlm-2613	88	9	of	of	ADP
ajlm-2613	88	10	47.3	47.3	NUM
ajlm-2613	88	11	years	year	NOUN
ajlm-2613	88	12	among	among	ADP
ajlm-2613	88	13	adenomatous	adenomatous	ADJ
ajlm-2613	88	14	polyps	polyp	NOUN
ajlm-2613	88	15	in	in	ADP
ajlm-2613	88	16	kano	kano	PROPN
ajlm-2613	88	17	,	,	PUNCT
ajlm-2613	88	18	nigeria.3	nigeria.3	PROPN
ajlm-2613	88	19	a	a	DET
ajlm-2613	88	20	mean	mean	ADJ
ajlm-2613	88	21	age	age	NOUN
ajlm-2613	88	22	of	of	ADP
ajlm-2613	88	23	47	47	NUM
ajlm-2613	88	24	years	year	NOUN
ajlm-2613	88	25	has	have	AUX
ajlm-2613	88	26	also	also	ADV
ajlm-2613	88	27	been	be	AUX
ajlm-2613	88	28	observed	observe	VERB
ajlm-2613	88	29	in	in	ADP
ajlm-2613	88	30	china	china	PROPN
ajlm-2613	88	31	,	,	PUNCT
ajlm-2613	88	32	although	although	SCONJ
ajlm-2613	88	33	the	the	DET
ajlm-2613	88	34	peak	peak	NOUN
ajlm-2613	88	35	age	age	NOUN
ajlm-2613	88	36	at	at	ADP
ajlm-2613	88	37	which	which	PRON
ajlm-2613	88	38	adenomas	adenoma	NOUN
ajlm-2613	88	39	was	be	AUX
ajlm-2613	88	40	observed	observe	VERB
ajlm-2613	88	41	was	be	AUX
ajlm-2613	88	42	65	65	NUM
ajlm-2613	88	43	years.22	years.22	NOUN
ajlm-2613	88	44	adenomas	adenoma	NOUN
ajlm-2613	88	45	are	be	AUX
ajlm-2613	88	46	more	more	ADV
ajlm-2613	88	47	frequent	frequent	ADJ
ajlm-2613	88	48	in	in	ADP
ajlm-2613	88	49	the	the	DET
ajlm-2613	88	50	western	western	ADJ
ajlm-2613	88	51	world	world	NOUN
ajlm-2613	88	52	than	than	ADP
ajlm-2613	88	53	in	in	ADP
ajlm-2613	88	54	africa	africa	PROPN
ajlm-2613	88	55	and	and	CCONJ
ajlm-2613	88	56	asia	asia	PROPN
ajlm-2613	88	57	,	,	PUNCT
ajlm-2613	88	58	but	but	CCONJ
ajlm-2613	88	59	they	they	PRON
ajlm-2613	88	60	occur	occur	VERB
ajlm-2613	88	61	more	more	ADV
ajlm-2613	88	62	in	in	ADP
ajlm-2613	88	63	older	old	ADJ
ajlm-2613	88	64	populations	population	NOUN
ajlm-2613	88	65	in	in	ADP
ajlm-2613	88	66	the	the	DET
ajlm-2613	88	67	united	united	PROPN
ajlm-2613	88	68	states	states	PROPN
ajlm-2613	88	69	and	and	CCONJ
ajlm-2613	88	70	the	the	DET
ajlm-2613	88	71	united	united	ADJ
ajlm-2613	88	72	kingdom	kingdom	PROPN
ajlm-2613	88	73	,	,	PUNCT
ajlm-2613	88	74	and	and	CCONJ
ajlm-2613	88	75	a	a	DET
ajlm-2613	88	76	mean	mean	ADJ
ajlm-2613	88	77	age	age	NOUN
ajlm-2613	88	78	as	as	ADV
ajlm-2613	88	79	high	high	ADJ
ajlm-2613	88	80	as	as	ADP
ajlm-2613	88	81	64	64	NUM
ajlm-2613	88	82	years	year	NOUN
ajlm-2613	88	83	and	and	CCONJ
ajlm-2613	88	84	68	68	NUM
ajlm-2613	88	85	years	year	NOUN
ajlm-2613	88	86	has	have	AUX
ajlm-2613	88	87	been	be	AUX
ajlm-2613	88	88	reported	report	VERB
ajlm-2613	88	89	,	,	PUNCT
ajlm-2613	88	90	thereby	thereby	ADV
ajlm-2613	88	91	mirroring	mirror	VERB
ajlm-2613	88	92	the	the	DET
ajlm-2613	88	93	age	age	NOUN
ajlm-2613	88	94	pattern	pattern	NOUN
ajlm-2613	88	95	of	of	ADP
ajlm-2613	88	96	crc	crc	NOUN
ajlm-2613	88	97	in	in	ADP
ajlm-2613	88	98	these	these	DET
ajlm-2613	88	99	regions.23,24	regions.23,24	NOUN
ajlm-2613	88	100	the	the	DET
ajlm-2613	88	101	possible	possible	ADJ
ajlm-2613	88	102	reason	reason	NOUN
ajlm-2613	88	103	for	for	ADP
ajlm-2613	88	104	higher	high	ADJ
ajlm-2613	88	105	occurrence	occurrence	NOUN
ajlm-2613	88	106	in	in	ADP
ajlm-2613	88	107	the	the	DET
ajlm-2613	88	108	areas	area	NOUN
ajlm-2613	88	109	may	may	AUX
ajlm-2613	88	110	be	be	AUX
ajlm-2613	88	111	largely	largely	ADV
ajlm-2613	88	112	because	because	SCONJ
ajlm-2613	88	113	of	of	ADP
ajlm-2613	88	114	exposure	exposure	NOUN
ajlm-2613	88	115	to	to	ADP
ajlm-2613	88	116	modifiable	modifiable	ADJ
ajlm-2613	88	117	risk	risk	NOUN
ajlm-2613	88	118	factors	factor	NOUN
ajlm-2613	88	119	such	such	ADJ
ajlm-2613	88	120	as	as	ADP
ajlm-2613	88	121	the	the	DET
ajlm-2613	88	122	western	western	ADJ
ajlm-2613	88	123	-	-	PUNCT
ajlm-2613	88	124	type	type	NOUN
ajlm-2613	88	125	diet	diet	NOUN
ajlm-2613	88	126	similar	similar	ADJ
ajlm-2613	88	127	to	to	ADP
ajlm-2613	88	128	that	that	PRON
ajlm-2613	88	129	of	of	ADP
ajlm-2613	88	130	the	the	DET
ajlm-2613	88	131	crc	crc	NOUN
ajlm-2613	88	132	.	.	PUNCT
ajlm-2613	89	1	the	the	DET
ajlm-2613	89	2	male	male	ADJ
ajlm-2613	89	3	preponderance	preponderance	NOUN
ajlm-2613	89	4	of	of	ADP
ajlm-2613	89	5	colorectal	colorectal	ADJ
ajlm-2613	89	6	adenomas	adenoma	NOUN
ajlm-2613	89	7	in	in	ADP
ajlm-2613	89	8	this	this	DET
ajlm-2613	89	9	study	study	NOUN
ajlm-2613	89	10	mirrors	mirror	NOUN
ajlm-2613	89	11	that	that	PRON
ajlm-2613	89	12	of	of	ADP
ajlm-2613	89	13	the	the	DET
ajlm-2613	89	14	crc	crc	NOUN
ajlm-2613	89	15	and	and	CCONJ
ajlm-2613	89	16	has	have	AUX
ajlm-2613	89	17	also	also	ADV
ajlm-2613	89	18	been	be	AUX
ajlm-2613	89	19	reported	report	VERB
ajlm-2613	89	20	worldwide.8,9,25	worldwide.8,9,25	PROPN
ajlm-2613	89	21	it	it	PRON
ajlm-2613	89	22	is	be	AUX
ajlm-2613	89	23	difficult	difficult	ADJ
ajlm-2613	89	24	to	to	PART
ajlm-2613	89	25	explain	explain	VERB
ajlm-2613	89	26	the	the	DET
ajlm-2613	89	27	higher	high	ADJ
ajlm-2613	89	28	male	male	ADJ
ajlm-2613	89	29	affectation	affectation	NOUN
ajlm-2613	89	30	but	but	CCONJ
ajlm-2613	89	31	possible	possible	ADJ
ajlm-2613	89	32	reasons	reason	NOUN
ajlm-2613	89	33	have	have	AUX
ajlm-2613	89	34	been	be	AUX
ajlm-2613	89	35	attributed	attribute	VERB
ajlm-2613	89	36	to	to	ADP
ajlm-2613	89	37	differences	difference	NOUN
ajlm-2613	89	38	in	in	ADP
ajlm-2613	89	39	access	access	NOUN
ajlm-2613	89	40	to	to	ADP
ajlm-2613	89	41	crc	crc	NOUN
ajlm-2613	89	42	screening	screening	NOUN
ajlm-2613	89	43	,	,	PUNCT
ajlm-2613	89	44	differences	difference	NOUN
ajlm-2613	89	45	in	in	ADP
ajlm-2613	89	46	risk	risk	NOUN
ajlm-2613	89	47	factors	factor	NOUN
ajlm-2613	89	48	exposure	exposure	NOUN
ajlm-2613	89	49	,	,	PUNCT
ajlm-2613	89	50	hormonal	hormonal	ADJ
ajlm-2613	89	51	factors	factor	NOUN
ajlm-2613	89	52	,	,	PUNCT
ajlm-2613	89	53	and	and	CCONJ
ajlm-2613	89	54	socioeconomic	socioeconomic	ADJ
ajlm-2613	89	55	factors.8,9	factors.8,9	PROPN
ajlm-2613	89	56	it	it	PRON
ajlm-2613	89	57	is	be	AUX
ajlm-2613	89	58	more	more	ADV
ajlm-2613	89	59	likely	likely	ADJ
ajlm-2613	89	60	for	for	SCONJ
ajlm-2613	89	61	men	man	NOUN
ajlm-2613	89	62	to	to	PART
ajlm-2613	89	63	deposit	deposit	VERB
ajlm-2613	89	64	visceral	visceral	ADJ
ajlm-2613	89	65	fat	fat	NOUN
ajlm-2613	89	66	than	than	ADP
ajlm-2613	89	67	women	woman	NOUN
ajlm-2613	89	68	,	,	PUNCT
ajlm-2613	89	69	which	which	PRON
ajlm-2613	89	70	is	be	AUX
ajlm-2613	89	71	a	a	DET
ajlm-2613	89	72	risk	risk	NOUN
ajlm-2613	89	73	factor	factor	NOUN
ajlm-2613	89	74	for	for	ADP
ajlm-2613	89	75	both	both	CCONJ
ajlm-2613	89	76	adenoma	adenoma	ADJ
ajlm-2613	89	77	and	and	CCONJ
ajlm-2613	89	78	crc.26,27	crc.26,27	DET
ajlm-2613	89	79	men	man	NOUN
ajlm-2613	89	80	are	be	AUX
ajlm-2613	89	81	also	also	ADV
ajlm-2613	89	82	more	more	ADV
ajlm-2613	89	83	likely	likely	ADJ
ajlm-2613	89	84	to	to	PART
ajlm-2613	89	85	have	have	VERB
ajlm-2613	89	86	a	a	DET
ajlm-2613	89	87	high	high	ADJ
ajlm-2613	89	88	consumption	consumption	NOUN
ajlm-2613	89	89	of	of	ADP
ajlm-2613	89	90	red	red	ADJ
ajlm-2613	89	91	meat	meat	NOUN
ajlm-2613	89	92	,	,	PUNCT
ajlm-2613	89	93	processed	process	VERB
ajlm-2613	89	94	meat	meat	NOUN
ajlm-2613	89	95	,	,	PUNCT
ajlm-2613	89	96	heavy	heavy	ADJ
ajlm-2613	89	97	alcohol	alcohol	NOUN
ajlm-2613	89	98	,	,	PUNCT
ajlm-2613	89	99	and	and	CCONJ
ajlm-2613	89	100	cigarette	cigarette	NOUN
ajlm-2613	89	101	smoking.27,28,29	smoking.27,28,29	PUNCT
ajlm-2613	89	102	for	for	ADP
ajlm-2613	89	103	histological	histological	ADJ
ajlm-2613	89	104	sub	sub	NOUN
ajlm-2613	89	105	-	-	NOUN
ajlm-2613	89	106	types	type	NOUN
ajlm-2613	89	107	and	and	CCONJ
ajlm-2613	89	108	grade	grade	NOUN
ajlm-2613	89	109	,	,	PUNCT
ajlm-2613	89	110	the	the	DET
ajlm-2613	89	111	predominant	predominant	ADJ
ajlm-2613	89	112	histological	histological	ADJ
ajlm-2613	89	113	sub	sub	NOUN
ajlm-2613	89	114	-	-	NOUN
ajlm-2613	89	115	types	type	NOUN
ajlm-2613	89	116	were	be	AUX
ajlm-2613	89	117	tubular	tubular	ADJ
ajlm-2613	89	118	adenoma	adenoma	ADJ
ajlm-2613	89	119	(	(	PUNCT
ajlm-2613	89	120	62.1	62.1	NUM
ajlm-2613	89	121	%	%	NOUN
ajlm-2613	89	122	)	)	PUNCT
ajlm-2613	89	123	,	,	PUNCT
ajlm-2613	89	124	and	and	CCONJ
ajlm-2613	89	125	for	for	ADP
ajlm-2613	89	126	the	the	DET
ajlm-2613	89	127	grade	grade	NOUN
ajlm-2613	89	128	,	,	PUNCT
ajlm-2613	89	129	high	high	ADJ
ajlm-2613	89	130	-	-	PUNCT
ajlm-2613	89	131	grade	grade	NOUN
ajlm-2613	89	132	colorectal	colorectal	ADJ
ajlm-2613	89	133	adenoma	adenoma	NOUN
ajlm-2613	89	134	accounted	account	VERB
ajlm-2613	89	135	for	for	ADP
ajlm-2613	89	136	51.7	51.7	NUM
ajlm-2613	89	137	%	%	NOUN
ajlm-2613	89	138	of	of	ADP
ajlm-2613	89	139	all	all	DET
ajlm-2613	89	140	grades	grade	NOUN
ajlm-2613	89	141	.	.	PUNCT
ajlm-2613	90	1	similar	similar	ADJ
ajlm-2613	90	2	findings	finding	NOUN
ajlm-2613	90	3	have	have	AUX
ajlm-2613	90	4	also	also	ADV
ajlm-2613	90	5	been	be	AUX
ajlm-2613	90	6	documented.3,25	documented.3,25	ADV
ajlm-2613	90	7	cyclooxygenase-2	cyclooxygenase-2	NUM
ajlm-2613	90	8	expression	expression	NOUN
ajlm-2613	90	9	in	in	ADP
ajlm-2613	90	10	adenomas	adenoma	NOUN
ajlm-2613	90	11	in	in	ADP
ajlm-2613	90	12	the	the	DET
ajlm-2613	90	13	present	present	ADJ
ajlm-2613	90	14	study	study	NOUN
ajlm-2613	90	15	,	,	PUNCT
ajlm-2613	90	16	cox-2	cox-2	NOUN
ajlm-2613	90	17	expression	expression	NOUN
ajlm-2613	90	18	in	in	ADP
ajlm-2613	90	19	the	the	DET
ajlm-2613	90	20	adenomas	adenoma	NOUN
ajlm-2613	90	21	was	be	AUX
ajlm-2613	90	22	3.4	3.4	NUM
ajlm-2613	90	23	%	%	NOUN
ajlm-2613	90	24	(	(	PUNCT
ajlm-2613	90	25	1	1	NUM
ajlm-2613	90	26	out	out	ADP
ajlm-2613	90	27	of	of	ADP
ajlm-2613	90	28	29	29	NUM
ajlm-2613	90	29	cases	case	NOUN
ajlm-2613	90	30	)	)	PUNCT
ajlm-2613	90	31	.	.	PUNCT
ajlm-2613	91	1	the	the	DET
ajlm-2613	91	2	available	available	ADJ
ajlm-2613	91	3	data	datum	NOUN
ajlm-2613	91	4	demonstrate	demonstrate	VERB
ajlm-2613	91	5	relatively	relatively	ADV
ajlm-2613	91	6	lower	low	ADJ
ajlm-2613	91	7	cox-2	cox-2	ADJ
ajlm-2613	91	8	expression	expression	NOUN
ajlm-2613	91	9	in	in	ADP
ajlm-2613	91	10	adenoma	adenoma	ADV
ajlm-2613	91	11	than	than	ADP
ajlm-2613	91	12	in	in	ADP
ajlm-2613	91	13	the	the	DET
ajlm-2613	91	14	crc	crc	NOUN
ajlm-2613	91	15	.	.	PUNCT
ajlm-2613	92	1	the	the	DET
ajlm-2613	92	2	possible	possible	ADJ
ajlm-2613	92	3	reason	reason	NOUN
ajlm-2613	92	4	why	why	SCONJ
ajlm-2613	92	5	cox-2	cox-2	NUM
ajlm-2613	92	6	expression	expression	NOUN
ajlm-2613	92	7	is	be	AUX
ajlm-2613	92	8	higher	high	ADJ
ajlm-2613	92	9	in	in	ADP
ajlm-2613	92	10	crcs	crcs	NOUN
ajlm-2613	92	11	than	than	SCONJ
ajlm-2613	92	12	in	in	ADP
ajlm-2613	92	13	adenomas	adenoma	NOUN
ajlm-2613	92	14	may	may	AUX
ajlm-2613	92	15	be	be	AUX
ajlm-2613	92	16	that	that	SCONJ
ajlm-2613	92	17	although	although	SCONJ
ajlm-2613	92	18	cox-2	cox-2	VERB
ajlm-2613	92	19	expression	expression	NOUN
ajlm-2613	92	20	is	be	AUX
ajlm-2613	92	21	involved	involve	VERB
ajlm-2613	92	22	in	in	ADP
ajlm-2613	92	23	tumour	tumour	ADJ
ajlm-2613	92	24	initiation	initiation	NOUN
ajlm-2613	92	25	,	,	PUNCT
ajlm-2613	92	26	it	it	PRON
ajlm-2613	92	27	is	be	AUX
ajlm-2613	92	28	also	also	ADV
ajlm-2613	92	29	a	a	DET
ajlm-2613	92	30	marker	marker	NOUN
ajlm-2613	92	31	for	for	ADP
ajlm-2613	92	32	advanced	advanced	ADJ
ajlm-2613	92	33	lesions	lesion	NOUN
ajlm-2613	92	34	(	(	PUNCT
ajlm-2613	92	35	from	from	ADP
ajlm-2613	92	36	dysplasia	dysplasia	NOUN
ajlm-2613	92	37	in	in	ADP
ajlm-2613	92	38	adenomas	adenoma	NOUN
ajlm-2613	92	39	to	to	PART
ajlm-2613	92	40	frank	frank	VERB
ajlm-2613	92	41	malignancy	malignancy	NOUN
ajlm-2613	92	42	and	and	CCONJ
ajlm-2613	92	43	invasiveness	invasiveness	VERB
ajlm-2613	92	44	in	in	ADP
ajlm-2613	92	45	carcinomas).30,31	carcinomas).30,31	NOUN
ajlm-2613	92	46	for	for	ADP
ajlm-2613	92	47	example	example	NOUN
ajlm-2613	92	48	,	,	PUNCT
ajlm-2613	92	49	it	it	PRON
ajlm-2613	92	50	has	have	AUX
ajlm-2613	92	51	been	be	AUX
ajlm-2613	92	52	shown	show	VERB
ajlm-2613	92	53	that	that	SCONJ
ajlm-2613	92	54	cox-2	cox-2	VERB
ajlm-2613	92	55	expression	expression	NOUN
ajlm-2613	92	56	has	have	VERB
ajlm-2613	92	57	a	a	DET
ajlm-2613	92	58	positive	positive	ADJ
ajlm-2613	92	59	correlation	correlation	NOUN
ajlm-2613	92	60	with	with	ADP
ajlm-2613	92	61	adenoma	adenoma	ADJ
ajlm-2613	92	62	size	size	NOUN
ajlm-2613	92	63	,	,	PUNCT
ajlm-2613	92	64	dysplasia	dysplasia	NOUN
ajlm-2613	92	65	,	,	PUNCT
ajlm-2613	92	66	and	and	CCONJ
ajlm-2613	92	67	grade	grade	NOUN
ajlm-2613	92	68	but	but	CCONJ
ajlm-2613	92	69	not	not	PART
ajlm-2613	92	70	with	with	ADP
ajlm-2613	92	71	the	the	DET
ajlm-2613	92	72	tumour	tumour	NOUN
ajlm-2613	92	73	location	location	NOUN
ajlm-2613	92	74	or	or	CCONJ
ajlm-2613	92	75	configuration	configuration	NOUN
ajlm-2613	92	76	,	,	PUNCT
ajlm-2613	92	77	and	and	CCONJ
ajlm-2613	92	78	the	the	DET
ajlm-2613	92	79	expression	expression	NOUN
ajlm-2613	92	80	is	be	AUX
ajlm-2613	92	81	higher	high	ADJ
ajlm-2613	92	82	in	in	ADP
ajlm-2613	92	83	the	the	DET
ajlm-2613	92	84	crc.30,32,33,34,35	crc.30,32,33,34,35	NOUN
ajlm-2613	92	85	this	this	PRON
ajlm-2613	92	86	may	may	AUX
ajlm-2613	92	87	also	also	ADV
ajlm-2613	92	88	explain	explain	VERB
ajlm-2613	92	89	why	why	SCONJ
ajlm-2613	92	90	the	the	DET
ajlm-2613	92	91	expression	expression	NOUN
ajlm-2613	92	92	of	of	ADP
ajlm-2613	92	93	cox-2	cox-2	NOUN
ajlm-2613	92	94	in	in	ADP
ajlm-2613	92	95	colorectal	colorectal	ADJ
ajlm-2613	92	96	adenomas	adenoma	NOUN
ajlm-2613	92	97	demonstrates	demonstrate	VERB
ajlm-2613	92	98	a	a	DET
ajlm-2613	92	99	wide	wide	ADJ
ajlm-2613	92	100	variation	variation	NOUN
ajlm-2613	92	101	similar	similar	ADJ
ajlm-2613	92	102	to	to	ADP
ajlm-2613	92	103	that	that	PRON
ajlm-2613	92	104	of	of	ADP
ajlm-2613	92	105	the	the	DET
ajlm-2613	92	106	crc	crc	NOUN
ajlm-2613	92	107	,	,	PUNCT
ajlm-2613	92	108	from	from	ADP
ajlm-2613	92	109	38	38	NUM
ajlm-2613	92	110	%	%	NOUN
ajlm-2613	92	111	to	to	PART
ajlm-2613	92	112	100	100	NUM
ajlm-2613	92	113	%	%	NOUN
ajlm-2613	92	114	,	,	PUNCT
ajlm-2613	92	115	because	because	SCONJ
ajlm-2613	92	116	of	of	ADP
ajlm-2613	92	117	adenoma	adenoma	ADJ
ajlm-2613	92	118	size	size	NOUN
ajlm-2613	92	119	,	,	PUNCT
ajlm-2613	92	120	presence	presence	NOUN
ajlm-2613	92	121	of	of	ADP
ajlm-2613	92	122	dysplasia	dysplasia	NOUN
ajlm-2613	92	123	,	,	PUNCT
ajlm-2613	92	124	histological	histological	ADJ
ajlm-2613	92	125	subtype	subtype	NOUN
ajlm-2613	92	126	,	,	PUNCT
ajlm-2613	92	127	and	and	CCONJ
ajlm-2613	92	128	key	key	ADJ
ajlm-2613	92	129	genetic	genetic	ADJ
ajlm-2613	92	130	mutation.35,36	mutation.35,36	NOUN
ajlm-2613	92	131	early	early	ADJ
ajlm-2613	92	132	adenomas	adenoma	NOUN
ajlm-2613	92	133	are	be	AUX
ajlm-2613	92	134	usually	usually	ADV
ajlm-2613	92	135	small	small	ADJ
ajlm-2613	92	136	and	and	CCONJ
ajlm-2613	92	137	the	the	DET
ajlm-2613	92	138	progression	progression	NOUN
ajlm-2613	92	139	of	of	ADP
ajlm-2613	92	140	most	most	ADJ
ajlm-2613	92	141	small	small	ADJ
ajlm-2613	92	142	adenomas	adenoma	NOUN
ajlm-2613	92	143	is	be	AUX
ajlm-2613	92	144	slow	slow	ADJ
ajlm-2613	92	145	,	,	PUNCT
ajlm-2613	92	146	over	over	ADP
ajlm-2613	92	147	several	several	ADJ
ajlm-2613	92	148	years	year	NOUN
ajlm-2613	92	149	,	,	PUNCT
ajlm-2613	92	150	even	even	ADV
ajlm-2613	92	151	though	though	SCONJ
ajlm-2613	92	152	not	not	PART
ajlm-2613	92	153	all	all	DET
ajlm-2613	92	154	adenomas	adenoma	NOUN
ajlm-2613	92	155	progress	progress	NOUN
ajlm-2613	92	156	.	.	PUNCT
ajlm-2613	93	1	some	some	PRON
ajlm-2613	93	2	may	may	AUX
ajlm-2613	93	3	remain	remain	VERB
ajlm-2613	93	4	stable	stable	ADJ
ajlm-2613	93	5	,	,	PUNCT
ajlm-2613	93	6	regress	regress	ADJ
ajlm-2613	93	7	or	or	CCONJ
ajlm-2613	93	8	new	new	ADJ
ajlm-2613	93	9	ones	one	NOUN
ajlm-2613	93	10	may	may	AUX
ajlm-2613	93	11	form	form	VERB
ajlm-2613	93	12	.	.	PUNCT
ajlm-2613	94	1	the	the	DET
ajlm-2613	94	2	progression	progression	NOUN
ajlm-2613	94	3	in	in	ADP
ajlm-2613	94	4	the	the	DET
ajlm-2613	94	5	spectrum	spectrum	NOUN
ajlm-2613	94	6	of	of	ADP
ajlm-2613	94	7	the	the	DET
ajlm-2613	94	8	adenoma	adenoma	ADJ
ajlm-2613	94	9	-	-	PUNCT
ajlm-2613	94	10	carcinoma	carcinoma	NOUN
ajlm-2613	94	11	sequence	sequence	NOUN
ajlm-2613	94	12	may	may	AUX
ajlm-2613	94	13	involve	involve	VERB
ajlm-2613	94	14	more	more	ADJ
ajlm-2613	94	15	genetic	genetic	ADJ
ajlm-2613	94	16	mutations	mutation	NOUN
ajlm-2613	94	17	and	and	CCONJ
ajlm-2613	94	18	molecular	molecular	ADJ
ajlm-2613	94	19	interplay	interplay	NOUN
ajlm-2613	94	20	,	,	PUNCT
ajlm-2613	94	21	including	include	VERB
ajlm-2613	94	22	over	over	ADP
ajlm-2613	94	23	-	-	PUNCT
ajlm-2613	94	24	expression	expression	NOUN
ajlm-2613	94	25	of	of	ADP
ajlm-2613	94	26	cox-2	cox-2	NOUN
ajlm-2613	94	27	.	.	PUNCT
ajlm-2613	95	1	to	to	PART
ajlm-2613	95	2	illustrate	illustrate	VERB
ajlm-2613	95	3	this	this	PRON
ajlm-2613	95	4	,	,	PUNCT
ajlm-2613	95	5	immunohistochemical	immunohistochemical	ADJ
ajlm-2613	95	6	studies	study	NOUN
ajlm-2613	95	7	have	have	AUX
ajlm-2613	95	8	shown	show	VERB
ajlm-2613	95	9	that	that	SCONJ
ajlm-2613	95	10	37.9	37.9	NUM
ajlm-2613	95	11	%	%	NOUN
ajlm-2613	95	12	of	of	ADP
ajlm-2613	95	13	39	39	NUM
ajlm-2613	95	14	cases	case	NOUN
ajlm-2613	95	15	of	of	ADP
ajlm-2613	95	16	adenoma	adenoma	ADJ
ajlm-2613	95	17	were	be	AUX
ajlm-2613	95	18	cox-2	cox-2	ADV
ajlm-2613	95	19	positive	positive	ADJ
ajlm-2613	95	20	;	;	PUNCT
ajlm-2613	95	21	90.9	90.9	NUM
ajlm-2613	95	22	%	%	NOUN
ajlm-2613	95	23	of	of	ADP
ajlm-2613	95	24	these	these	DET
ajlm-2613	95	25	positive	positive	ADJ
ajlm-2613	95	26	cases	case	NOUN
ajlm-2613	95	27	had	have	VERB
ajlm-2613	95	28	a	a	DET
ajlm-2613	95	29	kirsten	kirsten	ADJ
ajlm-2613	95	30	rat	rat	NOUN
ajlm-2613	95	31	sarcoma	sarcoma	NOUN
ajlm-2613	95	32	mutation	mutation	NOUN
ajlm-2613	95	33	that	that	PRON
ajlm-2613	95	34	correlates	correlate	VERB
ajlm-2613	95	35	with	with	ADP
ajlm-2613	95	36	tumour	tumour	NOUN
ajlm-2613	95	37	size	size	NOUN
ajlm-2613	95	38	(	(	PUNCT
ajlm-2613	95	39	larger	large	ADJ
ajlm-2613	95	40	tumour	tumour	NOUN
ajlm-2613	95	41	)	)	PUNCT
ajlm-2613	95	42	,	,	PUNCT
ajlm-2613	95	43	and	and	CCONJ
ajlm-2613	95	44	the	the	DET
ajlm-2613	95	45	positivity	positivity	NOUN
ajlm-2613	95	46	is	be	AUX
ajlm-2613	95	47	more	more	ADV
ajlm-2613	95	48	frequent	frequent	ADJ
ajlm-2613	95	49	in	in	ADP
ajlm-2613	95	50	tubulovillous	tubulovillous	ADJ
ajlm-2613	95	51	(	(	PUNCT
ajlm-2613	95	52	63.3	63.3	NUM
ajlm-2613	95	53	%	%	NOUN
ajlm-2613	95	54	)	)	PUNCT
ajlm-2613	95	55	than	than	ADP
ajlm-2613	95	56	tubular	tubular	ADJ
ajlm-2613	95	57	adenoma	adenoma	ADJ
ajlm-2613	95	58	(	(	PUNCT
ajlm-2613	95	59	36.4%).36	36.4%).36	NUM
ajlm-2613	95	60	contrary	contrary	ADV
ajlm-2613	95	61	to	to	ADP
ajlm-2613	95	62	this	this	DET
ajlm-2613	95	63	assertion	assertion	NOUN
ajlm-2613	95	64	that	that	SCONJ
ajlm-2613	95	65	the	the	DET
ajlm-2613	95	66	cox-2	cox-2	ADJ
ajlm-2613	95	67	expression	expression	NOUN
ajlm-2613	95	68	is	be	AUX
ajlm-2613	95	69	a	a	DET
ajlm-2613	95	70	marker	marker	NOUN
ajlm-2613	95	71	of	of	ADP
ajlm-2613	95	72	progression	progression	NOUN
ajlm-2613	95	73	,	,	PUNCT
ajlm-2613	95	74	a	a	DET
ajlm-2613	95	75	cox-2	cox-2	ADJ
ajlm-2613	95	76	immunohistochemical	immunohistochemical	ADJ
ajlm-2613	95	77	study	study	NOUN
ajlm-2613	95	78	of	of	ADP
ajlm-2613	95	79	nine	nine	NUM
ajlm-2613	95	80	advanced	advanced	ADJ
ajlm-2613	95	81	crc	crc	NOUN
ajlm-2613	95	82	and	and	CCONJ
ajlm-2613	95	83	12	12	NUM
ajlm-2613	95	84	adenoma	adenoma	ADJ
ajlm-2613	95	85	cases	case	NOUN
ajlm-2613	95	86	in	in	ADP
ajlm-2613	95	87	japan	japan	PROPN
ajlm-2613	95	88	by	by	ADP
ajlm-2613	95	89	bamba	bamba	PROPN
ajlm-2613	95	90	et	et	PROPN
ajlm-2613	95	91	al	al	PROPN
ajlm-2613	95	92	.	.	PROPN
ajlm-2613	95	93	showed	show	VERB
ajlm-2613	95	94	a	a	DET
ajlm-2613	95	95	higher	high	ADJ
ajlm-2613	95	96	expression	expression	NOUN
ajlm-2613	95	97	in	in	ADP
ajlm-2613	95	98	adenomas	adenoma	NOUN
ajlm-2613	95	99	than	than	SCONJ
ajlm-2613	95	100	in	in	ADP
ajlm-2613	95	101	crcs.37	crcs.37	PROPN
ajlm-2613	95	102	bamba	bamba	NOUN
ajlm-2613	95	103	et	et	PROPN
ajlm-2613	95	104	al	al	PROPN
ajlm-2613	95	105	.	.	PROPN
ajlm-2613	95	106	’s	’s	PART
ajlm-2613	95	107	contrary	contrary	ADJ
ajlm-2613	95	108	observation	observation	NOUN
ajlm-2613	95	109	is	be	AUX
ajlm-2613	95	110	difficult	difficult	ADJ
ajlm-2613	95	111	to	to	PART
ajlm-2613	95	112	decode	decode	VERB
ajlm-2613	95	113	,	,	PUNCT
ajlm-2613	95	114	but	but	CCONJ
ajlm-2613	95	115	it	it	PRON
ajlm-2613	95	116	may	may	AUX
ajlm-2613	95	117	stem	stem	VERB
ajlm-2613	95	118	from	from	ADP
ajlm-2613	95	119	the	the	DET
ajlm-2613	95	120	low	low	ADJ
ajlm-2613	95	121	sample	sample	NOUN
ajlm-2613	95	122	size	size	NOUN
ajlm-2613	95	123	in	in	ADP
ajlm-2613	95	124	their	their	PRON
ajlm-2613	95	125	study.37	study.37	NOUN
ajlm-2613	95	126	the	the	DET
ajlm-2613	95	127	cox-2	cox-2	ADJ
ajlm-2613	95	128	expression	expression	NOUN
ajlm-2613	95	129	(	(	PUNCT
ajlm-2613	95	130	3.4	3.4	NUM
ajlm-2613	95	131	%	%	NOUN
ajlm-2613	95	132	,	,	PUNCT
ajlm-2613	95	133	1	1	NUM
ajlm-2613	95	134	out	out	ADP
ajlm-2613	95	135	of	of	ADP
ajlm-2613	95	136	29	29	NUM
ajlm-2613	95	137	cases	case	NOUN
ajlm-2613	95	138	)	)	PUNCT
ajlm-2613	95	139	in	in	ADP
ajlm-2613	95	140	this	this	DET
ajlm-2613	95	141	study	study	NOUN
ajlm-2613	95	142	confirms	confirm	VERB
ajlm-2613	95	143	the	the	DET
ajlm-2613	95	144	assertion	assertion	NOUN
ajlm-2613	95	145	that	that	SCONJ
ajlm-2613	95	146	cox-2	cox-2	ADV
ajlm-2613	95	147	is	be	AUX
ajlm-2613	95	148	a	a	DET
ajlm-2613	95	149	marker	marker	NOUN
ajlm-2613	95	150	of	of	ADP
ajlm-2613	95	151	progression	progression	NOUN
ajlm-2613	95	152	in	in	ADP
ajlm-2613	95	153	the	the	DET
ajlm-2613	95	154	adenoma	adenoma	ADJ
ajlm-2613	95	155	-	-	PUNCT
ajlm-2613	95	156	carcinoma	carcinoma	NOUN
ajlm-2613	95	157	spectrum	spectrum	NOUN
ajlm-2613	95	158	,	,	PUNCT
ajlm-2613	95	159	but	but	CCONJ
ajlm-2613	95	160	it	it	PRON
ajlm-2613	95	161	is	be	AUX
ajlm-2613	95	162	relatively	relatively	ADV
ajlm-2613	95	163	lower	low	ADJ
ajlm-2613	95	164	than	than	ADP
ajlm-2613	95	165	other	other	ADJ
ajlm-2613	95	166	studies	study	NOUN
ajlm-2613	95	167	.	.	PUNCT
ajlm-2613	96	1	it	it	PRON
ajlm-2613	96	2	is	be	AUX
ajlm-2613	96	3	difficult	difficult	ADJ
ajlm-2613	96	4	to	to	PART
ajlm-2613	96	5	determine	determine	VERB
ajlm-2613	96	6	the	the	DET
ajlm-2613	96	7	reasons	reason	NOUN
ajlm-2613	96	8	,	,	PUNCT
ajlm-2613	96	9	but	but	CCONJ
ajlm-2613	96	10	the	the	DET
ajlm-2613	96	11	possibilities	possibility	NOUN
ajlm-2613	96	12	may	may	AUX
ajlm-2613	96	13	include	include	VERB
ajlm-2613	96	14	racial	racial	ADJ
ajlm-2613	96	15	factors	factor	NOUN
ajlm-2613	96	16	,	,	PUNCT
ajlm-2613	96	17	as	as	SCONJ
ajlm-2613	96	18	most	most	ADJ
ajlm-2613	96	19	studies	study	NOUN
ajlm-2613	96	20	involve	involve	VERB
ajlm-2613	96	21	non	non	ADJ
ajlm-2613	96	22	-	-	ADJ
ajlm-2613	96	23	african	african	ADJ
ajlm-2613	96	24	subjects	subject	NOUN
ajlm-2613	96	25	,	,	PUNCT
ajlm-2613	96	26	genetic	genetic	ADJ
ajlm-2613	96	27	make	make	NOUN
ajlm-2613	96	28	-	-	PUNCT
ajlm-2613	96	29	up	up	NOUN
ajlm-2613	96	30	–	–	PUNCT
ajlm-2613	96	31	particularly	particularly	ADV
ajlm-2613	96	32	cox-2	cox-2	ADJ
ajlm-2613	96	33	gene	gene	NOUN
ajlm-2613	96	34	polymorphism	polymorphism	NOUN
ajlm-2613	96	35	,	,	PUNCT
ajlm-2613	96	36	and	and	CCONJ
ajlm-2613	96	37	the	the	DET
ajlm-2613	96	38	fact	fact	NOUN
ajlm-2613	96	39	that	that	SCONJ
ajlm-2613	96	40	most	most	ADJ
ajlm-2613	96	41	adenomas	adenoma	NOUN
ajlm-2613	96	42	analysed	analyse	VERB
ajlm-2613	96	43	in	in	ADP
ajlm-2613	96	44	this	this	DET
ajlm-2613	96	45	current	current	ADJ
ajlm-2613	96	46	study	study	NOUN
ajlm-2613	96	47	were	be	AUX
ajlm-2613	96	48	colonoscopic	colonoscopic	ADJ
ajlm-2613	96	49	biopsies	biopsy	NOUN
ajlm-2613	96	50	,	,	PUNCT
ajlm-2613	96	51	which	which	PRON
ajlm-2613	96	52	may	may	AUX
ajlm-2613	96	53	not	not	PART
ajlm-2613	96	54	represent	represent	VERB
ajlm-2613	96	55	the	the	DET
ajlm-2613	96	56	entire	entire	ADJ
ajlm-2613	96	57	tumour	tumour	NOUN
ajlm-2613	96	58	heterogeneity	heterogeneity	NOUN
ajlm-2613	96	59	,	,	PUNCT
ajlm-2613	96	60	even	even	ADV
ajlm-2613	96	61	though	though	SCONJ
ajlm-2613	96	62	the	the	DET
ajlm-2613	96	63	adenomas	adenoma	NOUN
ajlm-2613	96	64	from	from	ADP
ajlm-2613	96	65	three	three	NUM
ajlm-2613	96	66	colectomy	colectomy	NOUN
ajlm-2613	96	67	cases	case	NOUN
ajlm-2613	96	68	did	do	AUX
ajlm-2613	96	69	not	not	PART
ajlm-2613	96	70	express	express	VERB
ajlm-2613	96	71	cox-2	cox-2	NOUN
ajlm-2613	96	72	as	as	ADV
ajlm-2613	96	73	well	well	ADV
ajlm-2613	96	74	.	.	PUNCT
ajlm-2613	97	1	more	more	ADJ
ajlm-2613	97	2	studies	study	NOUN
ajlm-2613	97	3	are	be	AUX
ajlm-2613	97	4	needed	need	VERB
ajlm-2613	97	5	for	for	SCONJ
ajlm-2613	97	6	africa	africa	PROPN
ajlm-2613	97	7	to	to	PART
ajlm-2613	97	8	explain	explain	VERB
ajlm-2613	97	9	the	the	DET
ajlm-2613	97	10	possible	possible	ADJ
ajlm-2613	97	11	racial	racial	ADJ
ajlm-2613	97	12	disparity	disparity	NOUN
ajlm-2613	97	13	in	in	ADP
ajlm-2613	97	14	cox-2	cox-2	ADJ
ajlm-2613	97	15	expression	expression	NOUN
ajlm-2613	97	16	in	in	ADP
ajlm-2613	97	17	adenomas	adenoma	NOUN
ajlm-2613	97	18	,	,	PUNCT
ajlm-2613	97	19	because	because	SCONJ
ajlm-2613	97	20	most	most	ADV
ajlm-2613	97	21	available	available	ADJ
ajlm-2613	97	22	cox-2	cox-2	ADJ
ajlm-2613	97	23	studies	study	NOUN
ajlm-2613	97	24	on	on	ADP
ajlm-2613	97	25	colorectal	colorectal	ADJ
ajlm-2613	97	26	adenomas	adenoma	NOUN
ajlm-2613	97	27	and	and	CCONJ
ajlm-2613	97	28	crcs	crcs	NOUN
ajlm-2613	97	29	are	be	AUX
ajlm-2613	97	30	from	from	ADP
ajlm-2613	97	31	america	america	PROPN
ajlm-2613	97	32	and	and	CCONJ
ajlm-2613	97	33	asian	asian	ADJ
ajlm-2613	97	34	countries	country	NOUN
ajlm-2613	97	35	.	.	PUNCT
ajlm-2613	98	1	carriers	carrier	NOUN
ajlm-2613	98	2	of	of	ADP
ajlm-2613	98	3	the	the	DET
ajlm-2613	98	4	cox-2	cox-2	ADJ
ajlm-2613	98	5	a-1195	a-1195	NOUN
ajlm-2613	98	6	g	g	PROPN
ajlm-2613	98	7	ag	ag	PROPN
ajlm-2613	98	8	polymorphism	polymorphism	NOUN
ajlm-2613	98	9	have	have	AUX
ajlm-2613	98	10	increased	increase	VERB
ajlm-2613	98	11	risk	risk	NOUN
ajlm-2613	98	12	for	for	ADP
ajlm-2613	98	13	crc	crc	NOUN
ajlm-2613	98	14	and	and	CCONJ
ajlm-2613	98	15	adenoma	adenoma	ADJ
ajlm-2613	98	16	,	,	PUNCT
ajlm-2613	98	17	and	and	CCONJ
ajlm-2613	98	18	mutation	mutation	NOUN
ajlm-2613	98	19	in	in	ADP
ajlm-2613	98	20	the	the	DET
ajlm-2613	98	21	adenomatous	adenomatous	ADJ
ajlm-2613	98	22	polyposis	polyposis	NOUN
ajlm-2613	98	23	coli	coli	NOUN
ajlm-2613	98	24	(	(	PUNCT
ajlm-2613	98	25	apc	apc	PROPN
ajlm-2613	98	26	)	)	PUNCT
ajlm-2613	98	27	gene	gene	NOUN
ajlm-2613	98	28	has	have	AUX
ajlm-2613	98	29	been	be	AUX
ajlm-2613	98	30	shown	show	VERB
ajlm-2613	98	31	to	to	PART
ajlm-2613	98	32	correlate	correlate	VERB
ajlm-2613	98	33	with	with	ADP
ajlm-2613	98	34	cox-2	cox-2	ADJ
ajlm-2613	98	35	expression	expression	NOUN
ajlm-2613	98	36	in	in	ADP
ajlm-2613	98	37	both	both	DET
ajlm-2613	98	38	adenomas	adenoma	NOUN
ajlm-2613	98	39	and	and	CCONJ
ajlm-2613	98	40	crcs.10,38,39	crcs.10,38,39	NOUN
ajlm-2613	98	41	more	more	ADJ
ajlm-2613	98	42	studies	study	NOUN
ajlm-2613	98	43	are	be	AUX
ajlm-2613	98	44	needed	need	VERB
ajlm-2613	98	45	to	to	PART
ajlm-2613	98	46	establish	establish	VERB
ajlm-2613	98	47	the	the	DET
ajlm-2613	98	48	role	role	NOUN
ajlm-2613	98	49	of	of	ADP
ajlm-2613	98	50	race	race	NOUN
ajlm-2613	98	51	in	in	ADP
ajlm-2613	98	52	cox-2	cox-2	ADJ
ajlm-2613	98	53	expression	expression	NOUN
ajlm-2613	98	54	in	in	ADP
ajlm-2613	98	55	adenoma	adenoma	ADJ
ajlm-2613	98	56	.	.	PUNCT
ajlm-2613	99	1	implications	implication	NOUN
ajlm-2613	99	2	and	and	CCONJ
ajlm-2613	99	3	recommendations	recommendation	NOUN
ajlm-2613	99	4	colorectal	colorectal	ADJ
ajlm-2613	99	5	adenomas	adenoma	NOUN
ajlm-2613	99	6	are	be	AUX
ajlm-2613	99	7	known	know	VERB
ajlm-2613	99	8	precursor	precursor	NOUN
ajlm-2613	99	9	lesions	lesion	NOUN
ajlm-2613	99	10	of	of	ADP
ajlm-2613	99	11	crc	crc	NOUN
ajlm-2613	99	12	with	with	ADP
ajlm-2613	99	13	similar	similar	ADJ
ajlm-2613	99	14	risk	risk	NOUN
ajlm-2613	99	15	factors.6,7,8	factors.6,7,8	NOUN
ajlm-2613	99	16	thus	thus	ADV
ajlm-2613	99	17	efforts	effort	NOUN
ajlm-2613	99	18	are	be	AUX
ajlm-2613	99	19	required	require	VERB
ajlm-2613	99	20	to	to	PART
ajlm-2613	99	21	interrupt	interrupt	VERB
ajlm-2613	99	22	the	the	DET
ajlm-2613	99	23	possibility	possibility	NOUN
ajlm-2613	99	24	of	of	ADP
ajlm-2613	99	25	the	the	DET
ajlm-2613	99	26	progression	progression	NOUN
ajlm-2613	99	27	of	of	ADP
ajlm-2613	99	28	adenomas	adenoma	NOUN
ajlm-2613	99	29	to	to	ADP
ajlm-2613	99	30	colorectal	colorectal	ADJ
ajlm-2613	99	31	cancer.6	cancer.6	NOUN
ajlm-2613	99	32	the	the	DET
ajlm-2613	99	33	expression	expression	NOUN
ajlm-2613	99	34	of	of	ADP
ajlm-2613	99	35	cox-2	cox-2	PRON
ajlm-2613	99	36	provides	provide	VERB
ajlm-2613	99	37	vital	vital	ADJ
ajlm-2613	99	38	information	information	NOUN
ajlm-2613	99	39	for	for	ADP
ajlm-2613	99	40	the	the	DET
ajlm-2613	99	41	uses	use	NOUN
ajlm-2613	99	42	of	of	ADP
ajlm-2613	99	43	nonsteroidal	nonsteroidal	NOUN
ajlm-2613	99	44	anti	anti	ADJ
ajlm-2613	99	45	-	-	ADJ
ajlm-2613	99	46	inflammatory	inflammatory	ADJ
ajlm-2613	99	47	drugs	drug	NOUN
ajlm-2613	99	48	in	in	ADP
ajlm-2613	99	49	the	the	DET
ajlm-2613	99	50	prevention	prevention	NOUN
ajlm-2613	99	51	and	and	CCONJ
ajlm-2613	99	52	treatment	treatment	NOUN
ajlm-2613	99	53	of	of	ADP
ajlm-2613	99	54	adenoma	adenoma	ADJ
ajlm-2613	99	55	and	and	CCONJ
ajlm-2613	99	56	hurting	hurt	VERB
ajlm-2613	99	57	adenoma	adenoma	ADJ
ajlm-2613	99	58	progression	progression	NOUN
ajlm-2613	99	59	into	into	ADP
ajlm-2613	99	60	carcinoma	carcinoma	NOUN
ajlm-2613	99	61	.	.	PUNCT
ajlm-2613	100	1	thus	thus	ADV
ajlm-2613	100	2	,	,	PUNCT
ajlm-2613	100	3	in	in	ADP
ajlm-2613	100	4	terms	term	NOUN
ajlm-2613	100	5	of	of	ADP
ajlm-2613	100	6	the	the	DET
ajlm-2613	100	7	prognosis	prognosis	NOUN
ajlm-2613	100	8	and	and	CCONJ
ajlm-2613	100	9	cox-2	cox-2	ADV
ajlm-2613	100	10	targeted	target	VERB
ajlm-2613	100	11	therapy	therapy	NOUN
ajlm-2613	100	12	in	in	ADP
ajlm-2613	100	13	the	the	DET
ajlm-2613	100	14	near	near	ADJ
ajlm-2613	100	15	future	future	NOUN
ajlm-2613	100	16	,	,	PUNCT
ajlm-2613	100	17	this	this	DET
ajlm-2613	100	18	study	study	NOUN
ajlm-2613	100	19	provides	provide	VERB
ajlm-2613	100	20	a	a	DET
ajlm-2613	100	21	strong	strong	ADJ
ajlm-2613	100	22	rationale	rationale	NOUN
ajlm-2613	100	23	for	for	ADP
ajlm-2613	100	24	additional	additional	ADJ
ajlm-2613	100	25	studies	study	NOUN
ajlm-2613	100	26	in	in	ADP
ajlm-2613	100	27	nigeria	nigeria	PROPN
ajlm-2613	100	28	and	and	CCONJ
ajlm-2613	100	29	africa	africa	PROPN
ajlm-2613	100	30	at	at	ADP
ajlm-2613	100	31	large	large	ADJ
ajlm-2613	100	32	.	.	PUNCT
ajlm-2613	101	1	limitations	limitation	NOUN
ajlm-2613	101	2	the	the	DET
ajlm-2613	101	3	limitation	limitation	NOUN
ajlm-2613	101	4	of	of	ADP
ajlm-2613	101	5	this	this	DET
ajlm-2613	101	6	study	study	NOUN
ajlm-2613	101	7	is	be	AUX
ajlm-2613	101	8	the	the	DET
ajlm-2613	101	9	inability	inability	NOUN
ajlm-2613	101	10	to	to	PART
ajlm-2613	101	11	include	include	VERB
ajlm-2613	101	12	rare	rare	ADJ
ajlm-2613	101	13	histological	histological	ADJ
ajlm-2613	101	14	sub	sub	NOUN
ajlm-2613	101	15	-	-	NOUN
ajlm-2613	101	16	types	type	NOUN
ajlm-2613	101	17	of	of	ADP
ajlm-2613	101	18	adenoma	adenoma	ADJ
ajlm-2613	101	19	and	and	CCONJ
ajlm-2613	101	20	relatively	relatively	ADV
ajlm-2613	101	21	low	low	ADJ
ajlm-2613	101	22	cases	case	NOUN
ajlm-2613	101	23	of	of	ADP
ajlm-2613	101	24	adenomas	adenoma	NOUN
ajlm-2613	101	25	in	in	ADP
ajlm-2613	101	26	this	this	DET
ajlm-2613	101	27	study	study	NOUN
ajlm-2613	101	28	.	.	PUNCT
ajlm-2613	102	1	to	to	PART
ajlm-2613	102	2	improve	improve	VERB
ajlm-2613	102	3	this	this	PRON
ajlm-2613	102	4	,	,	PUNCT
ajlm-2613	102	5	a	a	DET
ajlm-2613	102	6	multicentre	multicentre	NOUN
ajlm-2613	102	7	study	study	NOUN
ajlm-2613	102	8	across	across	ADP
ajlm-2613	102	9	africa	africa	PROPN
ajlm-2613	102	10	will	will	AUX
ajlm-2613	102	11	give	give	VERB
ajlm-2613	102	12	a	a	DET
ajlm-2613	102	13	better	well	ADJ
ajlm-2613	102	14	reflection	reflection	NOUN
ajlm-2613	102	15	of	of	ADP
ajlm-2613	102	16	cox-2	cox-2	ADJ
ajlm-2613	102	17	expression	expression	NOUN
ajlm-2613	102	18	in	in	ADP
ajlm-2613	102	19	colorectal	colorectal	ADJ
ajlm-2613	102	20	adenoma	adenoma	NOUN
ajlm-2613	102	21	in	in	ADP
ajlm-2613	102	22	africa	africa	PROPN
ajlm-2613	102	23	.	.	PUNCT
ajlm-2613	103	1	conclusion	conclusion	NOUN
ajlm-2613	103	2	adenomas	adenoma	NOUN
ajlm-2613	103	3	occurred	occur	VERB
ajlm-2613	103	4	twice	twice	ADV
ajlm-2613	103	5	as	as	ADV
ajlm-2613	103	6	commonly	commonly	ADV
ajlm-2613	103	7	in	in	ADP
ajlm-2613	103	8	men	man	NOUN
ajlm-2613	103	9	as	as	ADP
ajlm-2613	103	10	in	in	ADP
ajlm-2613	103	11	women	woman	NOUN
ajlm-2613	103	12	.	.	PUNCT
ajlm-2613	104	1	tubular	tubular	ADJ
ajlm-2613	104	2	adenomas	adenoma	NOUN
ajlm-2613	104	3	constituted	constitute	VERB
ajlm-2613	104	4	62.1	62.1	NUM
ajlm-2613	104	5	%	%	NOUN
ajlm-2613	104	6	of	of	ADP
ajlm-2613	104	7	all	all	DET
ajlm-2613	104	8	adenomas	adenoma	NOUN
ajlm-2613	104	9	,	,	PUNCT
ajlm-2613	104	10	and	and	CCONJ
ajlm-2613	104	11	51.7	51.7	NUM
ajlm-2613	104	12	%	%	NOUN
ajlm-2613	104	13	of	of	ADP
ajlm-2613	104	14	adenomas	adenoma	NOUN
ajlm-2613	104	15	are	be	AUX
ajlm-2613	104	16	high	high	ADJ
ajlm-2613	104	17	-	-	PUNCT
ajlm-2613	104	18	grade	grade	NOUN
ajlm-2613	104	19	adenomas	adenoma	NOUN
ajlm-2613	104	20	.	.	PUNCT
ajlm-2613	105	1	the	the	DET
ajlm-2613	105	2	rate	rate	NOUN
ajlm-2613	105	3	of	of	ADP
ajlm-2613	105	4	over	over	ADP
ajlm-2613	105	5	-	-	PUNCT
ajlm-2613	105	6	expression	expression	NOUN
ajlm-2613	105	7	of	of	ADP
ajlm-2613	105	8	cox-2	cox-2	NOUN
ajlm-2613	105	9	in	in	ADP
ajlm-2613	105	10	adenomas	adenoma	NOUN
ajlm-2613	105	11	is	be	AUX
ajlm-2613	105	12	3.4	3.4	NUM
ajlm-2613	105	13	%	%	NOUN
ajlm-2613	105	14	,	,	PUNCT
ajlm-2613	105	15	and	and	CCONJ
ajlm-2613	105	16	this	this	PRON
ajlm-2613	105	17	may	may	AUX
ajlm-2613	105	18	imply	imply	VERB
ajlm-2613	105	19	its	its	PRON
ajlm-2613	105	20	early	early	ADJ
ajlm-2613	105	21	involvement	involvement	NOUN
ajlm-2613	105	22	in	in	ADP
ajlm-2613	105	23	colorectal	colorectal	ADJ
ajlm-2613	105	24	tumourigenesis	tumourigenesis	NOUN
ajlm-2613	105	25	.	.	PUNCT
ajlm-2613	106	1	acknowledgements	acknowledgement	NOUN
ajlm-2613	106	2	competing	compete	VERB
ajlm-2613	106	3	interests	interest	NOUN
ajlm-2613	106	4	the	the	DET
ajlm-2613	106	5	authors	author	NOUN
ajlm-2613	106	6	declare	declare	VERB
ajlm-2613	106	7	that	that	SCONJ
ajlm-2613	106	8	they	they	PRON
ajlm-2613	106	9	have	have	VERB
ajlm-2613	106	10	no	no	DET
ajlm-2613	106	11	financial	financial	ADJ
ajlm-2613	106	12	or	or	CCONJ
ajlm-2613	106	13	personal	personal	ADJ
ajlm-2613	106	14	relationships	relationship	NOUN
ajlm-2613	106	15	that	that	PRON
ajlm-2613	106	16	may	may	AUX
ajlm-2613	106	17	have	have	AUX
ajlm-2613	106	18	inappropriately	inappropriately	ADV
ajlm-2613	106	19	influenced	influence	VERB
ajlm-2613	106	20	them	they	PRON
ajlm-2613	106	21	in	in	ADP
ajlm-2613	106	22	writing	write	VERB
ajlm-2613	106	23	this	this	DET
ajlm-2613	106	24	article	article	NOUN
ajlm-2613	106	25	.	.	PUNCT
ajlm-2613	107	1	authors	author	NOUN
ajlm-2613	107	2	’	’	PART
ajlm-2613	107	3	contributions	contribution	NOUN
ajlm-2613	107	4	a.a.j	a.a.j	PROPN
ajlm-2613	107	5	.	.	PUNCT
ajlm-2613	107	6	conceptualised	conceptualise	VERB
ajlm-2613	107	7	the	the	DET
ajlm-2613	107	8	idea	idea	NOUN
ajlm-2613	107	9	and	and	CCONJ
ajlm-2613	107	10	developed	develop	VERB
ajlm-2613	107	11	the	the	DET
ajlm-2613	107	12	protocol	protocol	NOUN
ajlm-2613	107	13	and	and	CCONJ
ajlm-2613	107	14	the	the	DET
ajlm-2613	107	15	first	first	ADJ
ajlm-2613	107	16	draft	draft	NOUN
ajlm-2613	107	17	of	of	ADP
ajlm-2613	107	18	the	the	DET
ajlm-2613	107	19	article	article	NOUN
ajlm-2613	107	20	.	.	PUNCT
ajlm-2613	108	1	a.a.j	a.a.j	PROPN
ajlm-2613	108	2	.	.	PROPN
ajlm-2613	108	3	,	,	PUNCT
ajlm-2613	108	4	z.a.a	z.a.a	PROPN
ajlm-2613	108	5	.	.	PROPN
ajlm-2613	108	6	,	,	PUNCT
ajlm-2613	108	7	m.w.r	m.w.r	PROPN
ajlm-2613	108	8	.	.	PUNCT
ajlm-2613	108	9	,	,	PUNCT
ajlm-2613	108	10	and	and	CCONJ
ajlm-2613	108	11	s.k.r	s.k.r	NOUN
ajlm-2613	108	12	.	.	PUNCT
ajlm-2613	108	13	participated	participate	VERB
ajlm-2613	108	14	in	in	ADP
ajlm-2613	108	15	data	datum	NOUN
ajlm-2613	108	16	collection	collection	NOUN
ajlm-2613	108	17	,	,	PUNCT
ajlm-2613	108	18	methodology	methodology	NOUN
ajlm-2613	108	19	,	,	PUNCT
ajlm-2613	108	20	supervision	supervision	NOUN
ajlm-2613	108	21	,	,	PUNCT
ajlm-2613	108	22	writing	writing	NOUN
ajlm-2613	108	23	,	,	PUNCT
ajlm-2613	108	24	and	and	CCONJ
ajlm-2613	108	25	analysis	analysis	NOUN
ajlm-2613	108	26	.	.	PUNCT
ajlm-2613	109	1	a.a.j	a.a.j	PROPN
ajlm-2613	109	2	.	.	PROPN
ajlm-2613	109	3	,	,	PUNCT
ajlm-2613	109	4	z.a.a	z.a.a	PROPN
ajlm-2613	109	5	.	.	PROPN
ajlm-2613	109	6	,	,	PUNCT
ajlm-2613	109	7	m.w.r	m.w.r	PROPN
ajlm-2613	109	8	.	.	PUNCT
ajlm-2613	110	1	and	and	CCONJ
ajlm-2613	110	2	s.k.r	s.k.r	NOUN
ajlm-2613	110	3	.	.	PUNCT
ajlm-2613	110	4	reviewed	review	VERB
ajlm-2613	110	5	and	and	CCONJ
ajlm-2613	110	6	provided	provide	VERB
ajlm-2613	110	7	overall	overall	ADJ
ajlm-2613	110	8	guidance	guidance	NOUN
ajlm-2613	110	9	in	in	ADP
ajlm-2613	110	10	the	the	DET
ajlm-2613	110	11	entire	entire	ADJ
ajlm-2613	110	12	write	write	NOUN
ajlm-2613	110	13	-	-	PUNCT
ajlm-2613	110	14	up	up	NOUN
ajlm-2613	110	15	and	and	CCONJ
ajlm-2613	110	16	approved	approve	VERB
ajlm-2613	110	17	the	the	DET
ajlm-2613	110	18	final	final	ADJ
ajlm-2613	110	19	version	version	NOUN
ajlm-2613	110	20	prior	prior	ADV
ajlm-2613	110	21	to	to	ADP
ajlm-2613	110	22	submission	submission	NOUN
ajlm-2613	110	23	.	.	PUNCT
ajlm-2613	111	1	a.a.j	a.a.j	PROPN
ajlm-2613	111	2	.	.	PROPN
ajlm-2613	111	3	,	,	PUNCT
ajlm-2613	111	4	z.a.a	z.a.a	PROPN
ajlm-2613	111	5	.	.	PROPN
ajlm-2613	111	6	,	,	PUNCT
ajlm-2613	111	7	m.w.r	m.w.r	PROPN
ajlm-2613	111	8	.	.	PUNCT
ajlm-2613	111	9	,	,	PUNCT
ajlm-2613	111	10	and	and	CCONJ
ajlm-2613	111	11	s.k.r	s.k.r	NOUN
ajlm-2613	111	12	.	.	PUNCT
ajlm-2613	111	13	are	be	AUX
ajlm-2613	111	14	accountable	accountable	ADJ
ajlm-2613	111	15	for	for	ADP
ajlm-2613	111	16	all	all	DET
ajlm-2613	111	17	aspects	aspect	NOUN
ajlm-2613	111	18	of	of	ADP
ajlm-2613	111	19	this	this	DET
ajlm-2613	111	20	article	article	NOUN
ajlm-2613	111	21	.	.	PUNCT
ajlm-2613	112	1	sources	source	NOUN
ajlm-2613	112	2	of	of	ADP
ajlm-2613	112	3	support	support	NOUN
ajlm-2613	112	4	this	this	DET
ajlm-2613	112	5	research	research	NOUN
ajlm-2613	112	6	received	receive	VERB
ajlm-2613	112	7	no	no	DET
ajlm-2613	112	8	specific	specific	ADJ
ajlm-2613	112	9	grant	grant	NOUN
ajlm-2613	112	10	from	from	ADP
ajlm-2613	112	11	any	any	DET
ajlm-2613	112	12	funding	funding	NOUN
ajlm-2613	112	13	agency	agency	NOUN
ajlm-2613	112	14	in	in	ADP
ajlm-2613	112	15	the	the	DET
ajlm-2613	112	16	public	public	ADJ
ajlm-2613	112	17	,	,	PUNCT
ajlm-2613	112	18	commercial	commercial	ADJ
ajlm-2613	112	19	,	,	PUNCT
ajlm-2613	112	20	or	or	CCONJ
ajlm-2613	112	21	not	not	PART
ajlm-2613	112	22	-	-	PUNCT
ajlm-2613	112	23	for	for	ADP
ajlm-2613	112	24	-	-	PUNCT
ajlm-2613	112	25	profit	profit	NOUN
ajlm-2613	112	26	sectors	sector	NOUN
ajlm-2613	112	27	.	.	PUNCT
ajlm-2613	113	1	data	datum	NOUN
ajlm-2613	113	2	availability	availability	NOUN
ajlm-2613	113	3	all	all	DET
ajlm-2613	113	4	relevant	relevant	ADJ
ajlm-2613	113	5	data	datum	NOUN
ajlm-2613	113	6	that	that	PRON
ajlm-2613	113	7	support	support	VERB
ajlm-2613	113	8	the	the	DET
ajlm-2613	113	9	findings	finding	NOUN
ajlm-2613	113	10	of	of	ADP
ajlm-2613	113	11	this	this	DET
ajlm-2613	113	12	study	study	NOUN
ajlm-2613	113	13	are	be	AUX
ajlm-2613	113	14	available	available	ADJ
ajlm-2613	113	15	within	within	ADP
ajlm-2613	113	16	the	the	DET
ajlm-2613	113	17	article	article	NOUN
ajlm-2613	113	18	.	.	PUNCT
ajlm-2613	114	1	disclaimer	disclaimer	VERB
ajlm-2613	114	2	the	the	DET
ajlm-2613	114	3	views	view	NOUN
ajlm-2613	114	4	and	and	CCONJ
ajlm-2613	114	5	opinions	opinion	NOUN
ajlm-2613	114	6	expressed	express	VERB
ajlm-2613	114	7	in	in	ADP
ajlm-2613	114	8	this	this	DET
ajlm-2613	114	9	article	article	NOUN
ajlm-2613	114	10	are	be	AUX
ajlm-2613	114	11	those	those	PRON
ajlm-2613	114	12	of	of	ADP
ajlm-2613	114	13	the	the	DET
ajlm-2613	114	14	authors	author	NOUN
ajlm-2613	114	15	and	and	CCONJ
ajlm-2613	114	16	are	be	AUX
ajlm-2613	114	17	the	the	DET
ajlm-2613	114	18	product	product	NOUN
ajlm-2613	114	19	of	of	ADP
ajlm-2613	114	20	professional	professional	ADJ
ajlm-2613	114	21	research	research	NOUN
ajlm-2613	114	22	.	.	PUNCT
ajlm-2613	115	1	the	the	DET
ajlm-2613	115	2	article	article	NOUN
ajlm-2613	115	3	does	do	AUX
ajlm-2613	115	4	not	not	PART
ajlm-2613	115	5	necessarily	necessarily	ADV
ajlm-2613	115	6	reflect	reflect	VERB
ajlm-2613	115	7	the	the	DET
ajlm-2613	115	8	official	official	ADJ
ajlm-2613	115	9	policy	policy	NOUN
ajlm-2613	115	10	or	or	CCONJ
ajlm-2613	115	11	position	position	NOUN
ajlm-2613	115	12	of	of	ADP
ajlm-2613	115	13	any	any	DET
ajlm-2613	115	14	affiliated	affiliated	ADJ
ajlm-2613	115	15	institution	institution	NOUN
ajlm-2613	115	16	,	,	PUNCT
ajlm-2613	115	17	funder	funder	NOUN
ajlm-2613	115	18	,	,	PUNCT
ajlm-2613	115	19	agency	agency	NOUN
ajlm-2613	115	20	,	,	PUNCT
ajlm-2613	115	21	or	or	CCONJ
ajlm-2613	115	22	that	that	PRON
ajlm-2613	115	23	of	of	ADP
ajlm-2613	115	24	the	the	DET
ajlm-2613	115	25	publisher	publisher	NOUN
ajlm-2613	115	26	.	.	PUNCT
ajlm-2613	116	1	the	the	DET
ajlm-2613	116	2	authors	author	NOUN
ajlm-2613	116	3	are	be	AUX
ajlm-2613	116	4	responsible	responsible	ADJ
ajlm-2613	116	5	for	for	ADP
ajlm-2613	116	6	this	this	DET
ajlm-2613	116	7	article	article	NOUN
ajlm-2613	116	8	’s	’s	PART
ajlm-2613	116	9	results	result	NOUN
ajlm-2613	116	10	,	,	PUNCT
ajlm-2613	116	11	findings	finding	NOUN
ajlm-2613	116	12	,	,	PUNCT
ajlm-2613	116	13	and	and	CCONJ
ajlm-2613	116	14	content	content	NOUN
ajlm-2613	116	15	.	.	PUNCT
ajlm-2613	117	1	references	reference	NOUN
ajlm-2613	117	2	ray	ray	NOUN
ajlm-2613	117	3	-	-	PUNCT
ajlm-2613	117	4	offor	offor	NOUN
ajlm-2613	117	5	e	e	NOUN
ajlm-2613	117	6	,	,	PUNCT
ajlm-2613	117	7	abdulkareem	abdulkareem	ADJ
ajlm-2613	117	8	fb	fb	INTJ
ajlm-2613	117	9	.	.	PUNCT
ajlm-2613	118	1	screening	screen	VERB
ajlm-2613	118	2	colonoscopy	colonoscopy	NOUN
ajlm-2613	118	3	in	in	ADP
ajlm-2613	118	4	port	port	NOUN
ajlm-2613	118	5	harcourt	harcourt	PROPN
ajlm-2613	118	6	,	,	PUNCT
ajlm-2613	118	7	nigeria	nigeria	PROPN
ajlm-2613	118	8	.	.	PUNCT
ajlm-2613	119	1	gastroenterol	gastroenterol	NOUN
ajlm-2613	119	2	insights	insight	NOUN
ajlm-2613	119	3	.	.	PUNCT
ajlm-2613	120	1	2019;10(1):7987	2019;10(1):7987	NUM
ajlm-2613	120	2	.	.	PUNCT
ajlm-2613	121	1	https://doi.org/10.4081/gi.2019.7987	https://doi.org/10.4081/gi.2019.7987	PROPN
ajlm-2613	121	2	oluyemi	oluyemi	PROPN
ajlm-2613	121	3	a	a	PRON
ajlm-2613	121	4	,	,	PUNCT
ajlm-2613	121	5	awolola	awolola	PROPN
ajlm-2613	121	6	n	n	CCONJ
ajlm-2613	121	7	,	,	PUNCT
ajlm-2613	121	8	oyedeji	oyedeji	PROPN
ajlm-2613	121	9	o.	o.	PROPN
ajlm-2613	121	10	clinicopathologic	clinicopathologic	PROPN
ajlm-2613	121	11	review	review	NOUN
ajlm-2613	121	12	of	of	ADP
ajlm-2613	121	13	polyps	polyp	NOUN
ajlm-2613	121	14	biopsied	biopsie	VERB
ajlm-2613	121	15	at	at	ADP
ajlm-2613	121	16	colonoscopy	colonoscopy	NOUN
ajlm-2613	121	17	in	in	ADP
ajlm-2613	121	18	lagos	lagos	PROPN
ajlm-2613	121	19	,	,	PUNCT
ajlm-2613	121	20	nigeria	nigeria	PROPN
ajlm-2613	121	21	.	.	PUNCT
ajlm-2613	122	1	pan	pan	PROPN
ajlm-2613	122	2	afr	afr	PROPN
ajlm-2613	122	3	med	med	PROPN
ajlm-2613	122	4	j.	j.	PROPN
ajlm-2613	122	5	2016;24:333	2016;24:333	PROPN
ajlm-2613	122	6	.	.	PUNCT
ajlm-2613	123	1	https://doi.org/10.11604/pamj.2016.24.333.9434	https://doi.org/10.11604/pamj.2016.24.333.9434	PROPN
ajlm-2613	123	2	ibrahim	ibrahim	PROPN
ajlm-2613	123	3	y	y	PROPN
ajlm-2613	123	4	,	,	PUNCT
ajlm-2613	123	5	dahiru	dahiru	PROPN
ajlm-2613	123	6	amc	amc	PROPN
ajlm-2613	123	7	.	.	PROPN
ajlm-2613	123	8	colorectal	colorectal	ADJ
ajlm-2613	123	9	polyps	polyp	NOUN
ajlm-2613	123	10	in	in	ADP
ajlm-2613	123	11	kano	kano	PROPN
ajlm-2613	123	12	:	:	PUNCT
ajlm-2613	123	13	a	a	DET
ajlm-2613	123	14	ten	ten	NUM
ajlm-2613	123	15	year	year	NOUN
ajlm-2613	123	16	histopathological	histopathological	ADJ
ajlm-2613	123	17	review	review	NOUN
ajlm-2613	123	18	.	.	PUNCT
ajlm-2613	124	1	bom	bom	PROPN
ajlm-2613	124	2	j.	j.	PROPN
ajlm-2613	124	3	2018;15(1):35–42	2018;15(1):35–42	PROPN
ajlm-2613	124	4	.	.	PROPN
ajlm-2613	124	5	bojuwoye	bojuwoye	PROPN
ajlm-2613	124	6	mo	mo	PROPN
ajlm-2613	124	7	,	,	PUNCT
ajlm-2613	124	8	olokoba	olokoba	PROPN
ajlm-2613	124	9	ab	ab	PROPN
ajlm-2613	124	10	,	,	PUNCT
ajlm-2613	124	11	ogunmodede	ogunmodede	ADP
ajlm-2613	124	12	ja	ja	PROPN
ajlm-2613	124	13	,	,	PUNCT
ajlm-2613	124	14	et	et	PROPN
ajlm-2613	124	15	al	al	PROPN
ajlm-2613	124	16	.	.	PUNCT
ajlm-2613	125	1	a	a	DET
ajlm-2613	125	2	clinicopathological	clinicopathological	ADJ
ajlm-2613	125	3	review	review	NOUN
ajlm-2613	125	4	of	of	ADP
ajlm-2613	125	5	colonic	colonic	ADJ
ajlm-2613	125	6	polyps	polyp	NOUN
ajlm-2613	125	7	in	in	ADP
ajlm-2613	125	8	a	a	DET
ajlm-2613	125	9	tertiary	tertiary	ADJ
ajlm-2613	125	10	hospital	hospital	NOUN
ajlm-2613	125	11	in	in	ADP
ajlm-2613	125	12	north	north	PROPN
ajlm-2613	125	13	central	central	PROPN
ajlm-2613	125	14	nigeria	nigeria	PROPN
ajlm-2613	125	15	.	.	PUNCT
ajlm-2613	126	1	sud	sud	PROPN
ajlm-2613	126	2	j	j	PROPN
ajlm-2613	126	3	med	med	PROPN
ajlm-2613	126	4	sci	sci	PROPN
ajlm-2613	126	5	.	.	PUNCT
ajlm-2613	127	1	2018;13(4):277–288	2018;13(4):277–288	X
ajlm-2613	127	2	.	.	X
ajlm-2613	128	1	alatise	alatise	PROPN
ajlm-2613	128	2	oi	oi	PROPN
ajlm-2613	128	3	,	,	PUNCT
ajlm-2613	128	4	arigbabu	arigbabu	NOUN
ajlm-2613	128	5	ao	ao	PROPN
ajlm-2613	128	6	,	,	PUNCT
ajlm-2613	128	7	agbakwuru	agbakwuru	PROPN
ajlm-2613	128	8	ae	ae	PROPN
ajlm-2613	128	9	,	,	PUNCT
ajlm-2613	128	10	et	et	PROPN
ajlm-2613	128	11	al	al	PROPN
ajlm-2613	128	12	.	.	PUNCT
ajlm-2613	128	13	polyp	polyp	NOUN
ajlm-2613	128	14	prevalence	prevalence	NOUN
ajlm-2613	128	15	at	at	ADP
ajlm-2613	128	16	colonoscopy	colonoscopy	NOUN
ajlm-2613	128	17	among	among	ADP
ajlm-2613	128	18	nigerians	nigerians	PROPN
ajlm-2613	128	19	:	:	PUNCT
ajlm-2613	128	20	a	a	DET
ajlm-2613	128	21	prospective	prospective	ADJ
ajlm-2613	128	22	observational	observational	ADJ
ajlm-2613	128	23	study	study	NOUN
ajlm-2613	128	24	.	.	PUNCT
ajlm-2613	129	1	niger	niger	PROPN
ajlm-2613	129	2	j	j	PROPN
ajlm-2613	129	3	clin	clin	PROPN
ajlm-2613	129	4	pract	pract	PROPN
ajlm-2613	129	5	.	.	PUNCT
ajlm-2613	130	1	2014;17(6):756–762	2014;17(6):756–762	X
ajlm-2613	130	2	.	.	PUNCT
ajlm-2613	130	3	https://doi.org/10.4103/1119-3077.144391	https://doi.org/10.4103/1119-3077.144391	PROPN
ajlm-2613	130	4	risio	risio	ADJ
ajlm-2613	130	5	m.	m.	NOUN
ajlm-2613	130	6	the	the	DET
ajlm-2613	130	7	natural	natural	ADJ
ajlm-2613	130	8	history	history	NOUN
ajlm-2613	130	9	of	of	ADP
ajlm-2613	130	10	adenomas	adenoma	NOUN
ajlm-2613	130	11	.	.	PUNCT
ajlm-2613	131	1	best	good	ADJ
ajlm-2613	131	2	pract	pract	PROPN
ajlm-2613	131	3	res	res	PROPN
ajlm-2613	131	4	clin	clin	PROPN
ajlm-2613	131	5	gastroenterol	gastroenterol	PROPN
ajlm-2613	131	6	.	.	PUNCT
ajlm-2613	132	1	2010;24(3):271–280	2010;24(3):271–280	NUM
ajlm-2613	132	2	.	.	PUNCT
ajlm-2613	133	1	https://doi.org/10.1016/j.bpg.2010.04.005	https://doi.org/10.1016/j.bpg.2010.04.005	PROPN
ajlm-2613	133	2	calderwood	calderwood	VERB
ajlm-2613	133	3	ah	ah	INTJ
ajlm-2613	133	4	,	,	PUNCT
ajlm-2613	133	5	lasser	lasser	PROPN
ajlm-2613	133	6	ke	ke	PROPN
ajlm-2613	133	7	,	,	PUNCT
ajlm-2613	133	8	roy	roy	PROPN
ajlm-2613	133	9	hk	hk	PROPN
ajlm-2613	133	10	.	.	PUNCT
ajlm-2613	134	1	colon	colon	NOUN
ajlm-2613	134	2	adenoma	adenoma	ADJ
ajlm-2613	134	3	features	feature	NOUN
ajlm-2613	134	4	and	and	CCONJ
ajlm-2613	134	5	their	their	PRON
ajlm-2613	134	6	impact	impact	NOUN
ajlm-2613	134	7	on	on	ADP
ajlm-2613	134	8	risk	risk	NOUN
ajlm-2613	134	9	of	of	ADP
ajlm-2613	134	10	future	future	ADJ
ajlm-2613	134	11	advanced	advanced	ADJ
ajlm-2613	134	12	adenomas	adenoma	NOUN
ajlm-2613	134	13	and	and	CCONJ
ajlm-2613	134	14	colorectal	colorectal	ADJ
ajlm-2613	134	15	cancer	cancer	NOUN
ajlm-2613	134	16	.	.	PUNCT
ajlm-2613	135	1	world	world	PROPN
ajlm-2613	135	2	j	j	PROPN
ajlm-2613	135	3	gastrointest	gastrointest	PROPN
ajlm-2613	135	4	oncol	oncol	PROPN
ajlm-2613	135	5	.	.	PUNCT
ajlm-2613	136	1	2016;8(12):826–834	2016;8(12):826–834	NOUN
ajlm-2613	136	2	.	.	PUNCT
ajlm-2613	137	1	https://doi.org/10.4251/wjgo.v8.i12.826	https://doi.org/10.4251/wjgo.v8.i12.826	PROPN
ajlm-2613	137	2	ashktorab	ashktorab	PROPN
ajlm-2613	137	3	h	h	NOUN
ajlm-2613	137	4	,	,	PUNCT
ajlm-2613	137	5	paydar	paydar	PROPN
ajlm-2613	137	6	m	m	PROPN
ajlm-2613	137	7	,	,	PUNCT
ajlm-2613	137	8	namin	namin	PROPN
ajlm-2613	137	9	hh	hh	PROPN
ajlm-2613	137	10	,	,	PUNCT
ajlm-2613	137	11	et	et	PROPN
ajlm-2613	137	12	al	al	PROPN
ajlm-2613	137	13	.	.	PUNCT
ajlm-2613	138	1	prevalence	prevalence	NOUN
ajlm-2613	138	2	of	of	ADP
ajlm-2613	138	3	colorectal	colorectal	ADJ
ajlm-2613	138	4	neoplasia	neoplasia	NOUN
ajlm-2613	138	5	among	among	ADP
ajlm-2613	138	6	young	young	ADJ
ajlm-2613	138	7	african	african	ADJ
ajlm-2613	138	8	americans	americans	PROPN
ajlm-2613	138	9	and	and	CCONJ
ajlm-2613	138	10	hispanic	hispanic	ADJ
ajlm-2613	138	11	americans	americans	PROPN
ajlm-2613	138	12	.	.	PUNCT
ajlm-2613	139	1	dig	dig	VERB
ajlm-2613	139	2	dis	dis	PROPN
ajlm-2613	139	3	sci	sci	PROPN
ajlm-2613	139	4	.	.	PUNCT
ajlm-2613	140	1	2013;59(2):446–450	2013;59(2):446–450	X
ajlm-2613	140	2	.	.	PUNCT
ajlm-2613	141	1	https://doi.org/10.1007/s10620-013-2898-0	https://doi.org/10.1007/s10620-013-2898-0	PROPN
ajlm-2613	141	2	lipka	lipka	PROPN
ajlm-2613	141	3	s	s	PROPN
ajlm-2613	141	4	,	,	PUNCT
ajlm-2613	141	5	zheng	zheng	PROPN
ajlm-2613	141	6	xe	xe	PROPN
ajlm-2613	141	7	,	,	PUNCT
ajlm-2613	141	8	hurtado	hurtado	PROPN
ajlm-2613	141	9	-	-	PUNCT
ajlm-2613	141	10	cordovi	cordovi	PROPN
ajlm-2613	141	11	j	j	PROPN
ajlm-2613	141	12	,	,	PUNCT
ajlm-2613	141	13	et	et	PROPN
ajlm-2613	141	14	al	al	PROPN
ajlm-2613	141	15	.	.	PUNCT
ajlm-2613	141	16	obesity	obesity	NOUN
ajlm-2613	141	17	,	,	PUNCT
ajlm-2613	141	18	metabolic	metabolic	NOUN
ajlm-2613	141	19	factors	factor	NOUN
ajlm-2613	141	20	,	,	PUNCT
ajlm-2613	141	21	and	and	CCONJ
ajlm-2613	141	22	colorectal	colorectal	ADJ
ajlm-2613	141	23	adenomas	adenoma	NOUN
ajlm-2613	141	24	:	:	PUNCT
ajlm-2613	141	25	a	a	DET
ajlm-2613	141	26	retrospective	retrospective	ADJ
ajlm-2613	141	27	study	study	NOUN
ajlm-2613	141	28	in	in	ADP
ajlm-2613	141	29	a	a	DET
ajlm-2613	141	30	racially	racially	ADV
ajlm-2613	141	31	diverse	diverse	ADJ
ajlm-2613	141	32	new	new	PROPN
ajlm-2613	141	33	york	york	PROPN
ajlm-2613	141	34	state	state	PROPN
ajlm-2613	141	35	hospital	hospital	NOUN
ajlm-2613	141	36	.	.	PUNCT
ajlm-2613	142	1	j	j	PROPN
ajlm-2613	142	2	gastrointest	gastroint	ADJ
ajlm-2613	142	3	cancer	cancer	NOUN
ajlm-2613	142	4	.	.	PUNCT
ajlm-2613	143	1	2013;44(3):270–276	2013;44(3):270–276	X
ajlm-2613	143	2	.	.	PROPN
ajlm-2613	143	3	https://doi.org/10.1007/s12029-013-9476-8	https://doi.org/10.1007/s12029-013-9476-8	PROPN
ajlm-2613	144	1	shomaf	shomaf	PROPN
ajlm-2613	144	2	m	m	PROPN
ajlm-2613	144	3	,	,	PUNCT
ajlm-2613	144	4	yousef	yousef	PROPN
ajlm-2613	144	5	a	a	X
ajlm-2613	144	6	,	,	PUNCT
ajlm-2613	144	7	ababna	ababna	NOUN
ajlm-2613	144	8	n	n	CCONJ
ajlm-2613	144	9	,	,	PUNCT
ajlm-2613	144	10	bobali	bobali	PROPN
ajlm-2613	144	11	y.	y.	NOUN
ajlm-2613	144	12	cyclooxygenase-2	cyclooxygenase-2	NUM
ajlm-2613	144	13	(	(	PUNCT
ajlm-2613	144	14	cox2	cox2	NOUN
ajlm-2613	144	15	)	)	PUNCT
ajlm-2613	144	16	gene	gene	NOUN
ajlm-2613	144	17	polymorphisms	polymorphism	NOUN
ajlm-2613	144	18	and	and	CCONJ
ajlm-2613	144	19	the	the	DET
ajlm-2613	144	20	risk	risk	NOUN
ajlm-2613	144	21	of	of	ADP
ajlm-2613	144	22	sporadic	sporadic	ADJ
ajlm-2613	144	23	colorectal	colorectal	ADJ
ajlm-2613	144	24	cancer	cancer	NOUN
ajlm-2613	144	25	and	and	CCONJ
ajlm-2613	144	26	polyps	polyp	NOUN
ajlm-2613	144	27	among	among	ADP
ajlm-2613	144	28	jordanian	jordanian	ADJ
ajlm-2613	144	29	population	population	NOUN
ajlm-2613	144	30	.	.	PUNCT
ajlm-2613	145	1	turk	turk	PROPN
ajlm-2613	145	2	j	j	PROPN
ajlm-2613	145	3	gastroenterol	gastroenterol	PROPN
ajlm-2613	145	4	.	.	PUNCT
ajlm-2613	146	1	2015;26(2):154–158	2015;26(2):154–158	X
ajlm-2613	146	2	.	.	PUNCT
ajlm-2613	147	1	https://doi.org/10.5152/tjg.2015.6174	https://doi.org/10.5152/tjg.2015.6174	ADJ
ajlm-2613	147	2	loomans	looman	NOUN
ajlm-2613	147	3	-	-	PUNCT
ajlm-2613	147	4	kropp	kropp	AUX
ajlm-2613	147	5	ha	ha	PROPN
ajlm-2613	147	6	,	,	PUNCT
ajlm-2613	147	7	pinsky	pinsky	PROPN
ajlm-2613	147	8	p	p	PROPN
ajlm-2613	147	9	,	,	PUNCT
ajlm-2613	147	10	cao	cao	PROPN
ajlm-2613	147	11	y	y	PROPN
ajlm-2613	147	12	,	,	PUNCT
ajlm-2613	147	13	chan	chan	PROPN
ajlm-2613	147	14	at	at	ADP
ajlm-2613	147	15	,	,	PUNCT
ajlm-2613	147	16	umar	umar	PROPN
ajlm-2613	147	17	a.	a.	PROPN
ajlm-2613	147	18	association	association	PROPN
ajlm-2613	147	19	of	of	ADP
ajlm-2613	147	20	aspirin	aspirin	NOUN
ajlm-2613	147	21	use	use	NOUN
ajlm-2613	147	22	with	with	ADP
ajlm-2613	147	23	mortality	mortality	NOUN
ajlm-2613	147	24	risk	risk	NOUN
ajlm-2613	147	25	among	among	ADP
ajlm-2613	147	26	older	old	ADJ
ajlm-2613	147	27	adult	adult	NOUN
ajlm-2613	147	28	participants	participant	NOUN
ajlm-2613	147	29	in	in	ADP
ajlm-2613	147	30	the	the	DET
ajlm-2613	147	31	prostate	prostate	NOUN
ajlm-2613	147	32	,	,	PUNCT
ajlm-2613	147	33	lung	lung	NOUN
ajlm-2613	147	34	,	,	PUNCT
ajlm-2613	147	35	colorectal	colorectal	NOUN
ajlm-2613	147	36	,	,	PUNCT
ajlm-2613	147	37	and	and	CCONJ
ajlm-2613	147	38	ovarian	ovarian	ADJ
ajlm-2613	147	39	cancer	cancer	NOUN
ajlm-2613	147	40	screening	screen	VERB
ajlm-2613	147	41	trial	trial	NOUN
ajlm-2613	147	42	.	.	PUNCT
ajlm-2613	148	1	jama	jama	PROPN
ajlm-2613	148	2	netw	netw	PROPN
ajlm-2613	148	3	open	open	ADJ
ajlm-2613	148	4	.	.	PUNCT
ajlm-2613	149	1	2019;2(12):e1916729	2019;2(12):e1916729	NUM
ajlm-2613	149	2	.	.	PUNCT
ajlm-2613	150	1	https://doi.org/10.1001/jamanetworkopen.2019.16729	https://doi.org/10.1001/jamanetworkopen.2019.16729	PROPN
ajlm-2613	150	2	liao	liao	PROPN
ajlm-2613	150	3	x	x	PROPN
ajlm-2613	150	4	,	,	PUNCT
ajlm-2613	150	5	lochhead	lochhead	VERB
ajlm-2613	150	6	p	p	PRON
ajlm-2613	150	7	,	,	PUNCT
ajlm-2613	150	8	nishihara	nishihara	NOUN
ajlm-2613	150	9	r	r	NOUN
ajlm-2613	150	10	,	,	PUNCT
ajlm-2613	150	11	et	et	PROPN
ajlm-2613	151	1	al	al	PROPN
ajlm-2613	151	2	.	.	PROPN
ajlm-2613	151	3	aspirin	aspirin	PROPN
ajlm-2613	151	4	use	use	NOUN
ajlm-2613	151	5	,	,	PUNCT
ajlm-2613	151	6	tumor	tumor	NOUN
ajlm-2613	151	7	pik3ca	pik3ca	NOUN
ajlm-2613	151	8	mutation	mutation	NOUN
ajlm-2613	151	9	,	,	PUNCT
ajlm-2613	151	10	and	and	CCONJ
ajlm-2613	151	11	colorectal	colorectal	ADJ
ajlm-2613	151	12	-	-	PUNCT
ajlm-2613	151	13	cancer	cancer	NOUN
ajlm-2613	151	14	survival	survival	NOUN
ajlm-2613	151	15	.	.	PUNCT
ajlm-2613	152	1	n	n	PROPN
ajlm-2613	152	2	engl	engl	PROPN
ajlm-2613	152	3	j	j	PROPN
ajlm-2613	152	4	med	med	PROPN
ajlm-2613	152	5	.	.	PUNCT
ajlm-2613	153	1	2012;367:1596–1606	2012;367:1596–1606	NUM
ajlm-2613	153	2	.	.	PUNCT
ajlm-2613	154	1	https://doi.org/10.1056/nejmoa1207756	https://doi.org/10.1056/nejmoa1207756	PROPN
ajlm-2613	154	2	fink	fink	PROPN
ajlm-2613	154	3	sp	sp	PROPN
ajlm-2613	154	4	,	,	PUNCT
ajlm-2613	154	5	yamauchi	yamauchi	PROPN
ajlm-2613	154	6	m	m	PROPN
ajlm-2613	154	7	,	,	PUNCT
ajlm-2613	154	8	nishihara	nishihara	PROPN
ajlm-2613	154	9	r	r	NOUN
ajlm-2613	154	10	,	,	PUNCT
ajlm-2613	154	11	et	et	PROPN
ajlm-2613	154	12	al	al	PROPN
ajlm-2613	154	13	.	.	PROPN
ajlm-2613	154	14	aspirin	aspirin	PROPN
ajlm-2613	154	15	and	and	CCONJ
ajlm-2613	154	16	the	the	DET
ajlm-2613	154	17	risk	risk	NOUN
ajlm-2613	154	18	of	of	ADP
ajlm-2613	154	19	colorectal	colorectal	ADJ
ajlm-2613	154	20	cancer	cancer	NOUN
ajlm-2613	154	21	in	in	ADP
ajlm-2613	154	22	relation	relation	NOUN
ajlm-2613	154	23	to	to	ADP
ajlm-2613	154	24	the	the	DET
ajlm-2613	154	25	expression	expression	NOUN
ajlm-2613	154	26	of	of	ADP
ajlm-2613	154	27	15	15	NUM
ajlm-2613	154	28	-	-	PUNCT
ajlm-2613	154	29	hydroxyprostaglandin	hydroxyprostaglandin	VERB
ajlm-2613	154	30	dehydrogenase	dehydrogenase	NOUN
ajlm-2613	154	31	(	(	PUNCT
ajlm-2613	154	32	hpgd	hpgd	NOUN
ajlm-2613	154	33	)	)	PUNCT
ajlm-2613	154	34	sci	sci	PROPN
ajlm-2613	154	35	transl	transl	PROPN
ajlm-2613	154	36	med	me	VERB
ajlm-2613	154	37	.	.	PUNCT
ajlm-2613	155	1	2014;6(233):233re2	2014;6(233):233re2	PROPN
ajlm-2613	155	2	.	.	PUNCT
ajlm-2613	156	1	https://doi.org/10.1126/scitranslmed.3008481	https://doi.org/10.1126/scitranslmed.3008481	PROPN
ajlm-2613	156	2	nan	nan	PROPN
ajlm-2613	156	3	h	h	PROPN
ajlm-2613	156	4	,	,	PUNCT
ajlm-2613	156	5	morikawa	morikawa	PROPN
ajlm-2613	156	6	t	t	PROPN
ajlm-2613	156	7	,	,	PUNCT
ajlm-2613	156	8	suuriniemi	suuriniemi	PROPN
ajlm-2613	156	9	m	m	PROPN
ajlm-2613	156	10	,	,	PUNCT
ajlm-2613	156	11	et	et	PROPN
ajlm-2613	156	12	al	al	PROPN
ajlm-2613	156	13	.	.	PROPN
ajlm-2613	156	14	aspirin	aspirin	PROPN
ajlm-2613	156	15	use	use	NOUN
ajlm-2613	156	16	,	,	PUNCT
ajlm-2613	156	17	8q24	8q24	NUM
ajlm-2613	156	18	single	single	ADJ
ajlm-2613	156	19	nucleotide	nucleotide	ADJ
ajlm-2613	156	20	polymorphism	polymorphism	NOUN
ajlm-2613	156	21	rs6983267	rs6983267	NOUN
ajlm-2613	156	22	,	,	PUNCT
ajlm-2613	156	23	and	and	CCONJ
ajlm-2613	156	24	colorectal	colorectal	ADJ
ajlm-2613	156	25	cancer	cancer	NOUN
ajlm-2613	156	26	according	accord	VERB
ajlm-2613	156	27	to	to	ADP
ajlm-2613	156	28	ctnnb1	ctnnb1	NOUN
ajlm-2613	156	29	alterations	alteration	NOUN
ajlm-2613	156	30	.	.	PUNCT
ajlm-2613	157	1	j	j	PROPN
ajlm-2613	157	2	natl	natl	PROPN
ajlm-2613	157	3	cancer	cancer	PROPN
ajlm-2613	157	4	inst	inst	PROPN
ajlm-2613	157	5	.	.	PUNCT
ajlm-2613	158	1	2013;105:1852–1861	2013;105:1852–1861	NUM
ajlm-2613	158	2	.	.	PUNCT
ajlm-2613	159	1	https://doi.org/10.1093/jnci/djt331	https://doi.org/10.1093/jnci/djt331	PROPN
ajlm-2613	159	2	claria	claria	PROPN
ajlm-2613	159	3	j.	j.	PROPN
ajlm-2613	159	4	cyclooxygenase-2	cyclooxygenase-2	PROPN
ajlm-2613	159	5	biology	biology	NOUN
ajlm-2613	159	6	.	.	PUNCT
ajlm-2613	160	1	curr	curr	PROPN
ajlm-2613	160	2	pharm	pharm	PROPN
ajlm-2613	160	3	des	des	PROPN
ajlm-2613	160	4	.	.	PROPN
ajlm-2613	160	5	2003;9(27):2177–2190	2003;9(27):2177–2190	NUM
ajlm-2613	160	6	.	.	PUNCT
ajlm-2613	161	1	https://doi.org/10.2174/1381612033454054	https://doi.org/10.2174/1381612033454054	X
ajlm-2613	162	1	wang	wang	PROPN
ajlm-2613	162	2	d	d	PROPN
ajlm-2613	162	3	,	,	PUNCT
ajlm-2613	162	4	fu	fu	PROPN
ajlm-2613	162	5	l	l	NOUN
ajlm-2613	162	6	,	,	PUNCT
ajlm-2613	162	7	sun	sun	PROPN
ajlm-2613	162	8	h	h	NOUN
ajlm-2613	162	9	,	,	PUNCT
ajlm-2613	162	10	guo	guo	PROPN
ajlm-2613	162	11	l	l	PROPN
ajlm-2613	162	12	,	,	PUNCT
ajlm-2613	162	13	dubois	dubois	PROPN
ajlm-2613	162	14	rn	rn	PROPN
ajlm-2613	162	15	.	.	PUNCT
ajlm-2613	163	1	prostaglandin	prostaglandin	PROPN
ajlm-2613	163	2	e2	e2	PROPN
ajlm-2613	163	3	promotes	promote	VERB
ajlm-2613	163	4	colorectal	colorectal	ADJ
ajlm-2613	163	5	cancer	cancer	NOUN
ajlm-2613	163	6	stem	stem	NOUN
ajlm-2613	163	7	cell	cell	NOUN
ajlm-2613	163	8	expansion	expansion	NOUN
ajlm-2613	163	9	and	and	CCONJ
ajlm-2613	163	10	metastasis	metastasis	NOUN
ajlm-2613	163	11	in	in	ADP
ajlm-2613	163	12	mice	mouse	NOUN
ajlm-2613	163	13	.	.	PUNCT
ajlm-2613	164	1	gastroenterology	gastroenterology	NOUN
ajlm-2613	164	2	.	.	PUNCT
ajlm-2613	165	1	2015;149(7):1884.e4–1895.e4	2015;149(7):1884.e4–1895.e4	VERB
ajlm-2613	165	2	.	.	PUNCT
ajlm-2613	166	1	https://doi.org/10.1053/j.gastro.2015.07.064	https://doi.org/10.1053/j.gastro.2015.07.064	PROPN
ajlm-2613	166	2	xu	xu	PROPN
ajlm-2613	166	3	l	l	PROPN
ajlm-2613	166	4	,	,	PUNCT
ajlm-2613	166	5	stevens	stevens	PROPN
ajlm-2613	166	6	j	j	PROPN
ajlm-2613	166	7	,	,	PUNCT
ajlm-2613	166	8	hilton	hilton	PROPN
ajlm-2613	166	9	mb	mb	ADP
ajlm-2613	166	10	,	,	PUNCT
ajlm-2613	166	11	et	et	PROPN
ajlm-2613	166	12	al	al	PROPN
ajlm-2613	166	13	.	.	PROPN
ajlm-2613	167	1	cox-2	cox-2	PRON
ajlm-2613	167	2	inhibition	inhibition	NOUN
ajlm-2613	167	3	potentiates	potentiate	VERB
ajlm-2613	167	4	antiangiogenic	antiangiogenic	ADJ
ajlm-2613	167	5	cancer	cancer	NOUN
ajlm-2613	167	6	therapy	therapy	NOUN
ajlm-2613	167	7	and	and	CCONJ
ajlm-2613	167	8	prevents	prevent	VERB
ajlm-2613	167	9	metastasis	metastasis	NOUN
ajlm-2613	167	10	in	in	ADP
ajlm-2613	167	11	preclinical	preclinical	ADJ
ajlm-2613	167	12	models	model	NOUN
ajlm-2613	167	13	.	.	PUNCT
ajlm-2613	168	1	sci	sci	PROPN
ajlm-2613	168	2	transl	transl	PROPN
ajlm-2613	168	3	med	med	PROPN
ajlm-2613	168	4	.	.	PUNCT
ajlm-2613	169	1	2014;6(242):242ra84	2014;6(242):242ra84	NUM
ajlm-2613	169	2	.	.	X
ajlm-2613	169	3	https://doi.org/10.1126/scitranslmed.3008455	https://doi.org/10.1126/scitranslmed.3008455	NOUN
ajlm-2613	169	4	wu	wu	PROPN
ajlm-2613	169	5	q	q	NOUN
ajlm-2613	169	6	-	-	PUNCT
ajlm-2613	169	7	b	b	NOUN
ajlm-2613	169	8	,	,	PUNCT
ajlm-2613	169	9	sun	sun	NOUN
ajlm-2613	169	10	g	g	PROPN
ajlm-2613	169	11	-	-	PUNCT
ajlm-2613	169	12	p.	p.	NOUN
ajlm-2613	169	13	expression	expression	NOUN
ajlm-2613	169	14	of	of	ADP
ajlm-2613	169	15	cox-2	cox-2	NOUN
ajlm-2613	169	16	and	and	CCONJ
ajlm-2613	169	17	her-2	her-2	X
ajlm-2613	169	18	in	in	ADP
ajlm-2613	169	19	colorectal	colorectal	ADJ
ajlm-2613	169	20	cancer	cancer	NOUN
ajlm-2613	169	21	and	and	CCONJ
ajlm-2613	169	22	their	their	PRON
ajlm-2613	169	23	correlation	correlation	NOUN
ajlm-2613	169	24	.	.	PUNCT
ajlm-2613	170	1	world	world	PROPN
ajlm-2613	170	2	j	j	PROPN
ajlm-2613	170	3	gastroenterol	gastroenterol	PROPN
ajlm-2613	170	4	.	.	PUNCT
ajlm-2613	171	1	2015;21(20):6206–6214	2015;21(20):6206–6214	X
ajlm-2613	171	2	.	.	PUNCT
ajlm-2613	172	1	https://doi.org/10.3748/wjg.v21.i20.6206	https://doi.org/10.3748/wjg.v21.i20.6206	ADP
ajlm-2613	172	2	nagtegaal	nagtegaal	NOUN
ajlm-2613	172	3	i	i	PROPN
ajlm-2613	172	4	d	d	PROPN
ajlm-2613	172	5	,	,	PUNCT
ajlm-2613	172	6	arends	arends	PROPN
ajlm-2613	172	7	mj	mj	PROPN
ajlm-2613	172	8	,	,	PUNCT
ajlm-2613	172	9	odze	odze	PROPN
ajlm-2613	172	10	rd	rd	PROPN
ajlm-2613	172	11	,	,	PUNCT
ajlm-2613	172	12	lam	lam	PROPN
ajlm-2613	172	13	ak	ak	PROPN
ajlm-2613	172	14	,	,	PUNCT
ajlm-2613	172	15	editors	editor	NOUN
ajlm-2613	172	16	;	;	PUNCT
ajlm-2613	172	17	world	world	NOUN
ajlm-2613	172	18	health	health	NOUN
ajlm-2613	172	19	organization	organization	NOUN
ajlm-2613	172	20	classification	classification	NOUN
ajlm-2613	172	21	of	of	ADP
ajlm-2613	172	22	tumours	tumours	PROPN
ajlm-2613	172	23	.	.	PUNCT
ajlm-2613	173	1	pathology	pathology	NOUN
ajlm-2613	173	2	and	and	CCONJ
ajlm-2613	173	3	genetics	genetic	NOUN
ajlm-2613	173	4	of	of	ADP
ajlm-2613	173	5	tumours	tumour	NOUN
ajlm-2613	173	6	of	of	ADP
ajlm-2613	173	7	the	the	DET
ajlm-2613	173	8	digestive	digestive	ADJ
ajlm-2613	173	9	system	system	NOUN
ajlm-2613	173	10	.	.	PUNCT
ajlm-2613	174	1	5th	5th	ADJ
ajlm-2613	174	2	ed	ed	NOUN
ajlm-2613	174	3	.	.	PUNCT
ajlm-2613	175	1	lyon	lyon	PROPN
ajlm-2613	175	2	:	:	PUNCT
ajlm-2613	175	3	iarc	iarc	PROPN
ajlm-2613	175	4	press	press	NOUN
ajlm-2613	175	5	,	,	PUNCT
ajlm-2613	175	6	2019	2019	NUM
ajlm-2613	175	7	;	;	PUNCT
ajlm-2613	176	1	p.	p.	PROPN
ajlm-2613	176	2	156–213	156–213	NUM
ajlm-2613	176	3	.	.	PUNCT
ajlm-2613	177	1	soslow	soslow	PROPN
ajlm-2613	177	2	ra	ra	PROPN
ajlm-2613	177	3	,	,	PUNCT
ajlm-2613	177	4	dannenberg	dannenberg	PROPN
ajlm-2613	177	5	aj	aj	PROPN
ajlm-2613	177	6	,	,	PUNCT
ajlm-2613	177	7	rush	rush	NOUN
ajlm-2613	177	8	d	d	PROPN
ajlm-2613	177	9	,	,	PUNCT
ajlm-2613	177	10	et	et	PROPN
ajlm-2613	177	11	al	al	PROPN
ajlm-2613	177	12	.	.	PROPN
ajlm-2613	177	13	cox-2	cox-2	NUM
ajlm-2613	177	14	is	be	AUX
ajlm-2613	177	15	expressed	express	VERB
ajlm-2613	177	16	in	in	ADP
ajlm-2613	177	17	human	human	ADJ
ajlm-2613	177	18	pulmonary	pulmonary	NOUN
ajlm-2613	177	19	,	,	PUNCT
ajlm-2613	177	20	colonic	colonic	ADJ
ajlm-2613	177	21	and	and	CCONJ
ajlm-2613	177	22	mammary	mammary	ADJ
ajlm-2613	177	23	tumors	tumor	NOUN
ajlm-2613	177	24	.	.	PUNCT
ajlm-2613	178	1	cancer	cancer	NOUN
ajlm-2613	178	2	.	.	PUNCT
ajlm-2613	179	1	2000;89:2637–2645	2000;89:2637–2645	NUM
ajlm-2613	179	2	.	.	PUNCT
ajlm-2613	180	1	https://doi.org/10.1002/1097-0142(20001215)89:12<2637::aid-cncr17>3.0.co;2-b	https://doi.org/10.1002/1097-0142(20001215)89:12<2637::aid-cncr17>3.0.co;2-b	PROPN
ajlm-2613	180	2	fedchenko	fedchenko	PROPN
ajlm-2613	180	3	n	n	CCONJ
ajlm-2613	180	4	,	,	PUNCT
ajlm-2613	180	5	reifenrath	reifenrath	PROPN
ajlm-2613	180	6	j.	j.	PROPN
ajlm-2613	180	7	different	different	ADJ
ajlm-2613	180	8	approaches	approach	NOUN
ajlm-2613	180	9	for	for	ADP
ajlm-2613	180	10	interpretation	interpretation	NOUN
ajlm-2613	180	11	and	and	CCONJ
ajlm-2613	180	12	reporting	reporting	NOUN
ajlm-2613	180	13	of	of	ADP
ajlm-2613	180	14	immunohistochemistry	immunohistochemistry	NOUN
ajlm-2613	180	15	analysis	analysis	NOUN
ajlm-2613	180	16	results	result	NOUN
ajlm-2613	180	17	in	in	ADP
ajlm-2613	180	18	the	the	DET
ajlm-2613	180	19	bone	bone	NOUN
ajlm-2613	180	20	tissue	tissue	NOUN
ajlm-2613	180	21	–	–	PUNCT
ajlm-2613	180	22	a	a	DET
ajlm-2613	180	23	review	review	NOUN
ajlm-2613	180	24	.	.	PUNCT
ajlm-2613	181	1	diagn	diagn	NOUN
ajlm-2613	181	2	pathol	pathol	NOUN
ajlm-2613	181	3	.	.	PUNCT
ajlm-2613	182	1	2014;9:221	2014;9:221	NOUN
ajlm-2613	182	2	.	.	PUNCT
ajlm-2613	183	1	https://doi.org/10.1186/s13000-014-0221-9	https://doi.org/10.1186/s13000-014-0221-9	NUM
ajlm-2613	184	1	hong	hong	PROPN
ajlm-2613	184	2	w	w	PROPN
ajlm-2613	184	3	,	,	PUNCT
ajlm-2613	184	4	dong	dong	PROPN
ajlm-2613	184	5	l	l	PROPN
ajlm-2613	184	6	,	,	PUNCT
ajlm-2613	184	7	stock	stock	NOUN
ajlm-2613	184	8	s	s	PROPN
ajlm-2613	184	9	,	,	PUNCT
ajlm-2613	184	10	basharat	basharat	PROPN
ajlm-2613	184	11	z	z	PROPN
ajlm-2613	184	12	,	,	PUNCT
ajlm-2613	184	13	zippi	zippi	PROPN
ajlm-2613	184	14	m	m	PROPN
ajlm-2613	184	15	,	,	PUNCT
ajlm-2613	184	16	zhou	zhou	PROPN
ajlm-2613	184	17	m.	m.	PROPN
ajlm-2613	184	18	prevalence	prevalence	NOUN
ajlm-2613	184	19	and	and	CCONJ
ajlm-2613	184	20	characteristics	characteristic	NOUN
ajlm-2613	184	21	of	of	ADP
ajlm-2613	184	22	colonic	colonic	ADJ
ajlm-2613	184	23	adenoma	adenoma	NOUN
ajlm-2613	184	24	in	in	ADP
ajlm-2613	184	25	mainland	mainland	PROPN
ajlm-2613	184	26	china	china	PROPN
ajlm-2613	184	27	.	.	PUNCT
ajlm-2613	185	1	dovepress	dovepress	NOUN
ajlm-2613	185	2	.	.	PUNCT
ajlm-2613	186	1	2018;10	2018;10	NOUN
ajlm-2613	186	2	:	:	PUNCT
ajlm-2613	187	1	2743–2755	2743–2755	NUM
ajlm-2613	187	2	.	.	PUNCT
ajlm-2613	188	1	https://doi.org/10.2147/cmar.s166186	https://doi.org/10.2147/cmar.s166186	PROPN
ajlm-2613	188	2	nouraie	nouraie	PROPN
ajlm-2613	188	3	m	m	PROPN
ajlm-2613	188	4	,	,	PUNCT
ajlm-2613	188	5	hosseinkhah	hosseinkhah	PROPN
ajlm-2613	188	6	f	f	NOUN
ajlm-2613	188	7	,	,	PUNCT
ajlm-2613	188	8	brim	brim	NOUN
ajlm-2613	188	9	h	h	NOUN
ajlm-2613	188	10	,	,	PUNCT
ajlm-2613	188	11	zamanifekri	zamanifekri	NOUN
ajlm-2613	188	12	b	b	NUM
ajlm-2613	188	13	,	,	PUNCT
ajlm-2613	188	14	smoot	smoot	PROPN
ajlm-2613	188	15	dt	dt	PROPN
ajlm-2613	188	16	,	,	PUNCT
ajlm-2613	188	17	ashktorab	ashktorab	PROPN
ajlm-2613	188	18	h.	h.	PROPN
ajlm-2613	188	19	clinicopathological	clinicopathological	ADJ
ajlm-2613	188	20	features	feature	NOUN
ajlm-2613	188	21	of	of	ADP
ajlm-2613	188	22	colon	colon	NOUN
ajlm-2613	188	23	polyps	polyp	NOUN
ajlm-2613	188	24	from	from	ADP
ajlm-2613	188	25	african	african	PROPN
ajlm-2613	188	26	-	-	PUNCT
ajlm-2613	188	27	americans	americans	PROPN
ajlm-2613	188	28	.	.	PUNCT
ajlm-2613	189	1	dig	dig	VERB
ajlm-2613	189	2	dis	dis	PROPN
ajlm-2613	189	3	sci	sci	PROPN
ajlm-2613	189	4	.	.	PUNCT
ajlm-2613	189	5	2010;55(5):1442–1449	2010;55(5):1442–1449	PROPN
ajlm-2613	189	6	.	.	PUNCT
ajlm-2613	190	1	https://doi.org/10.1007/s10620-010-1133-5	https://doi.org/10.1007/s10620-010-1133-5	PROPN
ajlm-2613	190	2	lim	lim	PROPN
ajlm-2613	190	3	tr	tr	VERB
ajlm-2613	190	4	,	,	PUNCT
ajlm-2613	190	5	mahesh	mahesh	PROPN
ajlm-2613	190	6	v	v	PROPN
ajlm-2613	190	7	,	,	PUNCT
ajlm-2613	190	8	singh	singh	PROPN
ajlm-2613	190	9	s	s	PROPN
ajlm-2613	190	10	,	,	PUNCT
ajlm-2613	190	11	et	et	PROPN
ajlm-2613	190	12	al	al	PROPN
ajlm-2613	190	13	.	.	PROPN
ajlm-2613	190	14	endoscopic	endoscopic	ADJ
ajlm-2613	190	15	mucosal	mucosal	NOUN
ajlm-2613	190	16	resection	resection	NOUN
ajlm-2613	190	17	of	of	ADP
ajlm-2613	190	18	colorectal	colorectal	ADJ
ajlm-2613	190	19	polyps	polyp	NOUN
ajlm-2613	190	20	in	in	ADP
ajlm-2613	190	21	typical	typical	ADJ
ajlm-2613	190	22	uk	uk	PROPN
ajlm-2613	190	23	hospitals	hospital	NOUN
ajlm-2613	190	24	.	.	PUNCT
ajlm-2613	191	1	world	world	PROPN
ajlm-2613	191	2	j	j	PROPN
ajlm-2613	191	3	gastroenterol	gastroenterol	PROPN
ajlm-2613	191	4	.	.	PUNCT
ajlm-2613	192	1	2010;16(42):5324–5328	2010;16(42):5324–5328	NUM
ajlm-2613	192	2	.	.	PUNCT
ajlm-2613	193	1	https://doi.org/10.3748/wjg.v16.i42.5324	https://doi.org/10.3748/wjg.v16.i42.5324	ADJ
ajlm-2613	193	2	ashktorab	ashktorab	NOUN
ajlm-2613	193	3	h	h	NOUN
ajlm-2613	193	4	,	,	PUNCT
ajlm-2613	193	5	paydar	paydar	PROPN
ajlm-2613	193	6	m	m	PROPN
ajlm-2613	193	7	,	,	PUNCT
ajlm-2613	193	8	yazdi	yazdi	PROPN
ajlm-2613	193	9	s	s	PROPN
ajlm-2613	193	10	,	,	PUNCT
ajlm-2613	193	11	et	et	PROPN
ajlm-2613	193	12	al	al	PROPN
ajlm-2613	193	13	.	.	PROPN
ajlm-2613	193	14	bmi	bmi	PROPN
ajlm-2613	193	15	and	and	CCONJ
ajlm-2613	193	16	the	the	DET
ajlm-2613	193	17	risk	risk	NOUN
ajlm-2613	193	18	of	of	ADP
ajlm-2613	193	19	colorectal	colorectal	ADJ
ajlm-2613	193	20	adenoma	adenoma	NOUN
ajlm-2613	193	21	in	in	ADP
ajlm-2613	193	22	african	african	ADJ
ajlm-2613	193	23	americans	americans	PROPN
ajlm-2613	193	24	.	.	PUNCT
ajlm-2613	194	1	obesity	obesity	NOUN
ajlm-2613	194	2	(	(	PUNCT
ajlm-2613	194	3	silver	silver	NOUN
ajlm-2613	194	4	spring	spring	NOUN
ajlm-2613	194	5	)	)	PUNCT
ajlm-2613	194	6	2014;22(5):1387–1391	2014;22(5):1387–1391	PROPN
ajlm-2613	194	7	.	.	PUNCT
ajlm-2613	195	1	https://doi.org/10.1002/oby.20702	https://doi.org/10.1002/oby.20702	PROPN
ajlm-2613	195	2	tchernof	tchernof	PROPN
ajlm-2613	195	3	a	a	PRON
ajlm-2613	195	4	,	,	PUNCT
ajlm-2613	195	5	després	després	PROPN
ajlm-2613	195	6	j	j	PROPN
ajlm-2613	195	7	-	-	PROPN
ajlm-2613	195	8	p.	p.	PROPN
ajlm-2613	195	9	pathophysiology	pathophysiology	NOUN
ajlm-2613	195	10	of	of	ADP
ajlm-2613	195	11	human	human	ADJ
ajlm-2613	195	12	visceral	visceral	ADJ
ajlm-2613	195	13	obesity	obesity	NOUN
ajlm-2613	195	14	:	:	PUNCT
ajlm-2613	195	15	an	an	DET
ajlm-2613	195	16	update	update	NOUN
ajlm-2613	195	17	.	.	PUNCT
ajlm-2613	196	1	physiol	physiol	PROPN
ajlm-2613	196	2	rev	rev	VERB
ajlm-2613	196	3	.	.	PUNCT
ajlm-2613	196	4	2013;93(1):359–404	2013;93(1):359–404	NOUN
ajlm-2613	196	5	.	.	PUNCT
ajlm-2613	197	1	https://doi.org/10.1152/physrev.00033.2011	https://doi.org/10.1152/physrev.00033.2011	PROPN
ajlm-2613	197	2	bassett	bassett	PROPN
ajlm-2613	197	3	jk	jk	PROPN
ajlm-2613	197	4	,	,	PUNCT
ajlm-2613	197	5	severi	severi	NOUN
ajlm-2613	197	6	g	g	PROPN
ajlm-2613	197	7	,	,	PUNCT
ajlm-2613	197	8	english	english	PROPN
ajlm-2613	197	9	dr	dr	PROPN
ajlm-2613	197	10	,	,	PUNCT
ajlm-2613	197	11	et	et	PROPN
ajlm-2613	197	12	al	al	PROPN
ajlm-2613	197	13	.	.	PROPN
ajlm-2613	197	14	body	body	NOUN
ajlm-2613	197	15	size	size	NOUN
ajlm-2613	197	16	,	,	PUNCT
ajlm-2613	197	17	weight	weight	NOUN
ajlm-2613	197	18	change	change	NOUN
ajlm-2613	197	19	,	,	PUNCT
ajlm-2613	197	20	and	and	CCONJ
ajlm-2613	197	21	risk	risk	NOUN
ajlm-2613	197	22	of	of	ADP
ajlm-2613	197	23	colon	colon	NOUN
ajlm-2613	197	24	cancer	cancer	NOUN
ajlm-2613	197	25	.	.	PUNCT
ajlm-2613	198	1	cancer	cancer	NOUN
ajlm-2613	198	2	epidemiol	epidemiol	PROPN
ajlm-2613	198	3	biomark	biomark	PROPN
ajlm-2613	198	4	prev	prev	PROPN
ajlm-2613	198	5	.	.	PUNCT
ajlm-2613	199	1	2010;19(11):2978–2986	2010;19(11):2978–2986	NUM
ajlm-2613	199	2	.	.	PUNCT
ajlm-2613	200	1	https://doi.org/10.1158/1055-9965.epi-10-0543	https://doi.org/10.1158/1055-9965.epi-10-0543	PROPN
ajlm-2613	200	2	chang	chang	PROPN
ajlm-2613	200	3	lc	lc	PROPN
ajlm-2613	200	4	,	,	PUNCT
ajlm-2613	200	5	wu	wu	PROPN
ajlm-2613	200	6	ms	ms	PROPN
ajlm-2613	200	7	,	,	PUNCT
ajlm-2613	200	8	tu	tu	PROPN
ajlm-2613	200	9	ch	ch	PROPN
ajlm-2613	200	10	,	,	PUNCT
ajlm-2613	200	11	lee	lee	PROPN
ajlm-2613	200	12	yc	yc	PROPN
ajlm-2613	200	13	,	,	PUNCT
ajlm-2613	200	14	shun	shun	PROPN
ajlm-2613	200	15	ct	ct	PROPN
ajlm-2613	200	16	,	,	PUNCT
ajlm-2613	200	17	chiu	chiu	PROPN
ajlm-2613	200	18	hm	hm	PROPN
ajlm-2613	200	19	.	.	PUNCT
ajlm-2613	200	20	metabolic	metabolic	PROPN
ajlm-2613	200	21	syndrome	syndrome	NOUN
ajlm-2613	200	22	and	and	CCONJ
ajlm-2613	200	23	smoking	smoking	NOUN
ajlm-2613	200	24	may	may	AUX
ajlm-2613	200	25	justify	justify	VERB
ajlm-2613	200	26	earlier	early	ADJ
ajlm-2613	200	27	colorectal	colorectal	ADJ
ajlm-2613	200	28	cancer	cancer	NOUN
ajlm-2613	200	29	screening	screening	NOUN
ajlm-2613	200	30	in	in	ADP
ajlm-2613	200	31	men	man	NOUN
ajlm-2613	200	32	.	.	PUNCT
ajlm-2613	201	1	gastrointest	gastrointest	ADJ
ajlm-2613	201	2	endosc	endosc	PROPN
ajlm-2613	201	3	.	.	PUNCT
ajlm-2613	202	1	2014;79(6):961–969	2014;79(6):961–969	X
ajlm-2613	202	2	.	.	PUNCT
ajlm-2613	202	3	https://doi.org/10.1016/j.gie.2013.11.035	https://doi.org/10.1016/j.gie.2013.11.035	PROPN
ajlm-2613	202	4	bates	bates	PROPN
ajlm-2613	202	5	b	b	PROPN
ajlm-2613	202	6	,	,	PUNCT
ajlm-2613	202	7	cox	cox	PROPN
ajlm-2613	202	8	l	l	PROPN
ajlm-2613	202	9	,	,	PUNCT
ajlm-2613	202	10	nicholson	nicholson	PROPN
ajlm-2613	202	11	s	s	PROPN
ajlm-2613	202	12	,	,	PUNCT
ajlm-2613	202	13	et	et	PROPN
ajlm-2613	202	14	al	al	PROPN
ajlm-2613	202	15	.	.	PUNCT
ajlm-2613	202	16	national	national	PROPN
ajlm-2613	202	17	diet	diet	PROPN
ajlm-2613	202	18	and	and	CCONJ
ajlm-2613	202	19	nutrition	nutrition	NOUN
ajlm-2613	202	20	survey	survey	NOUN
ajlm-2613	202	21	:	:	PUNCT
ajlm-2613	202	22	results	result	NOUN
ajlm-2613	202	23	from	from	ADP
ajlm-2613	202	24	years	year	NOUN
ajlm-2613	202	25	5	5	NUM
ajlm-2613	202	26	and	and	CCONJ
ajlm-2613	202	27	6	6	NUM
ajlm-2613	202	28	(	(	PUNCT
ajlm-2613	202	29	combined	combine	VERB
ajlm-2613	202	30	)	)	PUNCT
ajlm-2613	202	31	of	of	ADP
ajlm-2613	202	32	the	the	DET
ajlm-2613	202	33	rolling	rolling	ADJ
ajlm-2613	202	34	programme	programme	NOUN
ajlm-2613	202	35	(	(	PUNCT
ajlm-2613	202	36	2012/2013–2013/2014	2012/2013–2013/2014	NUM
ajlm-2613	202	37	)	)	PUNCT
ajlm-2613	202	38	.	.	PUNCT
ajlm-2613	203	1	london	london	PROPN
ajlm-2613	203	2	:	:	PUNCT
ajlm-2613	203	3	public	public	PROPN
ajlm-2613	203	4	health	health	PROPN
ajlm-2613	203	5	england	england	PROPN
ajlm-2613	203	6	;	;	PUNCT
ajlm-2613	203	7	2016	2016	NUM
ajlm-2613	203	8	.	.	PUNCT
ajlm-2613	204	1	kitamura	kitamura	PROPN
ajlm-2613	204	2	t	t	PROPN
ajlm-2613	204	3	,	,	PUNCT
ajlm-2613	204	4	itoh	itoh	PROPN
ajlm-2613	204	5	m	m	PROPN
ajlm-2613	204	6	,	,	PUNCT
ajlm-2613	204	7	noda	noda	PROPN
ajlm-2613	204	8	t	t	PROPN
ajlm-2613	204	9	,	,	PUNCT
ajlm-2613	204	10	et	et	PROPN
ajlm-2613	204	11	al	al	PROPN
ajlm-2613	204	12	.	.	PROPN
ajlm-2613	204	13	combined	combine	VERB
ajlm-2613	204	14	effects	effect	NOUN
ajlm-2613	204	15	of	of	ADP
ajlm-2613	204	16	prostaglandin	prostaglandin	ADJ
ajlm-2613	204	17	e	e	NOUN
ajlm-2613	204	18	receptor	receptor	NOUN
ajlm-2613	204	19	subtype	subtype	NOUN
ajlm-2613	204	20	ep1	ep1	NOUN
ajlm-2613	204	21	and	and	CCONJ
ajlm-2613	204	22	subtype	subtype	VERB
ajlm-2613	204	23	ep4	ep4	NOUN
ajlm-2613	204	24	antagonists	antagonist	NOUN
ajlm-2613	204	25	on	on	ADP
ajlm-2613	204	26	intestinal	intestinal	ADJ
ajlm-2613	204	27	tumorigenesis	tumorigenesis	NOUN
ajlm-2613	204	28	in	in	ADP
ajlm-2613	204	29	adenomatous	adenomatous	ADJ
ajlm-2613	204	30	polyposis	polyposis	NOUN
ajlm-2613	204	31	coli	coli	NOUN
ajlm-2613	204	32	gene	gene	NOUN
ajlm-2613	204	33	knockout	knockout	NOUN
ajlm-2613	204	34	mice	mouse	NOUN
ajlm-2613	204	35	.	.	PUNCT
ajlm-2613	205	1	cancer	cancer	PROPN
ajlm-2613	205	2	sci	sci	PROPN
ajlm-2613	205	3	.	.	PUNCT
ajlm-2613	205	4	2003;94(7):618–621	2003;94(7):618–621	NUM
ajlm-2613	205	5	.	.	PUNCT
ajlm-2613	206	1	https://doi.org/10.1111/j.1349-7006.2003.tb01492.x	https://doi.org/10.1111/j.1349-7006.2003.tb01492.x	PROPN
ajlm-2613	206	2	fukuda	fukuda	PROPN
ajlm-2613	206	3	r	r	PROPN
ajlm-2613	206	4	,	,	PUNCT
ajlm-2613	206	5	kelly	kelly	PROPN
ajlm-2613	206	6	b	b	PROPN
ajlm-2613	206	7	,	,	PUNCT
ajlm-2613	206	8	semenza	semenza	PROPN
ajlm-2613	206	9	gl	gl	PROPN
ajlm-2613	206	10	.	.	PROPN
ajlm-2613	206	11	vascular	vascular	ADJ
ajlm-2613	206	12	endothelial	endothelial	ADJ
ajlm-2613	206	13	growth	growth	NOUN
ajlm-2613	206	14	factor	factor	NOUN
ajlm-2613	206	15	gene	gene	NOUN
ajlm-2613	206	16	expression	expression	NOUN
ajlm-2613	206	17	in	in	ADP
ajlm-2613	206	18	colon	colon	NOUN
ajlm-2613	206	19	cancer	cancer	NOUN
ajlm-2613	206	20	cells	cell	NOUN
ajlm-2613	206	21	exposed	expose	VERB
ajlm-2613	206	22	to	to	ADP
ajlm-2613	206	23	prostaglandin	prostaglandin	NOUN
ajlm-2613	206	24	e2	e2	PROPN
ajlm-2613	206	25	is	be	AUX
ajlm-2613	206	26	mediated	mediate	VERB
ajlm-2613	206	27	by	by	ADP
ajlm-2613	206	28	hypoxia	hypoxia	NOUN
ajlm-2613	206	29	-	-	PUNCT
ajlm-2613	206	30	inducible	inducible	ADJ
ajlm-2613	206	31	factor	factor	NOUN
ajlm-2613	206	32	1	1	NUM
ajlm-2613	206	33	.	.	PUNCT
ajlm-2613	207	1	cancer	cancer	NOUN
ajlm-2613	207	2	res	re	NOUN
ajlm-2613	207	3	.	.	PUNCT
ajlm-2613	208	1	2003;63:2330–2334	2003;63:2330–2334	NUM
ajlm-2613	208	2	.	.	PUNCT
ajlm-2613	209	1	sato	sato	PROPN
ajlm-2613	209	2	t	t	PROPN
ajlm-2613	209	3	,	,	PUNCT
ajlm-2613	209	4	yoshinaga	yoshinaga	PROPN
ajlm-2613	209	5	k	k	NOUN
ajlm-2613	209	6	,	,	PUNCT
ajlm-2613	209	7	okabe	okabe	ADP
ajlm-2613	209	8	s	s	PART
ajlm-2613	209	9	,	,	PUNCT
ajlm-2613	209	10	et	et	PROPN
ajlm-2613	209	11	al	al	PROPN
ajlm-2613	209	12	.	.	PUNCT
ajlm-2613	209	13	cyclooxygenase-2	cyclooxygenase-2	NUM
ajlm-2613	209	14	expression	expression	NOUN
ajlm-2613	209	15	and	and	CCONJ
ajlm-2613	209	16	its	its	PRON
ajlm-2613	209	17	relationship	relationship	NOUN
ajlm-2613	209	18	with	with	ADP
ajlm-2613	209	19	proliferation	proliferation	NOUN
ajlm-2613	209	20	of	of	ADP
ajlm-2613	209	21	colorectal	colorectal	ADJ
ajlm-2613	209	22	adenomas	adenoma	NOUN
ajlm-2613	209	23	.	.	PUNCT
ajlm-2613	210	1	jpn	jpn	PROPN
ajlm-2613	210	2	j	j	PROPN
ajlm-2613	210	3	clin	clin	PROPN
ajlm-2613	210	4	oncol	oncol	PROPN
ajlm-2613	210	5	.	.	PUNCT
ajlm-2613	211	1	2003;33(12)631–635	2003;33(12)631–635	NUM
ajlm-2613	211	2	.	.	PUNCT
ajlm-2613	211	3	https://doi.org/10.1093/jjco/hyg114	https://doi.org/10.1093/jjco/hyg114	NOUN
ajlm-2613	211	4	elder	elder	NOUN
ajlm-2613	211	5	dj	dj	PROPN
ajlm-2613	211	6	,	,	PUNCT
ajlm-2613	211	7	baker	baker	PROPN
ajlm-2613	211	8	ja	ja	PROPN
ajlm-2613	211	9	,	,	PUNCT
ajlm-2613	211	10	banu	banu	PROPN
ajlm-2613	211	11	na	na	PROPN
ajlm-2613	211	12	,	,	PUNCT
ajlm-2613	211	13	moorghen	moorghen	PROPN
ajlm-2613	211	14	m	m	PROPN
ajlm-2613	211	15	,	,	PUNCT
ajlm-2613	211	16	paraskeva	paraskeva	PROPN
ajlm-2613	211	17	c.	c.	PROPN
ajlm-2613	211	18	human	human	ADJ
ajlm-2613	211	19	colorectal	colorectal	ADJ
ajlm-2613	211	20	adenomas	adenoma	NOUN
ajlm-2613	211	21	demonstrate	demonstrate	VERB
ajlm-2613	211	22	a	a	DET
ajlm-2613	211	23	size	size	NOUN
ajlm-2613	211	24	-	-	PUNCT
ajlm-2613	211	25	dependent	dependent	ADJ
ajlm-2613	211	26	increase	increase	NOUN
ajlm-2613	211	27	in	in	ADP
ajlm-2613	211	28	epithelial	epithelial	ADJ
ajlm-2613	211	29	cyclooxygenase-2	cyclooxygenase-2	NUM
ajlm-2613	211	30	expression	expression	NOUN
ajlm-2613	211	31	.	.	PUNCT
ajlm-2613	212	1	j	j	PROPN
ajlm-2613	212	2	pathol	pathol	NOUN
ajlm-2613	212	3	.	.	PUNCT
ajlm-2613	213	1	2002;198(4):428–434	2002;198(4):428–434	NUM
ajlm-2613	213	2	.	.	PUNCT
ajlm-2613	214	1	https://doi.org/10.1002/path.1232	https://doi.org/10.1002/path.1232	PROPN
ajlm-2613	214	2	watanabe	watanabe	PROPN
ajlm-2613	214	3	k	k	PROPN
ajlm-2613	214	4	,	,	PUNCT
ajlm-2613	214	5	kawamori	kawamori	X
ajlm-2613	214	6	t	t	PROPN
ajlm-2613	214	7	,	,	PUNCT
ajlm-2613	214	8	nakatsugi	nakatsugi	NOUN
ajlm-2613	214	9	s	s	PROPN
ajlm-2613	214	10	,	,	PUNCT
ajlm-2613	214	11	et	et	PROPN
ajlm-2613	214	12	al	al	PROPN
ajlm-2613	214	13	.	.	PROPN
ajlm-2613	215	1	inhibitory	inhibitory	ADJ
ajlm-2613	215	2	effect	effect	NOUN
ajlm-2613	215	3	of	of	ADP
ajlm-2613	215	4	a	a	DET
ajlm-2613	215	5	prostaglandin	prostaglandin	NOUN
ajlm-2613	215	6	e	e	NOUN
ajlm-2613	215	7	receptor	receptor	NOUN
ajlm-2613	215	8	subtype	subtype	NOUN
ajlm-2613	215	9	ep1	ep1	VERB
ajlm-2613	215	10	selective	selective	ADJ
ajlm-2613	215	11	antagonist	antagonist	NOUN
ajlm-2613	215	12	,	,	PUNCT
ajlm-2613	215	13	ono-8713	ono-8713	NOUN
ajlm-2613	215	14	,	,	PUNCT
ajlm-2613	215	15	on	on	ADP
ajlm-2613	215	16	development	development	NOUN
ajlm-2613	215	17	of	of	ADP
ajlm-2613	215	18	azoxymethane	azoxymethane	ADV
ajlm-2613	215	19	-	-	PUNCT
ajlm-2613	215	20	induced	induce	VERB
ajlm-2613	215	21	aberrant	aberrant	ADJ
ajlm-2613	215	22	crypt	crypt	NOUN
ajlm-2613	215	23	foci	focus	NOUN
ajlm-2613	215	24	in	in	ADP
ajlm-2613	215	25	mice	mouse	NOUN
ajlm-2613	215	26	.	.	PUNCT
ajlm-2613	216	1	cancer	cancer	NOUN
ajlm-2613	216	2	lett	lett	PROPN
ajlm-2613	216	3	.	.	PUNCT
ajlm-2613	217	1	2000;156(1):57–61	2000;156(1):57–61	X
ajlm-2613	217	2	.	.	PUNCT
ajlm-2613	217	3	https://doi.org/10.1016/s0304-3835(00)00440-7	https://doi.org/10.1016/s0304-3835(00)00440-7	PROPN
ajlm-2613	217	4	kotani	kotani	PROPN
ajlm-2613	217	5	m	m	PROPN
ajlm-2613	217	6	,	,	PUNCT
ajlm-2613	217	7	tanaka	tanaka	PROPN
ajlm-2613	217	8	i	i	PRON
ajlm-2613	217	9	,	,	PUNCT
ajlm-2613	217	10	ogawa	ogawa	PROPN
ajlm-2613	217	11	y	y	PROPN
ajlm-2613	217	12	,	,	PUNCT
ajlm-2613	217	13	et	et	PROPN
ajlm-2613	217	14	al	al	PROPN
ajlm-2613	217	15	.	.	PROPN
ajlm-2613	218	1	structural	structural	ADJ
ajlm-2613	218	2	organization	organization	NOUN
ajlm-2613	218	3	of	of	ADP
ajlm-2613	218	4	the	the	DET
ajlm-2613	218	5	human	human	ADJ
ajlm-2613	218	6	prostaglandin	prostaglandin	NOUN
ajlm-2613	218	7	ep3	ep3	NOUN
ajlm-2613	218	8	receptor	receptor	NOUN
ajlm-2613	218	9	subtype	subtype	NOUN
ajlm-2613	218	10	gene	gene	NOUN
ajlm-2613	218	11	(	(	PUNCT
ajlm-2613	218	12	ptger3	ptger3	NOUN
ajlm-2613	218	13	)	)	PUNCT
ajlm-2613	218	14	.	.	PUNCT
ajlm-2613	219	1	genomics	genomic	NOUN
ajlm-2613	219	2	.	.	PUNCT
ajlm-2613	220	1	1997;40(3):425–434	1997;40(3):425–434	X
ajlm-2613	220	2	.	.	PUNCT
ajlm-2613	221	1	https://doi.org/10.1006/geno.1996.4585	https://doi.org/10.1006/geno.1996.4585	PROPN
ajlm-2613	221	2	aoki	aoki	PROPN
ajlm-2613	221	3	t	t	PROPN
ajlm-2613	221	4	,	,	PUNCT
ajlm-2613	221	5	narumiya	narumiya	PROPN
ajlm-2613	221	6	s.	s.	PROPN
ajlm-2613	221	7	prostaglandin	prostaglandin	PROPN
ajlm-2613	221	8	e2	e2	PROPN
ajlm-2613	221	9	-	-	PUNCT
ajlm-2613	221	10	ep2	ep2	NOUN
ajlm-2613	221	11	signaling	signal	VERB
ajlm-2613	221	12	as	as	ADP
ajlm-2613	221	13	a	a	DET
ajlm-2613	221	14	node	node	NOUN
ajlm-2613	221	15	of	of	ADP
ajlm-2613	221	16	chronic	chronic	ADJ
ajlm-2613	221	17	inflammation	inflammation	NOUN
ajlm-2613	221	18	in	in	ADP
ajlm-2613	221	19	the	the	DET
ajlm-2613	221	20	colon	colon	NOUN
ajlm-2613	221	21	tumor	tumor	NOUN
ajlm-2613	221	22	microenvironment	microenvironment	NOUN
ajlm-2613	221	23	.	.	PUNCT
ajlm-2613	222	1	inflamm	inflamm	PROPN
ajlm-2613	222	2	.	.	PUNCT
ajlm-2613	223	1	regen	regen	PROPN
ajlm-2613	223	2	.	.	PUNCT
ajlm-2613	224	1	2017;37:4	2017;37:4	NUM
ajlm-2613	224	2	.	.	PUNCT
ajlm-2613	224	3	https://doi.org/10.1186/s41232-017-0036-7	https://doi.org/10.1186/s41232-017-0036-7	PROPN
ajlm-2613	224	4	bamba	bamba	PROPN
ajlm-2613	224	5	h	h	PROPN
ajlm-2613	224	6	,	,	PUNCT
ajlm-2613	224	7	ota	ota	PROPN
ajlm-2613	224	8	s	s	PROPN
ajlm-2613	224	9	,	,	PUNCT
ajlm-2613	224	10	kato	kato	PROPN
ajlm-2613	224	11	a	a	X
ajlm-2613	224	12	,	,	PUNCT
ajlm-2613	224	13	adachi	adachi	PROPN
ajlm-2613	224	14	a	a	X
ajlm-2613	224	15	,	,	PUNCT
ajlm-2613	224	16	itoyama	itoyama	NOUN
ajlm-2613	224	17	s	s	PROPN
ajlm-2613	224	18	,	,	PUNCT
ajlm-2613	224	19	matsuzaki	matsuzaki	PROPN
ajlm-2613	224	20	f.	f.	PROPN
ajlm-2613	224	21	high	high	ADJ
ajlm-2613	224	22	expression	expression	NOUN
ajlm-2613	224	23	of	of	ADP
ajlm-2613	224	24	cyclooxygenase-2	cyclooxygenase-2	NUM
ajlm-2613	224	25	in	in	ADP
ajlm-2613	224	26	macrophages	macrophage	NOUN
ajlm-2613	224	27	of	of	ADP
ajlm-2613	224	28	human	human	ADJ
ajlm-2613	224	29	colonic	colonic	NOUN
ajlm-2613	224	30	adenoma	adenoma	NOUN
ajlm-2613	224	31	.	.	PUNCT
ajlm-2613	225	1	jpn	jpn	PROPN
ajlm-2613	225	2	int	int	PROPN
ajlm-2613	225	3	j	j	PROPN
ajlm-2613	225	4	cancer	cancer	NOUN
ajlm-2613	225	5	.	.	PUNCT
ajlm-2613	226	1	1999;83(4):470–475	1999;83(4):470–475	X
ajlm-2613	226	2	.	.	PUNCT
ajlm-2613	227	1	https://doi.org/10.1002/(sici)1097-0215(19991112)83:4<470::aid-ijc6>3.0.co;2-f	https://doi.org/10.1002/(sici)1097-0215(19991112)83:4<470::aid-ijc6>3.0.co;2-f	PROPN
ajlm-2613	227	2	dimberg	dimberg	PROPN
ajlm-2613	227	3	j	j	PROPN
ajlm-2613	227	4	,	,	PUNCT
ajlm-2613	227	5	hugander	hugander	PROPN
ajlm-2613	227	6	a	a	NOUN
ajlm-2613	227	7	,	,	PUNCT
ajlm-2613	227	8	sirsjo	sirsjo	VERB
ajlm-2613	227	9	a	a	DET
ajlm-2613	227	10	,	,	PUNCT
ajlm-2613	227	11	soderkvist	soderkvist	PROPN
ajlm-2613	227	12	p.	p.	NOUN
ajlm-2613	227	13	enhanced	enhance	VERB
ajlm-2613	227	14	expression	expression	NOUN
ajlm-2613	227	15	of	of	ADP
ajlm-2613	227	16	cyclooxygenase-2	cyclooxygenase-2	NUM
ajlm-2613	227	17	and	and	CCONJ
ajlm-2613	227	18	nuclear	nuclear	ADJ
ajlm-2613	227	19	beta	beta	NOUN
ajlm-2613	227	20	-	-	PUNCT
ajlm-2613	227	21	catenin	catenin	NOUN
ajlm-2613	227	22	are	be	AUX
ajlm-2613	227	23	related	relate	VERB
ajlm-2613	227	24	to	to	ADP
ajlm-2613	227	25	mutations	mutation	NOUN
ajlm-2613	227	26	in	in	ADP
ajlm-2613	227	27	the	the	DET
ajlm-2613	227	28	apc	apc	PROPN
ajlm-2613	227	29	gene	gene	NOUN
ajlm-2613	227	30	in	in	ADP
ajlm-2613	227	31	human	human	ADJ
ajlm-2613	227	32	colorectal	colorectal	ADJ
ajlm-2613	227	33	cancer	cancer	NOUN
ajlm-2613	227	34	.	.	PUNCT
ajlm-2613	228	1	anticancer	anticancer	NOUN
ajlm-2613	228	2	res	re	NOUN
ajlm-2613	228	3	.	.	PUNCT
ajlm-2613	229	1	2001;21(2a):911–915	2001;21(2a):911–915	NUM
ajlm-2613	229	2	.	.	X
ajlm-2613	229	3	fujita	fujita	PROPN
ajlm-2613	229	4	m	m	PROPN
ajlm-2613	229	5	,	,	PUNCT
ajlm-2613	229	6	fukui	fukui	PROPN
ajlm-2613	229	7	h	h	PROPN
ajlm-2613	229	8	,	,	PUNCT
ajlm-2613	229	9	kusaka	kusaka	PROPN
ajlm-2613	229	10	t	t	PROPN
ajlm-2613	229	11	,	,	PUNCT
ajlm-2613	229	12	et	et	PROPN
ajlm-2613	229	13	al	al	PROPN
ajlm-2613	229	14	.	.	PROPN
ajlm-2613	229	15	relationship	relationship	NOUN
ajlm-2613	229	16	between	between	ADP
ajlm-2613	229	17	cyclooxygenase-2	cyclooxygenase-2	NUM
ajlm-2613	229	18	expression	expression	NOUN
ajlm-2613	229	19	and	and	CCONJ
ajlm-2613	229	20	k	k	NOUN
ajlm-2613	229	21	-	-	PUNCT
ajlm-2613	229	22	ras	ra	VERB
ajlm-2613	229	23	gene	gene	NOUN
ajlm-2613	229	24	mutation	mutation	NOUN
ajlm-2613	229	25	in	in	ADP
ajlm-2613	229	26	colorectal	colorectal	ADJ
ajlm-2613	229	27	adenomas	adenoma	NOUN
ajlm-2613	229	28	.	.	PUNCT
ajlm-2613	230	1	j	j	PROPN
ajlm-2613	230	2	gastroenterol	gastroenterol	NOUN
ajlm-2613	230	3	hepatol	hepatol	ADJ
ajlm-2613	230	4	.	.	PUNCT
ajlm-2613	231	1	2000;15(11):1277–1281	2000;15(11):1277–1281	X
ajlm-2613	231	2	.	.	PUNCT